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Introduction and aims of the study 
Introduction 
3 
The first decade of the 21st century has been labelled by the United Nations and 
the World Health Organization as the Bone and Joint Decade.1 Musculoskeletal 
diseases strike persons at all ages and across all socio-economic groups. They 
affect earnings and income during younger ages, as well as functioning and quality 
of life at older ages. During a survey in 1998, almost three-quarter of the Dutch 
population aged 25 years and over reported some form of musculoskeletal pain 
during the previous 12 months.2 In the Netherlands, musculoskeletal diseases are 
the third most costly diagnosis presenting in primary care and cost the Dutch 
economy yearly about €2.000 million, equivalent to about €125 per person.3 
 
Understanding the factors involved in the cause and course of specific 
musculoskeletal diseases is important and can provide valuable insights into the 
optimal way of managing these diseases. 
 
Osteoarthritis 
An important musculoskeletal disease is osteoarthritis (OA). OA is a chronic, 
degenerative disorder of multifactorial aetiology, characterised by loss of articular 
cartilage, periarticular bone remodelling and soft tissue changes. The process is 
clinically characterized by pain of the affected joint, (morning) stiffness, and a 
reduction of function. The prevalence, risk factors, clinical manifestations and 
prognosis vary according to the localisation; for example, the hip, knee and/or 
generalised OA. Since OA is a disease whose prevalence increases with age, it 
will become even more prevalent in the future as the cohort of ‘baby boomers’ 
grows older. It is expected that between 2000 and 2020, the number of persons 
suffering from OA will increase by 38%.4 Within the total costs for musculoskeletal 
diseases, OA (with €300 million) accounts for the largest part. 
In the present study we chose to focus on the hip, because hip OA is a disease 
causing much pain and disability and, compared to the knee, very little is known 
about its aetiology and prognosis. In a recent Dutch study, almost 10% of the 
population aged 55 years and over, developed radiological signs of hip OA during 
a mean follow-up period of 6.6 years.5 In another survey, almost 13% of the study 
population aged 25 years and over, reported hip pain during the previous 12 
months.2 
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Preventing or delaying the onset of OA could involve lifestyle changes that may 
prevent clinical problems, including musculoskeletal disability. In order to live a 
longer life happier, we need to delay the onset of hip OA and diminish its vigour. 
Therefore, more studies are needed to improve our understanding of the 
epidemiology of hip OA and to elucidate which factors predispose to the cause 
and course of this disorder. 
 
Trochanteric pain 
Of all patients presenting with hip pain in primary care, 10-20% can be attributed 
to trochanteric pain.6 Patients with this syndrome (also known as trochanteric 
bursitis or greater trochanter pain syndrome), suffer from pain at the lateral side of 
the upper thigh, often with radiation to the knee.7 Although this pain syndrome has 
been attributed to an inflammation of the bursa that covers the part of the greater 
trochanter, sonographic effusion of the bursa was seldom found. Moreover, 
effusion around the trochanteric tendons was more often present than in other 
patients with hip pain.8 
Up to now, scientific research on its incidence and on the prognosis is relatively 
scarce. More knowledge of this syndrome in primary care is needed in order to 
give the patient accurate information about the disease course and to provide the 
patient with the most optimal treatment. 
 
Aim of this thesis 
The main aim of the work in this thesis is to identify variables involved in the cause 
and course of hip pain in patients presenting in primary care.  
In the first part of the thesis our goal is to systematically summarize all available 
literature reporting on the relationship between the occurrence of hip OA and 
obesity, occupational activities, sporting activities and hip dysplasia, as well as on 
the prognosis of hip OA. 
In the second part, we will report on the prognosis of two of the main patient 
groups presenting with hip pain in general practice, namely osteoarthritis of the hip 
and trochanteric pain. 
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Influence of obesity on the development  
of osteoarthritis of the hip: 
a systematic review 
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Abstract 
Objective: To evaluate the evidence for the influence of obesity as a risk factor for 
the occurrence of osteoarthritis (OA) of the hip. 
Methods: A bibliographical search of Medline, Embase and the Cochrane library 
until April 2000 was carried out. Articles describing studies of the relationship 
between obesity and the occurrence of hip OA were selected. The quality of the 
studies was assessed with a standardized set of criteria. The outcome of the 
studies was compared with respect to study characteristics and the quality score 
for the studies. A best evidence synthesis was used to summarize the results of 
the individual studies. 
Results: Five longitudinal and 7 cross-sectional studies were included in this 
review. There was no association between outcome and study design or 
methodological quality. The associations between obesity and hip OA were, 
however, stronger in studies in which the diagnosis hip OA was based not only on 
radiological criteria, but on clinical symptoms as well. Overall, moderate evidence 
was found for a positive association between obesity and the occurrence of hip 
OA, with an OR of approximately 2. 
Conclusion: The evidence for a positive influence of obesity on the development 
of hip OA is moderate. 
 
Rheumatology 2002; 41(10): 1155-62. 
Review obesity and hip OA 
11 
Introduction 
Osteoarthritis (OA) of the hip is a major cause of morbidity and disability in the 
elderly. This problem increases with the current ageing of the population in 
western societies. In addition to the pain and discomfort it causes, OA has major 
economic consequences1. Studies in Europe have estimated that approximately 7-
25% of Caucasian individuals over the age of 55 years suffer from hip OA; these 
estimates vary due to differences in the definition of OA or the selection of the 
study population. The prevalence of hip OA appears to be lowest in Asians, 
followed by African black and Native American populations, and is highest in white 
Europeans.2-5 Over the last two decades many epidemiological studies have 
investigated the determinants of OA. These studies are important to improve our 
understanding of the mechanisms leading to OA and to determine whether 
(modifiable) risk factors exist for which preventive interventions can be developed 
and investigated. 
A frequently studied object of interest is weight, or body mass index (BMI) and its 
relationship with OA. A review published in 1988 showed that people with a higher 
BMI are more prone to the development of knee OA. However, due to sparse data 
and inconsistencies in the reported studies, the impact of obesity on hip OA was 
less clear.2 
Since several new studies investigating the relationship between hip OA and 
obesity have been published, we decided to investigate this topic using modern 
methods for systematically identifying and assessing the available studies. The 
result may be of considerable practical and theoretical importance for the 
management of this disease, including preventive measures. 
 
Methods 
Identification and selection of the literature 
To identify observational studies on this subject, relevant publications were 
searched using the following databases: Medline (1966 to April 2000), Cochrane 
library (1993 to April 2000) and EMBASE (1980 to April 2000). The following 
keywords were used: (hip and (arthritis or arthrosis or osteoarthritis or 
osteoarthrosis) or coxarthrosis) and (risk factor or causative or determinants or 
predictor or etiology) and (case-control or retrospective or prospective or 
Chapter 2 
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longitudinal or follow up or cohort). (A detailed list can be obtained from the 
corresponding author.) We optimized the search strategy by looking at the 
specificity and sensitivity of the different strategies. We tried to be as sensitive as 
possible within the bounds of feasibility, because of difficulty in finding the right key 
words and the different types of design. The search was extended by screening 
the reference lists of all relevant articles identified. 
A study was eligible for inclusion if it fulfilled all of the following criteria: 1) one of 
the aims of the study was to investigate an association between hip OA and 
obesity, 2) the articles were written in English, Dutch, German, French, Danish, 
Norwegian or Swedish, 3) the article was a full text article, 4) the patients in the 
studies had to suffer from radiological and/or clinical hip OA, a (total) hip 
replacement, or were on the waiting list for one, and 5) the study design was a 
cohort, a case-control, or a cross-sectional study. 
A study was excluded if the studied population had a specific underlying 
pathology, such as trauma (fractures), infection, rheumatoid arthritis, ankylosing 
spondylitis, Perthes' disease, tuberculosis, hemochromatosis, sickle cell disease, 
Cushing's disease, or femoral head necrosis. 
 
Publication bias 
Identification of all relevant articles is crucial to the validity of a systematic review.6 
The amount of potential publication bias in our study was analysed by means of a 
funnel plot, in which the study outcome was plotted against the sample size of the 
study. In the absence of publication bias, the plot will resemble a symmetrical 
inverted funnel.7 Because of the small number of included studies, and the lack of 
the required data, we could not perform a test for symmetry, so we visually 
examined the funnel plot for symmetry. 
 
Methodological quality assessment 
The methodological quality of observational studies can vary considerably, which 
may influence the results and conclusions of the studies at issue and consequently 
also the results and conclusions of a systematic review. Therefore, the quality of 
each included paper was assessed using the following method. 
Two reviewers (AML and SMABZ) independently scored the quality of the selected 
papers according to a standardised set of criteria (Appendix 1). These criteria 
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have been used in previous reviews of observational studies in the field of 
musculoskeletal disorders8-10 and were modified to cover the topic of our review. 
The criteria concern both the internal validity, and the informativeness of the study. 
Only items reflecting the internal validity of the studies were used to assess the 
methodological quality. 
In case of a disagreement both reviewers tried to achieve consensus; if 
disagreements were not resolved, a third reviewer (BWK) was consulted in order 
to achieve a final judgement. 
Several items are not applicable to certain types of study design (e.g. cohort or 
case-control study), and therefore do not contribute to the total score of that 
particular study. This means that the maximum score (100%) for each study was 
based only on the items applicable to that particular type of study design. Positive 
scores were summed up to give an overall internal validity score. 
 
Best evidence synthesis 
Because the observational studies were considered to be heterogeneous with 
regard to the population studied, methodological quality and determinants and 
outcome measures for hip OA11, we followed standard practice and refrained from 
statistically pooling the data and performed a "best evidence" synthesis.8,12-14 First 
the studies were classified according to the type of study design. A prospective 
cohort study was judged as the preferred design, followed by a case-control study, 
and than by a cross-sectional study. After that, the studies were ranked according 
to their methodological quality score. The following ranking of the levels of 
evidence was formulated.8,10,12 
1. Strong evidence is provided by generally consistent findings in multiple high 
quality cohort studies. 
2. Moderate evidence is provided by general consistent findings 
- in one high quality cohort study and two or more high quality case-control 
studies. 
- in three or more high quality case-control studies. 
3. Limited evidence is provided by (general consistent) findings 
- in a single cohort study 
- in one or two case-control studies 
- in multiple cross-sectional studies. 
Chapter 2 
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4. Conflicting evidence is provided by conflicting findings (i.e. <75% of the studies 
reported consistent findings). 
5. No evidence is provided when no studies could be found. 
A study was considered to be of high quality if the methodological quality score 
was ≥ 60%. 
 
Data extraction 
Two researchers (AML and SMABZ) collected the characteristics of the included 
studies independently of each other. They collected items on the definition of the 
study population, how the presence or absence of hip OA was assessed, the 
assessment of obesity, if the study corrected for potential confounding factors and 
which results were reported. 
When a study reported several outcomes because of a division of the study 
population into subgroups, the separate outcomes were combined (where 
possible) using Mantel Haenszel statistics, methods described by Clayton and 
Hills15 or the method described by Tan and colleagues16 as appropriate. 
 
Results 
Identification and selection of the literature 
A total of 2921 references were initially identified; of these, only 9 articles met our 
selection criteria.4,17-24 The most frequent reason for failing to meet our inclusion 
criteria were that there was not an appropriate study design (case reports, no data 
on the control group) or no specific information about the relationship between 
obesity and hip OA. After screening the reference lists of the selected studies, 
another four studies were included.25-28 All of them were indexed in Medline but 
used other descriptions of the study design. 
For one study, there were two publications reporting different aspects of the 
study.21,23 Both publications were used to extract data regarding the methods used 
and the results reported. Thus, finally, 12 studies were included in this review. 
 
Publication bias 
To investigate the amount of publication bias for our study, a funnel plot was made 
(Fig. 1). The plot shows the relationship between the distribution of the point 
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estimates of the association between obesity and hip OA, and the sample size (n). 
Although the plot shows a more or less equal distribution, there is a lack of small 
studies showing an inverse association. 
 
Figure 1: Funnel plot showing the distribution of the OR according to the 
sample size. Of the 12 included studies, only nine provided sufficient data to be 
included in this plot. The numbers in the graph represent the reference numbers 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Description of the studies included 
Table 1 gives a detailed description of the characteristics of the included studies. 
Only five studies had a longitudinal design; viz. one prospective cohort study18 and 
four retrospective case-control studies20-22,24, whereas the remaining seven studies 
reported only cross-sectional associations between obesity and the presence of 
OA only.4,17,19,25-28 In two of the 12 studies, the studied population was hospital 
based.22,26 The other 10 studies were population based.  
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Table 1: Details of the studies included in this review 
Cohort studies 
Author Definition population Assessment hip OA Adjusted for Results 
Gelber18 Male medical students (USA) 
age 20-29 yr. (n=1180) 
Follow-up 36 (31-47) yr. 
Clinical (self reported at 
follow-up questionnaire)  
age-physical 
activity-joint 
injury  
BMI < 23     OR 1 (index) 
BMI 23-25   OR 1.10 [0.4-2.8] 
BMI >25      OR 1.03 [0.4-2.6] 
Case-control studies 
Vingard23
Olsen21 
All men from 
Stockholm with a 
THR between 
1984-1988 age 40-
70 (n=239) 
Random men from 
Stockholm aged 
40-70 yr. (n=302) 
*THR age-smoking 
occupation-
sports 
BMI ≤ 25   OR 1 (index) 
BMI>25     OR 2.3 [1.2-4.4] 
Oliveria20 Fallon community 
health plan 
females (USA) 
aged 20-89 yr. with 
hip OA (n=134) 
Random selection 
of women from the 
Fallon Community  
(n=134) 
*Clinical(ACR/  
pain, stiff, 
swelling) Xray 
(osteophytes, 
hypertrophy) 
age-gender 
HRT-smoking 
BMI ≤ 24 OR 1 (index) 
BMI 24–28 OR 3.4 [0.4-25.6] 
BMI > 28   OR 1.4 [0.1-17.5] 
Vingard24 All women from 
South Sweden 
with THR between 
1992-1994 (n=230) 
Women from the 
same area without 
known hip 
disorders (n=273) 
*THR in that 
period 
age-children-
sports-HRT-
occupation-
smoking  
BMI ≤ 20    OR 1 (index) 
BMI 20-25  OR 1.2 [0.5-2.8] 
BMI >25      OR 2.1 [0.9-4.6] 
Roach22 Males in Chicago 
with a THR or 
signs of hip OA on 
X-ray (n= 99) 
Same population 
without signs of hip 
OA on IV-urograph 
(n=233) 
*Clinical (pain) 
Xray/IV-
urograph (JSW) 
or THR 
various 
confounders 
BMI ≤ 27.7   OR 1 
BMI > 27.7   OR 2.0 (1.0-4.0) 
Cross-sectional studies 
Cooper17 Patients on waiting 
list for THR at 2 
clinics in England 
aged > 45 yr. (n=611) 
Patients with 
the same GP, 
and no THR 
(n=611) 
Waiting list for 
THR  
age-gender 
Heberden’s 
nodes-hip-
trauma 
BMI 25-28    OR 1.3 [0.95-1.7] 
        Bilateral OR 1.3 [0.9-1.8] 
BMI ≥28        OR 1.6 [1.2-2.2] 
         Bilateral OR 1.7 [1.2-2.4] 
Heliovaara19 Finnish open population (n=7217) 
Age ≥30 yr. 
History of hip 
OA or physical 
findings 
age-gender-
trauma-stress 
at work 
BMI 25-30     OR 1.5 [1.1-1.9] 
         Bilateral OR 1.4 [1.0-2.0] 
BMI 30-35     OR 2.0 [1.5-2.7] 
         Bilateral OR 2.3 [1.5-3.5] 
Van 
Saase27 
Open population of Zoetermeer (the 
Netherlands) 45-64 yr. (n=2168) 
X-ray 
(Kellgren and 
Lawrence)  
age-gender "Association is absent" 
Hartz25 Open population of the USA 40-69 yr.  
(HANES I) (n=4225) 
X-ray (K&L) age-gender-
race  
"Relative weight was weakly 
associated with hip OA" 
Tepper4 Open population of USA ≥ 55 yr.  
(NHANES-1) (n=2358) 
X-ray (K&L) gender-race 
age education 
BMI ≤ 27    OR 1 (index) 
BMI>27      OR 1.02 [0.6-1.7] 
      Bilateral OR 2.0 [0.97-4.2] 
Kraus26 Patients referred by 
physicians with hip 
OA to one clinic in 
USA (n=100) 
Patients at 
the same 
hospital (surg-
ery/general 
med.(n=100) 
*Clinical 
(patients)  
X-ray?  
age-gender-
race 
<20% above ideal weight OR 1 
≥ 20% above ideal weight OR 
2.7 [1.4-5.4] 
Saville28 Patients with prim. 
hip OA at a dept. for 
special surgery 
(USA) aged 15-78 
years (n=121) 
- US normals 
height/weight 
- Pat. from 
same dept. 
and no hip 
OA (n=141) 
*Clinical 
(patients) 
X-ray (JSN, 
subchondral 
sclerosis) 
 "Body weight distribution 
among patients with hip OA 
was similar to that of normal 
men and women in the US" 
 
* Assessment of hip OA was only carried out for cases. ACR= American College of Rheumatology, THR= total hip 
replacemen JSN=joint space narrowing, JSW= joint space width, IV-urography= intravenous urography, HRT= hormone 
replacement therapy, BMI= bodymass index, K&L=Kellgren and Lawrence 
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Three studies included only males18,21,22, and two others included only 
females.20,24 The ages of the studied populations diverge, but most studies 
investigated subjects aged 40 years and older. All studies were carried out in the 
USA4,18,20,22,25,26,28 or in Northern Europe.17,19,21,24,27 Most of the studies determined 
obesity with the BMI. One study used the ideal body weight26, and another study 
used relative weight25; both measurements were derived from a normal distribution 
of height and weight in the population29. One study used weight only.28 
The assessment of hip OA varied in several studies. Two studies relied on clinical 
information only18,19 while three other studies used an X-ray score only4,25,27 and 
another three studies used a combination of these two20,22,28 as an outcome 
measure. Three studies used a (total) hip replacement (THR), or waiting for a THR 
in a specific period as an outcome.17,21,24 One study did not clearly describe how 
the assessment of hip OA was done; i.e. only clinically or also using an X-ray.26 
 
Results of the studies included 
Nine of the 12 studies showed exact data of the outcomes; the other three 
described the outcome in global terms only.25,27,28 
Seven studies showed a positive association between obesity and hip OA (OR ≥ 
1.25)17,19,20,22-24,26, of which five were statistically significant17,19,22,23,26, indicating 
that subjects with a higher BMI (approximately >25) have an increased risk for 
developing hip OA. Four of these 7 studies had a case-control design and the 
other three a cross-sectional design. 
Three studies showed a weak positive relation (RR/OR 1-1.25)4,18,25; one of these 
studies had a prospective cohort design. There were no studies reporting a 
negative association. 
There were four studies reporting outcomes on the association between moderate 
obesity (BMI >25) and hip OA, but also between more severe obesity (BMI >27) 
and hip OA.(19, 21, 22, 26) Three of these studies showed a clear dose-response 
relationship.(19, 21, 26) 
Three studies also investigated the relationship of the BMI and the presence of a 
bilateral disease.4,17,19 The outcomes show a comparable strength of the 
relationship as found in unilateral hip OA. 
In contrast with the nine studies which used clinical information (e.g. physical 
complaints, need for a THR) for the diagnosis of hip OA, the three studies using 
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only an X-ray as evidence for hip OA4,25,27 reported no, or only a very weak 
positive association with hip OA. 
 
Methodological quality assessment 
The two reviewers scored 404 items and agreed on 378 items (94%, kappa 0.87). 
The 26 disagreements were resolved in a single consensus meeting. Table 2 
shows the studies in order of their methodological quality score, subdivided in the 
different types of study design.  
The scores range from 15% to 77% of the maximum obtainable score for each 
study design. The mean quality score was 57%. The participation rates of the 
Table 2: Results of the quality-score of the studies. 
Criteria 
no. 
1 2 3 4 5 
* 
6 7 8 9 10 11 12 
* 
13 14 15 16 
* 
17 
* 
18 19 
S
co
re
 
O
b
ta
in
ab
le
 
T
o
ta
l 
sc
o
re
 
Cohort studies 
Gelber 18 1 - 1 - 1 1 - 1 1 0 0 0 1 1 1 0 1 0 1 9 12 75% 
Case-control studies 
Olsen 21/ 
Vingard 
23 
1 1 1 1 1 0 1 1 0 1 1 1 0 - - - 1 1 1 10 13 77% 
Oliveria 
20 
1 1 1 1 0 0 1 1 0 0 1 1 0 - - - 1 1 1 9 13 69% 
Vingard 
24 
1 1 1 1 1 0 1 0 0 1 1 1 0 - - - 1 1 1 9 13 69% 
Roach 22 0 1 0 0 1 0 1 0 0 1 1 1 0 - - - 1 1 1 6 13 46% 
Cross-sectional studies 
Cooper 17 1 1 1 0 1 0 1 0 1 1 1 1 0 - - - 1 1 1 9 13 69% 
Heliovaara 
19 
0 - 1 - 1 0 - 0 1 1 1 0 0 - - - 1 1 1 6 10 60% 
van 
Saase 27 
0 - 0 - 0 1 - 0 1 1 1 1 0 - - - 1 1 1 6 10 60% 
Hartz 25 0 - 0 - 1 0 - 0 1 1 1 1 0 - - - 1 1 1 5 10 50% 
Tepper 4 0 - 0 - 1 0 - 0 1 1 1 1 0 - - - 0 1 1 5 10 50% 
Kraus 26 1 1 1 1 1 0 1 0 0 0 0 0 0 - - - 1 0 1 6 13 46% 
Saville 28 1 0 0 0 0 0 1 0 0 0 0 0 0 - - - 1 0 0 2 13 15% 
Each item was scored as "1" when it met the specified criteria listed in the appendix A. (see chapter “appendices”) When it 
did not meet the criteria, or when it was not described at all, a “0“ was assigned. Positive scores were summed up to an 
overall internal validity score.  
 - = not applicable    *)= Informativity item. Not included in the analysis. 
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studied populations (Appendix 1, items 3, 4) scored very low; these criteria were 
fulfilled by three of the four case-control studies and the cohort study, but by only 
one out of the 7 cross-sectional studies. 
In contrast with the assessment of obesity, where there was almost always an 
identical or comparable assessment within the different groups of the population 
(Appendix 1, item 7), the assessment of hip OA (item 9) diverges substantially. In 
studies with a cohort as study base, (longitudinal and cross-sectional data) there 
was always an identical assessment of hip OA. 
No correlation was found between the quality score and the study outcome (Figure 
2) (Pearsons correlation -0.04 p-value 0.9). 
 
Figure 2: Quality score of nine of the 12 studies in relation to the  
odds ratio. The numbers in the graph represent the reference numbers 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Three of the 12 studies could not be plotted due to a lack of precise data on the 
OR/RR. Of these, van Saase and colleagues27 achieved a quality score of 67% 
and reported no association between obesity and hip OA. Hartz et al.25 scored 
56% and reported a weak association, whereas Saville and Dickson28 achieved a 
score of 17% and showed no association between obesity and hip OA. 
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Best evidence synthesis 
There were five longitudinal studies, and four of them reached the level of high 
quality. The high quality cohort study reported an OR of 1.03 (95% CI 0.41-2.60), 
whereas the three high quality case-control studies reported an association of 2.3 
(95% CI 1.2-4.4), 3.4 (95% CI 0.4-25.6) and 2.1 (95% CI 0.9-4.6). This means that 
there is moderate evidence for a positive association between obesity and hip OA 
with an OR of approximately 2. 
In the subgroup of studies reporting on the association between bilateral hip OA 
and obesity, only three cross-sectional studies were found, of which two reached 
the level of high quality.17,19 This means that with the best evidence synthesis we 
can conclude that there is only limited evidence for a positive association between 
obesity and the occurrence of bilateral hip OA. The strength of the association is 
comparable to the strength found for unilateral hip OA. 
For the subgroup of articles assessing hip OA on clinical information (e.g. physical 
complaints, need for a THR), six17-21,24 of the nine articles reached the level of high 
quality. One had a cohort design18, three a case-control20,21,24 and two a cross-
sectional design.17,19 The reported OR's were 1.03, 2.3, 3.4 and 2.1. This means 
that there is moderate evidence for a positive relation between clinically assessed 
hip OA and obesity.  
All three studies assessing hip OA with radiological parameters, had a cross-
sectional design.4,25,31 The reported outcomes were "absence of an association", 
"a weak association" and an OR of 1.02. One of them reached the level of high 
quality31, so there is limited evidence for no association in the subgroup of 
radiological assessed hip OA. 
 
Discussion 
In this systematic review, we summarized the available evidence in the literature 
on the influence of obesity on the development of OA of the hip. Based on the 
evidence, we may conclude that there is moderate evidence for a positive 
association between hip OA and obesity. For the subcategory bilateral hip OA only 
limited evidence was found. The strength found in this subgroup was comparable 
to the strength found in the overall conclusion. 
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For a subcategory of articles in which hip OA was assessed clinically, moderate 
evidence was found for a positive association, in contrast to radiological assessed 
hip OA, for which limited evidence for no association was found. This review may, 
however, suffer from several restrictions. 
 
Identification and selection of the literature 
Although we put much effort into identifying the relevant articles, our literature 
search might have some limitations. Some relevant articles may have been 
missed because they used other keywords or had unclear abstracts and not all 
published articles are indexed in databases. Besides that, we excluded articles 
written in languages other than English, Dutch, German, French, Danish, 
Norwegian or Swedish. 
The presumed absence of publication bias found in our results (Fig. 1) can be 
explained by a selection of studies that were published for their ‘exciting’ positive 
results that satisfy current dogma. When assessing the funnel plot, we have to 
keep in mind that three of the 11 studies could not be included in the analysis due 
to insufficient data to deduce a point estimate.25,27,28 We believe, however, that 
these data are unlikely to greatly influence our results. 
Unfortunately, only one prospective study studying the association between 
obesity and hip OA could be found. This type of study design is known to be the 
most valid type of observational studies. Having more data from this type of design 
would have allowed to provide a more valid and precise conclusion. 
The decision to include cross-sectional studies is based on the results of several 
studies reporting a similarity between current BMI and historical BMI in patients 
with hip OA.24,32,33 Our data support these findings. We acknowledge, however, 
that the strength of the evidence of cross-sectional studies is much lower than the 
evidence provided by prospective cohort studies and, to a lesser extent, case-
control studies. 
 
Quality assessment and best evidence synthesis 
The quality assessment was challenging because no tested and validated criteria 
lists have been published for observational studies in the field of OA. Also, limited 
data were found to perform a best evidence synthesis with observational studies. 
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Therefore we presented them in a reproducible manner, and the criteria we used 
were relatively strict. 
A very notable item in the quality assessment was the difference in the 
assessment of hip OA between the patients and controls in the case-control 
designed studies (either longitudinal or cross-sectional). Most studies took as 
cases all patients with hip OA, and as controls a sample of the underlying 
population, but without screening them for hip OA. This means that some controls 
might have had hip OA, so these studies would be biased towards a null result. 
There have been opinions suggesting that controls do not need to be evaluated for 
the occurrence of the disease, but rather must represent the base population, 
which will include such cases.34 Considering the fact that there are still 
contradictory opinions on this subject, we prefer to follow the classical point of 
view; namely that controls must be free of the disease in study. 
The most interesting finding in our study is the difference found between clinically 
assessed hip OA. Whereas the former group of studies shows that obese people 
suffer more from hip OA, the latter shows that there is no difference in the 
presence of hip OA. This may suggest that obese patients suffer more from the 
same radiological degree of hip OA than non-obese patients do. Thus, obese 
patients may have more hip complaints at an equal radiological stage, due to the 
weight on the hip joint, and therefore qualify earlier for THR than non-obese 
patients. Unfortunately, there are only few studies reporting on weight loss in 
relation to knee OA, and none in relation to hip OA, to support this explanation.35,36 
In view of the moderate evidence for an association, knowledge of the origin of the 
relationship between hip OA and obesity is important. Future research, especially 
well-designed prospective follow-up cohort studies with adequate follow-up time, 
will not only strengthen the conclusion of this review but might also throw light on 
the cause of this relationship. 
 
Conclusion 
This systematic review shows that in the literature, there is moderate evidence for 
a positive influence of obesity on the development of hip OA. 
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Abstract 
Objective: To evaluate the evidence for the influence of physical workload on the 
occurrence of osteoarthritis (OA) of the hip. 
Methods: We carried out a database search of Medline, Embase and Cochrane 
library to identify observational studies, and articles on the relationship between 
workload and hip OA were identified. Methodological quality of the selected 
studies was assessed using a standardised set of criteria. The outcome of the 
individual studies was compared with its study characteristics and methodological 
quality score. Finally, a best evidence synthesis was used to summarize the 
results from the individual studies. 
Results: Two retrospective cohort studies and 14 case-control studies were 
included in this review. There was a slight negative, but not significant association 
between the study outcome and the methodological quality score. Overall, 
moderate evidence was found for a positive association, with an OR of 
approximately 3, between previous heavy physical workload and the occurrence of 
hip OA. In addition, for the subcategories, i.e. ≥10 years farming or lifting heavy 
weights (≥25 kg), moderate evidence was found for a positive relationship with hip 
OA. Possible selection of the populations studied may be partly responsible for the 
association we identified. 
Conclusion: The evidence for the influence of previous heavy physical workload 
on the occurrence of hip OA is moderate. 
 
Journal of Rheumatology 2001; 28(11): 2520-8. 
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Introduction 
Osteoarthritis (OA) of the hip is a major cause of morbidity and disability in the 
elderly, and the problem will increase with the current aging of the population in 
Western societies. In addition to the personal and social discomfort, the economic 
consequences are enormous. Roughly, the costs of OA have risen over recent 
decades accounting for up to 1-2.5% of the gross national product for countries 
such as the USA, Canada, the UK, France and Australia.1 
Over the last few decades, many epidemiological studies have investigated 
potential determinants of OA. These studies are important for our understanding of 
the causes of OA and will lead to the further improvement of preventive measures. 
One of the recognised determinants of interest for hip OA is the amount of 
physical workload, where forces or loads act upon the hip joint. Besides several 
narrative reviews2-4, Meatzel and colleagues performed a systematic review on 
this topic in 1997, in which a consistently positive but weak association between 
work related exposure and hip OA was reported.5 However, several new articles 
have now become available, investigating the influence of workload on the 
development of hip OA. More data on this subject, gives us the opportunity to 
update the literature and carry out a subgroup analysis for the type of workload or 
a the way the hip OA was measured. 
We therefore performed a systematic review, using modern methods for 
systematically identifying and assessing the available studies to provide update 
knowledge of the proposed association of physical workload and the occurrence of 
OA of the hip. 
 
Methods 
Identification and selection of the literature 
To identify the observational studies on this subject, relevant publications were 
searched using the following databases: Medline (1966 to April 2000), Cochrane 
library (1993 to April 2000) and EMBASE (1980 to April 2000). The following 
keywords were used: (hip and (arthritis or arthrosis or osteoarthritis or 
osteoarthrosis) or coxarthrosis) and (risk factor or causative or determinants or 
predictor or etiology) and (case-control or retrospective or prospective or 
longitudinal or follow up or cohort). (A detailed list can be obtained from the 
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corresponding author.) The search was extended by screening the reference lists 
of all relevant articles identified. 
A study was eligible for inclusion if it fulfilled all the following criteria: 1) one of the 
aims of the study was to investigate an association between hip OA and the 
amount of workload, 2) the articles were written in English, Dutch, German, 
French, Danish, Norwegian or Swedish, 3) the article was a full text article, 4) the 
patients in the studies had to have a radiological and/or clinical hip OA, a (total) 
hip replacement, or were on the waiting list for one, and 5) the study design was a 
cohort or a case-control study. 
A study was excluded if the studied population had a specific underlying 
pathology, such as trauma (fractures), infection, rheumatoid arthritis, ankylosing 
spondylitis, Perthes' disease, tuberculosis, hemochromatosis, sickle cell disease, 
Cushing's disease, or femoral head necrosis. 
 
Methodological quality assessment 
Variation of the methodological quality of observational studies may influence the 
results and conclusions of our investigation. Therefore, the quality of each 
included study was assessed using the following procedure. Two reviewers (AML 
and SMABZ) independently scored the quality of the selected papers according to 
a standardised set of criteria (Appendix 1). These criteria have been used in 
previous reviews of observational studies in the field of musculoskeletal 
disorders7,6 and were modified to cover the topic of our review. The criteria 
concern both the internal validity, and the informativeness of the study. Only items 
reflecting the internal validity of the studies were used to assess the 
methodological quality. In case of a disagreement, both reviewers tried to achieve 
consensus; if disagreements were not resolved, a third reviewer (BWK) was 
consulted in order to achieve a final judgement. 
Several items are not applicable to a certain type of study design (e.g. cohort 
study or case-control study), and therefore do not contribute to the total score of 
that particular study. This means that the maximum score of each study (=100%) 
was based only on the items applicable to that particular type of study design. 
Positive scores were summed up to an overall internal validity score. 
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Best evidence synthesis 
Because observational studies are heterogeneous with regard to the study 
population, methodological quality and determinants and outcome measures for 
hip OA, we refrained from statistically pooling the data8, and performed a "best 
evidence" synthesis.9,10 The studies were divided into subgroups according to the 
type of study design. A cohort study was judged as the most valid design, followed 
by a case-control study. After that, the studies were ranked according to their 
methodological quality score.11 
1. Strong evidence is provided by generally consistent findings in multiple high 
quality cohort studies. 
2. Moderate evidence is provided by general consistent findings 
- in one high quality cohort study and two or more high quality case-control 
studies. 
- in three or more high quality case-control studies. 
3. Limited evidence is provided by (general consistent) findings 
- a single cohort study 
- in ≤ 2 case-control studies  
4. Conflicting evidence was provided by conflicting findings (i.e. <75% of the 
studies reported consistent findings). 
5. No evidence was provided when no studies could be found. 
A study was considered to be of high quality if the methodological quality score 
was > 60%. 
 
Data extraction 
Two researchers (AML and SMABZ) collected the characteristics of the included 
studies independently of each other. They collected items on the definition of the 
studied population, how the presence or absence of hip OA was assessed, the 
assessment of the amount of workload, if the study corrected for potential 
confounding factors, and which results were reported. 
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When a study reported several outcomes because of a division of the study 
population into subgroups, the outcomes were combined (where applicable and 
possible) using Mantel Haenszel statistics, methods described by Clayton and 
Hills12 or the method described by Tan and colleagues.13 Because of dissimilarity 
according to the outcome, where possible, we computed the odds ratios. We 
abstracted outcomes on heavy workload in general, and made subgroups for 
farming and heavy lifting, where possible. 
 
Publication bias 
For the validity of a systematic review, identification of all relevant articles is 
crucial.14 The amount of potential publication bias in our study was analysed by 
means of a funnel plot, in which the study outcome (OR) was plotted against the 
sample size of the study. In the absence of publication bias, the plot will resemble 
a symmetrical inverted funnel15; we visually examined the funnel plot for 
symmetry. 
 
Results 
Identification and selection of the literature 
2921 references were initially identified; of these, 16 articles met our selection 
criteria16-31. After screening the reference lists of the selected studies, another 
three studies were included.32-34 For three studies, there was more than one 
publication, reference numbers 22 and 28, 19 and 30 and 26 and 27, reporting 
different aspects of the study. All publications were used to extract data regarding 
the methods used and the results. Thus, finally 16 studies were included in this 
review. 
 
Publication bias 
To investigate the amount of publication bias for our study, a funnel plot was made 
(Fig. 1). The plot shows the relationship between the distribution of the point 
estimates of the association between obesity and hip OA, and the sample size (n). 
One study30 could not be plotted due to a lack of data to deduct an OR.  
The plot shows a more or less equal distribution. 
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Figure 1: Funnel plot. The numbers in the graph represent the reference 
numbers. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Description of the studies included 
Table 1 gives a description of the characteristics of the included studies. 
All studies collected their data in a retrospective manner. Two studies had a cohort 
design20, 17 and 14 studies were of a case-control design.16-19, 21, 23-25, 27-29, 31-33 
Eight studies included only males17, 18, 23, 24, 28, 32-34, whereas two included only 
females.29, 30 Fourteen studies were carried out in Northern Europe; most of them 
in Scandinavia20, 21, 24, 25, 27-29, 32, 34, but also in England.16-19, 23 The two others 
where carried out in the US33 and in Japan.31 
The assessment of physical workload was in 13 studies carried out by means of 
an interview or a questionnaire16-18, 20, 23-25, 28, 29, 31-34, whereas two studies used the 
inclusion criteria (e.g. workers at a shipyard or physical education teachers).19, 21 
One study used registered information.27 The assessment of the amount of 
physical workload was in nine of the 16 studies done by using the subjects' job 
title, e.g. agricultural workers, bricklayers, dockers etc.18, 19, 21, 23-25, 27, 32, 34. The 
seven other studies collected information on specific occupational activities, such 
as kneeling, squatting, heavy lifting etc. Besides workload in general, seven 
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studies reported on farming separately.17, 18, 24, 25, 27, 32, 34 Most of them used a cut-
off point of ≥10 years of farming and compared that with no, < 1 year or <10 years 
of farming. Six studies reported on heavy lifting activities separately16, 17, 28, 29, 31, 32, 
where heavy weight was mostly described as ≥25 kg. 
The assessment of hip OA was most of the times based on clinical information 
(e.g. on waiting list for a (total) hip replacement (THR), after a THR, physician 
diagnosed hip OA), but three studies characterised hip OA by radiographic 
materials only (e.g. X-ray, IV-urograph).17, 18, 21 
 
Results of the studies included 
All studies showed a positive association between heavy vs. light physical 
workload (defined in various ways) and hip OA. The OR diverged between 1.121 
and 13.834. Twelve studies reported a statistical significant outcome16-18, 20, 24, 25, 27, 
28, 31-34
, where the OR diverged between 1.916 and 13.8.34 
Looking at subgroups, the seven studies reporting on farming vs. light physical 
workload or no farming, the outcomes diverge between an OR of 2 and 13.8, of 
which six were statistically significant.18, 24, 25, 27, 32, 34 The six studies on lifting 
heavy weights, reported OR's between 1.5 and 3.5, when compared to no or a low 
exposure to lifting heavy weights. Five of these were statistically significant.16, 17, 28, 
29, 31, 32
 Twelve studies analyzed if the relationship changed with an increased 
exposure to the heaviness of the physical workload.16-18, 20, 24, 25, 28, 29, 31-34 Ten of 
these showed a clear dose-response relationship between hip OA and the amount 
of workload.16-18, 20, 24, 25, 28, 29, 31, 33, 34 No relationship could be found between the 
outcome of the individual studies, and the way they assessed hip OA (on clinical 
evaluations, or with X-ray only) or the gender studied (i.e. males or females). 
 
Methodological quality assessment 
The two reviewers scored 663 items and agreed on 630 items (95%, kappa 0.90). 
The 33 disagreements were resolved in a single consensus meeting. Table 2 
shows the studies in order of their methodological quality score, subdivided in the 
different types of study design (i.e. cohort and case-control studies). 
The scores range from 77% to 23%, and the average rating was 54%. 
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Table 1: Details of the studies included 
Cohort studies 
Author Definition population Assessment of hip OA Adjusted for Results 
Heliovaara20 Finnish open population  
Retrospective follow-up 
Age ≥30 (n=7217)  
Physician diagnosed 
(questionnaire) or findings 
at examination 
age, gender, 
trauma 
Heavy workload  
OR 2.7 (1.7-4.4) 
Vingard26, 27 Swedish open population  
Retrospective follow-up 11-13 yr. 
Age 45-75 (n=250217)  
Clinical (Registered ICD-
diagnose for hip OA) 
age, gender, 
county 
Heavy vs. light workload 
Male: RR 2.2 (1.6-2.8) 
Female: RR 1.6 (0.9-3.1) 
Farming (≥10 yr.) 
Male OR 3.8 (2.9-3.9) 
Female OR 1.5 (0.9-2.9)  
Case-control studies 
Author Definition cases/ 
population 
Definition controls Assessment 
of hip OA 
Adjusted for Results 
Yoshimura 
31 
Patients waiting for a 
THR in Japan  age ≥45 
(n=114) 
Random selection of 
the source population 
(n=114) 
Waiting list for 
THR 
age, gender, 
knee pain 
Lifting <10 kg OR 1 
Lifting ≥ 25 kg  
OR 3.5 (1.3-9.7)  
Coggon16 Residents of 2 districts 
in England waiting for a 
THR  
Age 45-91 (n=611) 
Random selection of 
the source population 
without hip problems 
age 45-91 (n=611) 
On waiting list 
for THR 
age, gender, 
BMI, trauma, 
Heberden’s 
nodes 
No lifting OR 1 Lifting ≥ 25 
kg ≥10 yr. OR 1.9 (1.2-3.0) 
Vingard29 Women in a region of 
Sweden with a THR 
Age 50-70 (n=230) 
Random selection of 
women in the same 
area without hip 
problems (n=273) 
After THR age, gender, 
BMI, sports 
smoking 
children, HRT 
Low exposure to lifting OR 1 
Heavy lifting  
OR 1.5 (0.9-2.5) 
Croft17 Males with signs of hip 
OA on an IV-urograph, 
or a THR in a district in 
England 
Age 60-75 (n=245) 
Males with an IV-
urograph without signs 
of hip OA 
(n=294) 
X-ray (JSW 
≤1,5 mm) or a 
THR 
age, gender, 
hospital 
Lifting ≥25 kg ≥20yr. vs. <1 
yr. OR 2.5 (1.0-7.3) 
Farming ≥10 yr. vs. <1 yr. 
OR 2.0 (0.9-4.4) 
Croft18 Random selection of 
male farmers at five 
general practices in 
England  
Age 60-76 (n=167) 
Random selection of 
man who spent there 
entire careers in office 
work  
(n=83) 
Complaints 
and X-ray 
(JSW ≤ 1,5 
mm) or THR 
age, gender, 
height, weight 
Heberden’s 
nodes 
Office work OR 1 
Farming ≥10 yr.  
OR 9.3 (1.9-44.5) 
Jacobsson 
32 
Males with signs of hip 
OA on an IV-urograph 
or  waiting for a THR in 
South Sweden (n=106) 
Males with an IV- 
urograph without signs 
of hip OA  (n=236) 
X-ray/IV-
urograph 
(JSW < 3 
mm) or 
waiting list 
gender Heavy work  
OR 7.2 (3.0-17.1) 
Farming OR 2.0 (1.3-3.2) 
Heavy lifting  
OR 2.4 (1.3-4.3) 
Olsen, 
Vingard22, 28 
Males in the area of 
Stockholm who 
received a THR age 50-
70 (n=239) 
Random selection of 
males in the same area 
(n=302) 
*After THR age, gender, 
BMI, smoking, 
sport 
Heavy work OR 2.4 (1.5-4.0) 
Heavy lifting (>40 kg < 30 yr. 
of age) 
OR 2.4 (1.5-3.7)  
Thelin24 Male patients of 2 
hospitals in Sweden 
who received a THR 
age 55-70 (n=98) 
Random selection of 
males from the same 
area 
Age 55-70 (n= 201) 
*After THR gender, 
residence 
Farming > 10 years vs. other 
jobs OR 3.2 (1.8-5.5) 
Thelin25 Population of province 
in Sweden with signs of 
hip OA on radiological 
examination  
Age >70 (n=216) 
Random selection of  
civilians of the same 
area  
(n=479) 
*X-ray (JSW < 
3 mm) 
age, gender 
residence 
Farming vs. no farming OR 
2.7 (1.9-3.8) 
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Author Definition cases/ 
population 
Definition controls Assessment 
of hip OA 
Adjusted for Results 
Roach33 Males in Chicago with a 
THR or signs of hip OA 
on X-ray 
(n= 99) 
Same population 
without signs of hip OA 
on IV-urograph (n=233) 
*Clinical 
(pain) 
THR/ X-
ray/IV-
urograph 
(JSW)  
various 
confounders 
Heavy vs. light workload 
≥ 15 yr.  
OR 2.4 (1.3-4.3) 
Eastmond, 
White19, 30 
Female physical 
education teachers of 
five colleges in England  
Age 48-54 (n=577) 
Women from general 
population (n=?) 
*Clinical 
(pain, 
stiffness) 
X-ray (Only 
for teachers)  
age, gender age 48-54  chi2=2.52 
age 55-60 chi2=0.43  
 
Vingard34 Swedish males from the 
Stockholm region with a 
disability pension due to 
hip OA (n=140) 
Random selection of 
males from the same 
area without disability 
pensions for hip OA 
(n=298) 
Disability 
pensions due 
to hip OA 
age, gender, 
residence 
Heavy workload >20 yr.  
OR 12.4 (6.7-23.0) 
Farm > 10 yr.  
OR 13.8 (4.0-48.1) 
Lindberg21 Heavy labour workers 
of shipyard at Malmö 
(n=332) 
-White collar workers at 
same shipyard and 
male teachers (n=352) 
-random sample of 
citizens of Malmö 
(n=438) 
*X-ray (JSW < 
4 mm at age 
< 70, JSW < 3 
mm at age > 
70)  
age, gender compared to controls 1  
OR 1.1 (0.5-2.5) 
compared to controls 2 
OR 2.1 (0.8-5.5) 
Partridge23 Civilian male dockers 
Age 25-64 (n=206) 
Male civil servants at 
government dep.  
Age 25-64 (n=171) 
Clinical (pain, 
physical 
examination) 
gender Civil servants OR 1 
OR 5.1 (0.6-42.8) 
*Assessment of hip OA was only carried out for cases 
THR= total hip replacement  HRT= hormone replacement therapy  JSW= joint space width 
 
A weak negative correlation between the quality score and the study outcome 
could be found (Spearman's correlation coefficient = -0.148), implying that the 
higher the quality score, the smaller the association between physical workload 
and hip OA (Figure 2). However, these findings were not statistically significant. 
Besides that, we have to keep in mind, that one study could not be plotted due to a 
lack of data to deduct a point estimate.30 
 
Best evidence synthesis 
The two cohort studies did not meet the criteria of high quality.20,27 However, nine 
of the 14 case-control studies16-18, 24, 25, 28, 29, 31, 32 could be labelled as 'high quality'. 
The outcomes of these studies diverge between an OR of 1.5 and 9.3 for high vs. 
light physical workload. This implies that there is moderate evidence for a positive 
association between previous physical workload and hip OA with an OR of 
approximately 3. 
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For the farming subgroup, the single cohort study did not reach the level of high 
quality study.27 Five of the seven case-control studies had a high quality score17, 18, 
24, 25, 32
, and the outcomes of these studies diverge between an OR of 2 and 9.3. 
So, also for this subcategory, there is moderate evidence for a positive relationship 
between a history of (more than ten years) farming, and the occurrence of hip OA, 
when compared with light workload or no farming. 
The six case-control studies reporting on the association between lifting heavy vs. 
low weights and hip OA, all had a high quality score.16, 17, 28, 29, 31, 32 The outcomes 
Table 2: Results of the quality score of the studies 
Item 1 2 3 4 5 
* 
6 7 8 9 10 11 12 
* 
13 14 15 16 
* 
17 
* 
18 19 
S
co
re
 
O
b
ta
in
ab
le
 
T
o
ta
l s
co
re
 
Cohort 
Heliovaara20 0 - 1 - 1 0 - 0 1 1 1 0 0 0 0 0 1 1 1 6 12 50% 
Vingard26, 27 0 - 1 - 0 0 - 0 1 0 0 0 0 1 0 0 1 1 1 5 12 42% 
Case-control 
Yoshimura31 1 1 1 1 1 0 1 0 1 1 1 1 0 - - - 1 1 1 10 13 77% 
Coggon16 1 1 1 0 1 0 1 0 1 1 1 1 0 - - - 1 1 1 9 13 69% 
Vingard29 0 1 1 1 1 0 1 0 1 1 1 1 0 - - - 1 1 1 9 13 69% 
Croft17 0 1 0 0 1 1 1 0 1 1 1 1 0 - - - 1 1 1 8 13 62% 
Croft18 1 1 0 0 1 0 1 0 1 1 1 1 0 - - - 1 1 1 8 13 62% 
Jacobsson32 1 1 1 1 1 0 1 0 1 1 1 1 0 - - - 1 0 0 8 13 62% 
Olsen, 
Vingard22, 28 
1 1 1 0 1 0 1 0 0 1 1 1 0 - - - 1 1 1 8 13 62% 
Thelin24 1 1 1 1 0 0 1 0 0 1 1 1 0 - - - 1 1 0 8 13 62% 
Thelin25 0 1 1 1 0 0 1 0 0 1 1 1 0 - - - 1 1 1 8 13 62% 
Roach33 0 1 0 0 1 0 1 0 0 1 1 1 0 - - - 1 1 1 6 13 46% 
Eastmond, 
White19, 20 
1 0 0 0 0 0 0 0 0 1 1 1 0 - - - 1 1 1 5 13 38% 
Vingard34 0 1 0 0 0 1 0 0 1 0 0 0 0 - - - 1 1 1 5 13 38% 
Lindberg21 1 1 1 1 0 0 0 0 0 0 0 0 0 - - - 1 0 1 5 13 38% 
Partridge23 0 0 1 1 0 0 0 0 1 0 0 0 0 - - - 1 0 0 3 13 23% 
 
Each item was scored as "1" when it met the specified criteria listed in Appendix A. (see chapter “appendices”) 
When it did not meet the criteria a "0" was assigned. Positive scores were summed up to an overall score.  
 *= informativity item. Not included in the analysis    - = not applicable 
Chapter 3 
38 
diverge between an OR 1.5 and 3.5. This also implies that there is moderate 
evidence for a relationship between a history of frequent lifting heavy weights (≥25 
kg), and the occurrence of hip OA. 
 
Figure 2: Quality score as a function of the OR.  
The numbers in the graph represent the reference numbers. 
 
 
 
 
 
 
 
 
 
 
 
 
Discussion 
In this systematic review, we summarized the available evidence in the literature 
on the influence of physical workload on the development of OA of the hip. Based 
on the evidence, we may conclude that there is moderate evidence for a positive 
association between hip OA and previous workload in general, as well as for the 
subcategories farming and lifting heavy weights.  
Although 12 of the included 16 studies showed a significant positive association 
between previous heavy workload and hip OA, the evidence could not reach the 
level of strong evidence. The main reason is that there are no high quality cohort 
studies. The two cohort studies included in this review, as well as the case-control 
studies, all had a retrospective design. With this type of design, we have to be 
cautious with recall bias occurring in the way physical workload was defined; on 
job title only or with a questionnaire asking for specific activities. Although a 
specific questionnaire will provide more precise information, the amount of recall 
bias will be more extensive. In addition to restrictions of the included studies, this 
review may have other limitations, as follows. 
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Identification and selection of the literature 
Although we put much effort into identifying all relevant articles, our literature 
search might have some limitations. First, some relevant articles may have been 
missed because they used other keywords or had unclear abstracts. Second, not 
all published articles are indexed in databases. Third, we excluded articles written 
in languages other than English, Dutch, German, French, Danish, Norwegian or 
Swedish. The presumed absence of publication bias found in our results (Figure 1) 
might be expected in this field of research. Studies that would have found no (or a 
negative) relationship have, in our opinion, the same opportunities for publication 
because there are no obvious conflicts of interest. 
 
Quality assessment and best evidence synthesis 
The quality assessment was challenging because there were no previously tested 
and validated criteria lists published for observational studies in the field of OA. In 
addition, limited data was found on performing a best evidence synthesis with 
observational studies (in contrast with RCT's). Thus we presented them in a 
reproducible manner, and the criteria we used were relatively strict. 
 
Comparison with the results of previous reviews 
It is interesting that the results of this review differ from the conclusions drawn in 
the systematic review of Meatzel et al.5. Generally, besides considerably more 
evidence for the relation between physical workload and the occurrence of hip OA, 
this review shows that this relation is stronger than suggested in the earlier review. 
This difference is partly due to the fact that five studies, published before 1994, 
could be included20, 23, 27, 30, 34, and partly to the fact that there has been an 
expansion in this field of research in recent years, what resulted in four more 
articles.16, 25, 29, 31 
 
Explanation for the relationship 
Considering the possibility for recall bias in all papers we studied, this could at the 
most only partly explain the relationship we found between high workload and hip 
OA. In our opinion, the most reasonable explanation is studied by Radin and 
colleagues35. They described that microfractures appear in the subchondral bone 
due to repeated high forces across a joint. Because of a less absorbing capacity of 
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the more compact and rigid bone structure, the overlaying cartilage has to absorb 
more forces. These forces will in fact cause degeneration of the cartilage tissue. 
Thus, by this mechanism, exposure to repetitive mechanical stress can lead to the 
development of hip OA. This explanation is supported by our finding that 10 of the 
16 studies, showed a clear dose-response relationship; one of the criteria for a 
biological gradient.36 
A frequently postulated explanation for the relationship between high physical 
workload and hip OA is that people with physical high demanding jobs, may obtain 
treatment earlier and/or more often than people in less demanding occupations; 
not necessarily because they have a higher incidence of OA, but possibly because 
they are more handicapped by it when it occurs. These people will be 
overrepresented; the exposure of interest may then be associated with the 
decision to seek treatment. This kind of selection is suggested in an earlier review 
on the influence of weight on the occurrence of hip OA37, where a difference was 
found between the clinically assessed hip OA vs. the radiological OA. In this 
review however, the outcome of the individual studies is not related to the way 
they assessed hip OA; clinically16, 20, 23-25, 27-34 or radiologically.17, 18, 21 The precise 
reason for the increased risk remains uncertain. Prospective studies providing 
information on the causal factors of the association between physical workload 
and hip OA are needed. 
 
Conclusion 
The available evidence found in the literature indicates that there is moderate 
evidence for a positive association between the amount of physical workload and 
the occurrence of hip OA. Also for the subgroups farming and lifting heavy 
weights, the evidence found is moderate. Future studies, especially prospective 
cohort studies, should further clarify the precise reasons for this relationship. 
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Abstract 
Objective: To evaluate the evidence for the existence of sporting activities as a 
risk factor for the occurrence of osteoarthritis (OA) of the hip. 
Methods: A bibliographical search of Medline, Embase and the Cochrane library 
until April 2000 was carried out. Articles with the aim to study a relationship 
between sporting activities and the occurrence of hip OA were selected. The 
quality of the studies was assessed using a standardised set of criteria. The 
outcome of the studies was compared with respect to study characteristics, and 
the quality score. A best evidence synthesis was used to summarise the results of 
the individual studies. 
Results: One cohort study and 21 cross-sectional studies were included in this 
review. Overall, moderate evidence was found for a positive association between 
physical sporting activities and the occurrence of hip OA, with an OR of 
approximately 2. Possible selection of the studied populations may partly be 
responsible for the association found, or may have diluted the real association. 
Conclusion: The evidence for a positive association between certain sporting 
activities and the development of hip OA is moderate. The highest risks are found 
in high intensity activities, especially for hip OA with a clinical presentation. 
 
Arthritis Rheumatism 2003; 49(2): 228-36. 
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Introduction 
Osteoarthritis (OA) of the hip is a common cause of disability of the elderly in 
western societies. It affects 7-25% of the Caucasian people over the age of 55.1 
Besides pain and discomfort, hip OA has substantial economic consequences2, 
and with the aging of the population this problem will increase. 
Recreational physical activities, including sporting activities, are widely 
encouraged as a major public health initiative to reduce cardiovascular diseases 
and osteoporosis.3,4 Also recent research suggests that regular exercise can be 
helpful in reducing the discomfort and dysfunction of OA5-7, but the risks 
associated with increased sporting activities are yet unclear. 
In recent years, more studies have become available investigating sporting 
activities and its association with hip OA, and even several reviews have been 
published on sporting activities and hip OA.8-11 However, none of the published 
reviews included clearly defined in- and exclusion criteria, a methodological quality 
assessment of the studies, as well as explicit criteria on which the assessment of 
the strength of the evidence was based.  
We therefore performed a systematic review, using modern methods for 
systematically identifying and assessing the available studies, in order to provide 
update knowledge for patients, doctors and policy makers, on the relation between 
sporting activities and the occurrence of hip OA. A similar evaluation of the 
evidence for physical workload as a risk factor for hip OA has been reported 
elsewhere.12 
 
Methods 
Identification and selection of the literature 
To identify observational studies on this subject, relevant publications were 
searched using the following databases: Medline (1966 to April 2000), Cochrane 
library (1993 to April 2000) and EMBASE (1980 to April 2000). The following 
keywords were used: (hip and (arthritis or arthrosis or osteoarthritis or 
osteoarthrosis) or coxarthrosis) and (risk factor or causative or determinants or 
predictor or etiology) and (case-control or retrospective or prospective or 
longitudinal or follow up or cohort). A detailed list can be obtained from the 
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corresponding author. The search was extended by screening the reference lists 
of all relevant articles identified. 
A study was eligible for inclusion if it fulfilled all of the following criteria: 1) one of 
the aims of the study was to investigate an association between hip OA and 
physical sporting activities, 2) the articles were written in English, Dutch, German, 
French, Danish, Norwegian or Swedish, 3) the article was a full text article, 4) the 
patients in the studies had to suffer from radiological and/or clinical hip OA, a 
(total) hip replacement, or were on the waiting list for one, and 5) the study design 
was a cohort or a case-control study. 
A study was excluded if the population studied had a specific underlying 
pathology, such as trauma (fractures), infection, rheumatoid arthritis, ankylosing 
spondylitis, Perthes' disease, tuberculosis, hemochromatosis, sickle cell disease, 
Cushing's disease, or femoral head necrosis. 
 
Publication bias 
Identification of all relevant articles is crucial to the validity of a systematic 
review.13 The amount of potential publication bias in our study was analysed by 
means of a funnel plot, in which the study outcome (Odds ratio (OR) on a log 
scale) was plotted against the sample size of the study. In the absence of 
publication bias, the plot will resemble a symmetrical inverted funnel.14 Because of 
the lack of required data, we could not perform a statistical test, so we visually 
examined the funnel plot for symmetry. 
 
Methodological quality assessment 
The methodological quality of observational studies can vary considerably, which 
may influence the results and conclusions of the studies at issue and consequently 
also the results and conclusions of a systematic review. Therefore, the quality of 
each included paper was assessed using the following method. Two reviewers 
(AML and SMABZ) independently scored the quality of the selected papers 
according to a standardised set of criteria (Appendix 1). These criteria have been 
used in previous reviews of observational studies in the field of musculoskeletal 
disorders12,15,16 and were modified to cover the topic of our review. The criteria 
concern both the internal validity, and the informativeness of the study. Only items 
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reflecting the internal validity of the studies were used to assess the 
methodological quality. 
In case of a disagreement the reviewers tried to achieve consensus; if 
disagreements were not resolved, a third reviewer (BWK) was consulted in order 
to achieve a final judgement. 
Several items are not applicable to a certain type of study design (e.g. cohort 
study or case-control study), and therefore do not contribute to the total score of 
that particular study. This means that the maximum score of each study (100%) 
was based only on the items applicable to that particular type of study design. 
Positive scores were summed up to an overall internal validity score. 
 
Best evidence synthesis 
Because the observational studies were considered to be heterogeneous with 
regard to the population studied, methodological quality and determinants and 
outcome measures for hip OA17, we refrained from statistically pooling of the data 
and performed a best evidence synthesis.12,18,19 First the studies were classified 
according to the type of study design. A prospective cohort study was judged as 
the most valid design, followed by a case-control study. After that, the studies 
were ranked according to their methodological quality score. The following ranking 
of the levels of evidence was formulated.12,20 
1. Strong evidence is provided by generally consistent findings in multiple high 
quality cohort studies. 
2. Moderate evidence is provided by general consistent findings 
- in one high quality cohort study and two or more high quality case-control 
studies. 
- in three or more high quality case-control studies. 
3. Limited evidence is provided by (general consistent) findings 
- in a single cohort study 
- in ≤ 2 case-control studies 
4. Conflicting evidence is provided by conflicting findings (i.e. <75% of the studies 
reported consistent findings). 
5. No evidence is provided when no studies could be found. 
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A study was considered to be of high quality if the methodological quality score 
was ≥ 60%. 
 
Data extraction 
Two researchers (AML and SMABZ) collected the characteristics of the included 
studies independently of each other. They collected items on the definition of the 
study population, how the presence or absence of hip OA was assessed, the 
assessment of sporting activities, if the study corrected for potential confounding 
factors and which results were reported. 
When a study reported several outcomes because of a division of the study 
population into subgroups, the separate outcomes were combined (where 
possible) using Mantel Haenszel statistics, methods described by Clayton and 
Hills21 or the method described by Tan and colleagues.22 We abstracted outcomes 
on sporting activities in general, and made subgroups for (long distance-) running, 
soccer, athletic activities, and ballet dancing, where possible. 
 
Results 
Identification and selection of the literature 
A total of 2921 references were initially identified; of these, 24 articles met our 
selection criteria.23-46 After screening the reference lists of the selected studies, 
another 3 studies were included.47-49 
For 4 of the studies, there appeared to be more than one publication (29,30, 37,38, 
25,46
 and 39,42,43), reporting different aspects of the study. All publications were used 
to extract data regarding the methods used and the results. Thus, finally, 22 
studies were included in this review. 
 
Publication bias 
To investigate the amount of publication bias for our study, a funnel plot was made 
(Figure 1). The plot shows the relationship between the point estimates of the 
association between sporting activities and hip OA, and the sample size (n). 
Nineteen of the 22 included studies, provided sufficient data to be included in the 
plot. The plot shows a more or less symmetrical shape. 
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Figure 1: Funnel plot showing the distribution of the OR according to the 
sample size. Of the 22 included studies, 19 provided sufficient data to be 
included in this plot. The numbers in the graph represent the reference 
numbers. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Description of the studies included 
Table 1 gives a description of the characteristics of the included studies. 
One cohort34, and 21 case-control studies23-29,31-33,35-37,39-41,44,45,47-49 were included 
in this review, of which only one had a prospective design.26 
Within the case-control studies, 17 of the 21 studies defined the cases by people 
who participated in sporting activities, and the controls by people who did not.23,26-
29,32,33,35,36,38,40,41,45-49
 These studies are sometimes referred to as trohoc studies.50 
The other four case-control studies defined the cases by people with, and the 
controls without hip OA.24,31,39,44 
Seven studies included only males27,29,33,36,39,45,47, whereas five others included 
only females.25,34,40,41,44 All studies were carried out in the USA31,34,35,47,49, or in 
Europe.23-29,32,33,36,38-41,44,45,48 Different kinds of sporting activities were studied. 
Eight studies reported results on a combination of different sporting activities as a 
group, like basketball, hockey, weight lifting, soccer, bowling, jogging, long 
distance running, swimming, golf.24-27,32,34,43,44 Ten studies reported on long 
distance/cross-country running separately.27,29,32,35,38-40,43,47,49 Five studies reported 
on soccer players24,27,28,36,39, four on athletics31,32,45,48, and two on ballet.23,41 
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Table 1: Details of the studies included 
Cohort study 
Author Definition population Assessment of hip OA Assessment 
of sports 
Adjusted 
for 
Results 
Lane34 All women from 
population based 
listings in 4 areas of the 
USA n=6418 age ≥65 
Clinical (pain) 
X-ray (JSN, osteophytes, 
cysts, sclerosis, femoral 
neck deformity) 
Times per 
year in 
different sports 
activities 
age, 
gender, 
BMI 
Clinical hip OA:  
1vs. 0x week OR 1.1 (0.7-1.7) 
>4 vs. 0x week OR 1.6 (1.0-2.5) 
X-ray hip OA  OR 1.3 (0.9-2.0) 
Case-control studies 
Author Cases/population Controls Hip OA Sports Adjusted  Results 
Marti37,38 Swiss national 
teams in long 
distance running 
n=27 age 35 yr. 
Healthy untrained 
volunteers and 
bobsleigh n=32 age 
42 yr. 
Clinical (pain 
function,) X-
ray (JSN, 
sclerosis,) 
Trohoc design age, 
gender 
Hip pain OR 26.7 (1.5-
490.4) 
X-ray hip OA OR 12.4 (0.6-
242.5) 
Vingard44 All female patients 
with a THR due to 
prim. hip OA in 5 
counties in Sweden 
n=242 age 50-70 yr. 
Random selection of 
women from same 
area without hip 
problems n=298 age 
50-70 yr. 
After THR Total hours of 
different kind 
of sports 
activities 
gender, 
age, BMI, 
workload, 
hormone 
Med. vs. low sports:  
OR 1.5 (0.9-2.5) 
High vs. low sports:  
OR 2.3 (1.5-3.7) 
Cooper24 Patients on waiting 
list for THR (prim 
OA) at 2 clinics in 
England n=611 age 
≥45 yr. 
Patients with the 
same GP n=611 age 
≥45 yr. 
Waiting for 
THR 
Freq. and 
duration of 
sports since 
leaving high 
school,  
age, 
gender, 
Heberden's 
nodes, hip 
trauma 
All sports OR 1.2 (0.9-1.6) 
Soccer OR 1.1 (0.7-1.6) 
Kujala32 Former male Finn 
athletes competing 
in int. championship 
from ‘20-‘65 n=2049 
Finnish males who at 
their 20 were fit 
(military exam). 
n=1403 
Clinical 
(physician 
diagnosed. 
ICD-codes) 
Trohoc design age, 
gender, 
area of 
residence 
All sports OR 2.4 (1.5-4.0) 
Endurance OR 1.7 (1.0-3.0) 
Mixed OR 1.9 (1.2-2.9) 
Power OR 2.2 (1.4-3.3) 
Konradsen 
29,30 
Danish cross 
country and long 
distance runners in 
nat. championships 
between ‘50-‘55 
n=27 age 50-68 yr. 
Males who have had 
a pelvic radiograph 
n=27 age 53-65 yr. 
X-ray 
(JSW<3mm, 
sclerosis, 
osteophytes) 
Trohoc design age, 
gender, 
BMI, 
workload 
X-ray hip OA OR 1.4 (0.4-
5.8) 
Olsen39  
Vingard42,43 
All male patients 
with a THR due to 
prim. hip OA in 
Stockholm  n=233 
age 50-70 yr.  
Random selection of 
man living in the 
referral areas n=302 
age 50-70 yr. 
After THR Total hours of 
different kind 
of sports 
activities 
age, 
gender, 
BMI, work, 
smoking 
Med. vs. low exposure  
OR 2.6 (1.5-4.5) High 
exposure OR 4.5 (2.7-7.6) 
Soccer OR 2.3 (0.7-7.7) 
Long run OR 2.1 (0.6-6.8) 
Lindberg36 Men from 10 soccer 
clubs in Malmö 
(Sweden) 
n=286 age 40-88 yr. 
Random selection of 
male population of 
Malmö n=572 age 
40-88 yr. 
Clinical (need 
for THR)  
X-ray (JSW) 
Trohoc design age, 
gender 
THR OR 10.2 (1.2-87.3) 
X-ray OR 2.1 (1.0-4.2) 
vs. controls (elite OR 3.7 
(1.4-10.1) non-elite OR 1.0 
(0.2-4.1)) 
Vingard45 All former Swedish 
male winner 
athletes n=109 age 
50-80 yr.  
Random selection of 
males from the 
population records 
n=302 age 50-80 
Clinical 
(reported 
diagnosis) 
Trohoc design age, 
gender 
Clinical hip OA OR 1.4 (0.3-
5.7) 
Prevalence ratio 3.6 (1.4-
9.3) 
Kettunen27 Former male elite 
sporters from 
Finland n=88 age 
58 (45-67) yr. 
Former male elite 
shooters n=29 age 
61 (50-68) 
Clinical (pain, 
disability) X-
ray (JSN, 
cysts, 
deformation 
femur head) 
Trohoc design gender Hip pain OR 0.8 (0.2-2.4) 
X-ray hip OA OR 0.5 (0.2-
1.6) 
Long distance running  
hip pain OR 1.3 (0.9-4.9)  
X-ray OR 0.4 (0.1-1.9) 
Soccer hip pain OR 0.7 (0.2-
3.0) X-ray OR 0.4 (0.1-1.9) 
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Author Cases/population Controls Hip OA Sports Adjusted  Results 
Kraus31 Patients referred by 
physicians with prim. 
hip OA (USA) (n=100) 
Patients at the same 
hospital at dep. surgery or 
general medicine (n=100) 
Clinical 
(patients) 
athletic 
activities 
during 
high 
school,  
age, 
gender, 
race 
Participating in 
athletic activities 
at high school OR 
1.7 (0.8-3.4) 
Kujala33 Orienteering male 
cross-country runners 
in Finland n=269 age 
37-61 yr. 
Finnish males who at their 
20 were fit (military exam). 
n=229 
Clinical (hip 
pain, physician 
diagnosed) 
Trohoc 
design 
age, 
gender, 
area of 
residence 
Clinical hip OA 
OR 0.8 (0.35-
1.73) 
Lane35 Long distance runners 
living in the USA n=28 
age 66.4 
Persons living within 100 
miles of the Stanford 
university  
n=27 age 66.4 
X-ray (JSN, 
sclerosis, 
osteophytes) 
Trohoc 
design 
age, 
education, 
workload 
X-ray hip OA 
similar for runners 
and non runners 
Spector40 English female ex elite 
middle and long 
distance runners + 
tennis players n=81 age 
40-65 yr 
Females from the general 
population of N-E- London 
n=977 age 40-65 yr. 
Clinical (pain) 
X-ray (JSN, 
osteophytes) 
Trohoc 
design 
age, 
gender, 
height, 
weight 
Hip pain OR 1.12 
(0.6-2.0) 
X-ray hip OA OR 
1.6 (0.7-3.5) 
Sohn49 Cross country runners 
of 7 USA colleges 
competing between ‘30-
‘60 n=504 age 23-77 yr. 
Swimmers of 3 schools 
who competed between 
‘30-‘60 n=287 age 23-77 
Clinical (pain, 
need for a 
THR) 
Trohoc 
design 
age, 
gender, 
weight, 
education, 
soc. class 
THR OR 0.6 (0.1-
2.28) 
White46 
Eastmond25 
Female physical 
education teachers of 
five colleges in England 
n=440 age 46-60 yr. 
Woman from general 
population n=887 
X-ray 
(Kellgren and 
Lawrence) 
Trohoc 
design 
age, 
gender 
X-ray hip OA OR 
1.8 (0.8-3.9) 
Jucker26 Sporters from 
Switzerland n=41 age 
35 yr. 
Volunteers n=38 age 36 Clinical 
(function) 
X-ray (not 
specified) 
Trohoc 
design 
- Hip pain OR 2.0 
(0.5-8.6) 
X-ray hip OA OR 
32.6 (0.1-9492) 
Klunder28 Former active football 
players in Vejle 
(Denmark) n=57 age 
40-79 yr. 
Patients without lower 
extremity problems and 
never active footballers 
n=57 age 42-80 yr. 
X-ray (JSN, 
sclerosis, cyst) 
Trohoc 
design 
age, 
gender, 
weight 
X-ray hip OA OR 
2.7 (1.2-5.9) 
Panush47 Volunteer current male 
runners n=17 age 50-74 
Male volunteer non 
runners n=18 age 50-74 
Clinical 
(complaints, 
physical 
examination) 
Trohoc 
design 
gender Hip pain OR 2.5 
(0.4-15.6) 
Van Dijk41 Former female 
members of major 
Dutch ballet companies 
n=19 age 50-70 yr.  
Female patients of the 
plastic and orthopaedic 
surgery without lower 
extremity problems n=19 
X-ray (JSW, 
osteophytes, 
sclerosis, 
cysts, bone 
destruction) 
Trohoc 
design 
age, 
gender, 
height, 
weight 
No statistically 
difference in the 
two groups. 
Puranen48 All male athletes from 
Finland from int. 
championships in ‘20-
‘65 n=74 age (31-81) yr. 
Files and X-rays of male 
patients at univ. hospital. 
without hip complaints 
n=115 age 40-75 yr. 
X-ray 
(osteophytes 
and OA 
changes) 
Trohoc 
design 
gender X-ray hip OA OR 
0.4 (0.1-1.7) 
Andersson23 Former ballet dancers 
from 5 places in 
Sweden n=44 age 44-
80 yr. 
General population in 2 
cities in Sweden n=? 
Clinical 
(history, need 
for THR) 
X-ray (JSN) 
Trohoc 
design 
- OA occurred more 
often in ballet 
dancers (p<0.001) 
THR= total hip replacemen JSN=joint space narrowing, JSN= joint space narrowing, JSW= joint space width, BMI= bodymass index, 
K&L=Kellgren and Lawrence 
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Four studies specified the amount of sporting activities and made different levels 
of the amount of sporting (e.g. lowest quartile vs. highest quartile of total amount 
of hours sported)34,37,43,44, whereas all others analysed the odds ratio (OR) with 
participation in the sporting activity or not.23,25-28,30-33,35,41,45,47-49 
The assessment of hip OA also varies in several studies. Fourteen studies relied 
on clinical information (e.g. seen at a clinic, need for a THR)24,26,27,31-33,36,38-
40,44,45,47,49
, and 11 studies reported data with a radiological assessment of hip 
OA.25-29,35,36,38,40,47,48 The other studies based the presence of hip OA on a 
combination of clinical and radiological parameters.23,34,41 
 
Methodological quality assessment 
The two reviewers scored 620 items and agreed on 568 items (92%, kappa 0.83). 
The 52 disagreements were resolved in a single consensus meeting. Table 2 
shows the studies in order of their methodological quality score, subdivided in the 
different types of study design (i.e. cohort and case-control studies). The scores 
range from 0% to 77% of the maximum obtainable score for each study design. 
The mean quality score was 47%. Six of the 22 (27%) studies were considered of 
high quality (≥60%).  
A clear correlation was found between the quality score and the study outcome 
(Figure 2) (Pearson correlation 0.5, p-value 0.05) 
 
Figure 2: Quality score of 19 of the 22 studies in relation to the odds ratio. The 
numbers in the graph represent the reference numbers. The lines represent the 
linear regression line and the 95% confidence interval. 
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This implies that the higher the quality score of the study, the stronger the reported 
association between sporting activities and hip OA. However, three of the 22 
studies could not be plotted due to a lack of precise data on the OR/RR.  
 
Table 2: Results of the quality score of the studies 
Item 1 2 3 4 5 
* 
6 7 8 9 10 11 12 
* 
13 14 15 16 
* 
17 
* 
18 19 
S
co
re
 
O
b
ta
in
ab
le
 
T
o
ta
l s
co
re
 
Cohort 
Lane 34 1 - 0 - 1 0 - 0 1 1 1 1 0 1 0 0 1 1 1 7 12 58% 
Case-control 
Marti 37,38 0 0 1 1 0 1 1 1 1 1 1 1 0 - - - 1 1 1 10 13 77% 
Vingard 44 1 1 1 1 1 0 1 0 1 1 1 1 0 - - - 1 1 1 10 13 77% 
Cooper 24 1 1 1 0 1 0 1 0 1 1 1 1 0 - - - 1 1 1 9 13 69% 
Kujala 32 0 1 1 1 1 1 1 1 1 0 0 0 0 - - - 1 1 1 9 13 69% 
Konradsen 29 1 0 1 0 1 0 0 1 1 1 1 1 0 - - - 1 1 1 8 13 62% 
Olsen/Vingard 
39,42,43 
1 1 1 0 1 0 1 0 0 1 1 1 0 - - - 1 1 1 8 13 62% 
Lindberg 36 0 1 0 0 0 1 0 1 0 1 1 1 0 - - - 1 1 1 7 13 54% 
Vingard 45 0 1 1 1 1 0 0 1 1 0 0 0 0 - - - 1 1 1 7 13 54% 
Kettunen 27 0 0 1 1 1 1 1 0 1 0 0 0 0 - - - 1 1 0 6 13 46% 
Kraus 31 1 1 1 1 1 0 1 0 0 0 0 0 0 - - - 1 0 1 6 13 46% 
Kujala 33 0 1 1 1 0 0 0 0 1 0 0 0 0 - - - 1 1 1 6 13 46% 
Lane 35 0 1 0 0 0 1 0 1 1 1 1 1 0 - - - 1 0 0 6 13 46% 
Spector 40 0 0 0 0 0 1 0 0 1 1 1 1 0 - - - 1 1 1 6 13 46% 
Sohn 49 0 1 0 0 0 0 1 1 1 0 0 0 0 - - - 0 0 1 5 13 38% 
White 25,46 1 0 0 0 0 0 0 0 0 1 1 1 0 - - - 1 1 1 5 13 38% 
Jucker 26 0 0 0 0 0 1 0 1 1 0 0 0 1 - - - 1 0 0 4 13 31% 
Klunder 28 0 0 1 0 1 0 0 0 1 0 0 0 0 - - - 1 1 1 4 13 31% 
Panush 47 0 0 0 0 1 0 1 0 1 1 1 0 0 - - - 1 0 0 4 13 31% 
van Dijk 41 1 0 0 0 1 0 0 0 1 0 0 0 0 - - - 1 1 1 4 13 31% 
Puranen 48 0 0 0 0 0 1 0 1 0 0 0 0 0 - - - 1 0 0 2 13 15% 
Andersson 23 0 0 0 0 0 0 0 0 0 0 0 0 0 - - - 1 0 0 0 13 0% 
 
Each item was scored as "1" when it met the specified criteria listed in Appendix A. (see chapter “appendices”) 
When it did not meet the criteria, or it was not described at all a "0" was assigned 
Positive validity scores were summed up to an overall internal validity score. 
*= informativity item. Not included in the analysis    - = not applicable 
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Of these, Lane and colleagues35 achieved a quality score of 54% and reported no 
association between sporting and hip OA. Van Dijk et al.41 scored 31% and 
reported no association, but Andersson23 achieved a score of 0% and reported a 
significant positive association between sporting and hip OA. 
One of the main concerns of the internal validity of observational studies is that of 
confounding.51 In case of confounding, the observed effect may occur due to a 
combination of several determinants that are prevalent in the study population. In 
hip OA two potential confounders are age and gender, and there should have 
been a correction for at least these determinants in the individual studies. Six of 
the 22 studies did not meet this criterion23,26,27,35,47,48, all the others did by means 
of matching, restriction or adjustment in the analysis. 
 
Strength of relationship 
Nineteen of the 22 studies showed exact data on the outcomes; the other three 
described the outcome in global terms.23,35,41. 
Fourteen studies showed a positive association between sporting activities and hip 
OA (OR ≥ 1.25)23,25,26,28,29,31,32,34,36,38,39,44,45,47 of which five were statistically 
significant28,32,36,43,44, indicating that subjects with certain sporting activities have 
an increased risk for developing hip OA as compared to non sporters. Five of 
these studies reached the level of high quality.29,32,34,38,44 
Four studies reported a negative relationship27,33,48,49, but none of these were 
statistically significant or reached the level of high quality. Four studies reported no 
association (0.8< OR <1.25).24,35,40,41 One reached the level of high quality.24 In 
order to investigate the existence of a dose response relationship, we selected the 
studies reporting on different levels of sporting activities. We also compared the 
results of normal sporting activities vs. high intensity (elite) sporting activities. All of 
the four studies analysing different levels of sporting activities did report a clear 
dose response relationship (table 1).34,36,43,44 A higher level or frequency of 
sporting activities raised the OR with a factor 1.5 to 3.7. There were seven studies 
reporting activities on elite athletes.27,29,32,38,40,45,48 The controls in six of these 
studies were nonathletes. In one study they were elite shooters.27 The OR’s in 
these studies seem to be comparable to the OR’s found in studies reporting on 
normal sporting activities (table 1 and 3). 
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Looking at a division between a clinical vs. a radiological assessment of hip OA, 
four out of six studies26,27,34,36,38,40 reporting on both outcomes, reported a stronger 
association in the clinical, as compared to the radiological assessed hip 
OA.27,34,36,38 The other five studies reported on radiological hip OA only, and the 
OR’s were comparable to the OR’s found in studies with a clinical assessment of 
hip OA (table 1 and 3). 
 
Table 3: Best evidence synthesis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 X-ray Clinical Quality score Best evidence synthesis 
Combination of sports 
Vingard 44  2.3 (1.5-3.7) 77 
Cooper 24  1.2 (0.9-1.6) 69 
Kujala 32  2.4 (1.5-4.0) 69 
Lane 34 1.3 (0.9-2.0) 1.6 (1.0-2.5) 58 
>3 high quality case-control 
studies + consistent findings 
for a positive association = 
MODERATE EVIDENCE 
Kettunen 27 0.5 (0.2-1.6) 0.8 (0.2-2.4) 46  
Eastmond 25 1.8 (0.8-3.9)  38  
Jucker 26 32.6 (0,1-9492) 2.0 (0.5-8.6) 31  
Running 
Marti 38 12.4 (0.6-242.5) 26.7 (1.5-490.4) 77 
Kujala 32  1.7 (1.0-3.0) 69 
Olsen 39  2.1 (0.6-6.8) 62 
Kujala 33  0.8 (0.4-1.7) 46 
Lane 35 No difference  46 
>3 high quality case-control 
studies + consistent findings 
for a positive association = 
MODERATE EVIDENCE 
Kettunen 27 0.4 (0.1-1.9) 1.3 (0.9-4.9) 46  
Spector 40 1.6 (0.7-3.5) 1.1 (0.6-2.0) 46  
Sohn 49  0.6 (0.1-2.3) 38  
Panush 47 1.1 (0.0-56) 2.5 (0.4-15.6) 31  
Soccer 
Cooper 24  1.1 (0.7-1.6) 69 
Olsen 39  2.3 (0.7-7.7) 62 
Lindberg 36 2.1 (1.0-4.2) 10.2 (1.2-87.3) 54 
Kettunen 27 0.4 (0.1-1.9) 0.7 (0.2-3.0) 46 
2 high quality case-control 
studies + conflicting findings = 
CONFLICTING EVIDENCE 
Klunder 28 2.7 (1.2-5.9)  31  
Athletics 
Kujala 32  1.9 (1.2-2.9) 69 
Vingard 45  1.4 (0.3-5.7 54 
Kraus 31  1.7 (0.8-3.4) 46 
One high quality case-control 
study = 
 LIMITED EVIDENCE 
Puranen 48 0.4 (0.1-1.7)  15  
Ballet 
Van Dijk 41 No significant difference (X-ray) 31 
Andersson 23 Significant more in dancers (Clinical) 0 
   
Conflicting findings in the 2 
case-control studies = 
CONFLICTING EVIDENCE 
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Best evidence synthesis 
Based on the best evidence synthesis (Table 3), we may conclude that there is 
moderate evidence for a positive relationship between physical sporting activities 
in general and hip OA, with an OR of approximately 2. With the best evidence 
synthesis on the different subgroups, the evidence found on the relationship 
between running and the occurrence of hip OA, is also moderate, with an OR of 
approximately 2. On the subgroup of athletics and hip OA the evidence found is 
limited for a positive relationship, and for the subgroups of soccer playing and 
ballet dancing the evidence is conflicting. 
 
Discussion 
In this systematic review, we summarized the available evidence in the literature 
on the influence of physical sporting activities on the development of OA of the hip. 
Based on the evidence, we may conclude that there is moderate evidence for a 
positive association between hip OA and sporting activities. Notable was that most 
of the studies had a trohoc design, where the cases were people who performed 
some kind of sporting activities, and the controls were people who did not.23,25-
29,32,33,35,36,38,40,41,45,47-49
 In this type of design, bias can occur firstly because this 
design is retrospective, and secondly because sporters differed from non sporters 
on other prognostic factors possibly related to hip OA. Not only the life expectancy 
of sporters compared to the non sporters is higher52, also the BMI, the pain 
threshold40, the amount of trauma to the lower extremities, and the occupational 
and leisure activities of sporters may differ from non sporters. These confounders 
may cause an underestimate or an overestimate of the real OR, but in only some 
of these studies, there was a correction for the BMI29,40,41,49 or workload.29,35 These 
shortcomings of the included studies, as well as the heterogeneity in the studies 
population and outcomemeasures, limit the level of certainty of our conclusion. 
Besides limitations of the included studies, this review may suffer from several 
restrictions as well. 
Although we have put much effort into identifying the relevant articles, our 
literature search might suffer from some limitations. Some relevant articles may 
have been missed because they used other keywords or had unclear abstracts 
and not all published articles are indexed in databases. Besides that, we excluded 
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articles written in languages other than English, Dutch, German, French, Danish, 
Norwegian or Swedish. 
The presumed absence of publication bias found in our results (Figure 1) might be 
expected in this field of research. Studies that would have found no (or a negative) 
relationship have, in our opinion, the same opportunities for publication because 
there are no obvious conflicts of interest. When assessing the funnel plot, we have 
to keep in mind that three of the 22 studies could not be included in the analysis 
due to insufficient data to deduce a point estimate. We believe, however, that 
these data are unlikely to greatly influence our results. Unfortunately, only one 
cohort study studying the association between sporting activities and hip OA could 
be found. This type of study design is known to be the most valid type of 
observational studies. Having more data from this type of design would have 
allowed us to provide a more valid and precise conclusion. 
The quality assessment was challenging because there were no previously tested 
and validated criteria lists published for observational studies in the field of OA. 
Due to a lack of information about the induction time of the sporting activities on 
the development of hip OA, a part of the advantage of a longitudinal study versus 
a case-control study disposes.  
Also, limited data were found to perform a best evidence synthesis with 
observational studies. Therefore we presented them in a reproducible manner, 
and the criteria we used were relatively strict. 
Although we are aware of the possibility for bias in most of the articles, the best 
evidence synthesis results in moderate evidence for a positive relation between 
sporting activities and the occurrence of hip OA. In this review we found a stronger 
association in the clinically assessed hip OA, as compared with the radiological 
assessed hip OA. Similar results were found in another review.12 One explanation 
for this finding could be that people participating in regular sporting activities do 
suffer more from the same radiological degree of degeneration from the hip joint 
than do nonparticipants, because sporting activities place great demands on the 
body. Another explanation could be that the hip complaint reflect hip symptoms 
due to nonarticular problems (e.g. tendinitis, bursitis, muscle strain etc.), because 
in 5 of the 6 studies clinical hip OA was defined as ‘hip pain’. 
Should we now all stop participating in sporting activities?  
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 If the only thing we should prevent was hip OA, the answer to this question should 
probabilly be yes. But besides the scientifically marginal literature this review is 
based upon, we do not know if physical sporting activities accelerate the 
development of hip OA, or if sporters do suffer more from the same degree of hip 
OA than non sporters. 
 
Conclusion 
The best evidence synthesis in this systematic review shows that there is 
moderate evidence for a positive relation between certain physical sporting 
activities and the occurrence of hip OA . The quality of studies reporting on this 
relationship, however, is disappointingly low. Future studies, especially 
prospective cohort studies, are clearly needed to gain better evidence. 
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Abstract 
Objectives: It has been proposed that some patients with primary hip 
osteoarthritis (OA), the disease occurs as a consequence of acetabular dysplasia 
or hip dysplasia. To investigate the association between acetabular dysplasia and 
hip OA, we performed a systematic review. 
Methods: To identify all observational studies for this systematic review, a 
database search of Medline, Embase and Cochrane library was carried out, and 
articles that aim to study the relationship between HD and hip OA were identified. 
The methodological quality of the selected studies was assessed using a 
standardised set of criteria, and a best evidence synthesis was used to summarise 
the results from the individual studies. 
Results: Five cohort studies and four case-control studies were included in this 
review. One cohort study had the correct design to be able to address to the 
question and reached the level of high quality study. This study reported a positive 
association between HD and hip OA. Overall, limited evidence was found for a 
positive association between HD and hip OA. However, most studies included 
persons at a higher age group. In younger age groups the relation between HD 
and OA or hip complaints may be much higher.  
Conclusion: The evidence for the influence of HD on the occurrence of hip OA, at 
age 50-60 or older, is limited. 
 
Annals of the Rheumatic Diseases 2004; Jun;63(6):621-6. 
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Introduction 
Osteoarthritis of the hip (hip OA) is an increasing problem in western societies, 
and is a major cause of morbidity and disability, especially among the elderly. In 
addition to the pain and discomfort it causes, OA has major economic 
consequences.1 
The reported prevalence figures of hip OA varies widely due to differences in the 
definition of OA or the selection of the study population. Studies in Europe have 
estimated that approximately 7-25% of Caucasian individuals over the age of 55 
years suffer from hip OA. The prevalence of hip OA appears to be lowest in 
Asians, followed by African black and Native American populations, and is highest 
in white Europeans.2-5 
It has been proposed that in a part of patients with primary hip OA, the disease 
occurs as a consequence of acetabular dysplasia or hip dysplasia (HD), which 
persist into adult life. Some radiological observations in patients with hip OA, and 
follow-up studies of subjects with HD support this theory.6-8 However, not all 
studies have reported a positive association.9 
To investigate if HD pre-dates hip OA, we performed a systematic review, using 
modern methods for systematically identifying and assessing the available studies. 
 
Methods 
Identification and selection of the literature 
Relevant publications were searched using the Cochrane library (1993- April 
2000), Medline (1966- April 2000) and Embase (1980-April 2000) databases. The 
following keywords were used: (hip and (arthritis or arthrosis or osteoarthritis or 
osteoarthrosis) or coxarthrosis) and (risk factor or causative or determinants or 
predictor or aetiology) and (case-control or retrospective or prospective or 
longitudinal or follow up or cohort). A detailed list can be obtained from the 
corresponding author 
We extended the search by screening the reference lists of all relevant articles 
identified. 
A study was eligible for inclusion if it fulfilled all of the following criteria: 1) one of 
the aims of the study was to investigate an association between HD and hip OA, 
2) the articles were written in English, Dutch, German, French, Danish, Norwegian 
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or Swedish, 3) the article was a full text article, 4) the patients in the studies had to 
have a radiological and/or clinical hip OA, a (total) hip replacement, or were on the 
waiting list for one, and 5) the study design was a cohort or a case-control study. 
A study was excluded if the studied population had a specific underlying 
pathology, such as trauma (fractures), infection, rheumatoid arthritis, ankylosing 
spondylitis, Perthes' disease, tuberculosis, hemochromatosis, sickle cell disease, 
Cushing's disease, or femoral head necrosis. 
 
Methodological quality assessment 
The variation of the methodological quality of observational studies may influence 
the results and conclusions of a systematic review. Therefore, the quality of each 
included study was assessed using the following procedure. 
Two reviewers independently scored the quality of the selected papers according 
to a standardised set of criteria (Appendix 1). These criteria have been used in 
previous reviews of observational studies in the field of musculoskeletal disorders 
and were modified to cover the topic of our review.10-13 The criteria concern both 
the internal validity, and the informativeness of the study. Only items reflecting the 
internal validity of the studies were used to assess the methodological quality. 
In case of a disagreement, both reviewers tried to achieve consensus; if 
disagreements were not resolved, a third reviewer was consulted in order to 
achieve a final judgement. 
Several items are not applicable to a certain type of study design (e.g. cohort 
study or case-control study), and therefore do not contribute to the total score of 
that particular study. This means that the maximum score of each study (=100%) 
was based only on the items applicable to that particular type of study design. 
Positive scores were summed up to an overall internal validity score. 
 
Best evidence synthesis 
Because observational studies are heterogeneous with regard to the study 
population, methodological quality and determinants and outcome measures for 
hip OA, we refrained from statistically pooling the data,14 and performed a "best 
evidence synthesis”.10,11,14-17  
The studies were stratified according to the type of study design. In order to clarify 
the question whether AD pre-dates hip OA, the only studies which can really 
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address this question are prospective cohort studies: i.e. they follow patients 
without hip OA with the presence or absence of HD measured, forward in time, 
and identify who develops hip OA subsequently. Therefore these studies were 
judged as the most valid design. Studies with cross-sectional data on hip OA and 
HD were not considered in the best evidence synthesis. Furthermore, the studies 
were ranked according to their methodological quality score:10,11,18 
1. Strong evidence is provided by generally consistent findings in multiple high 
quality cohort studies. 
2. Moderate evidence is provided by general consistent findings 
- in one high quality cohort study and two or more high quality case-control 
studies. 
- in three or more high quality case-control studies. 
3. Limited evidence is provided by (general consistent) findings 
- a single cohort study 
- in ≤ 2 case-control studies  
4. Conflicting evidence was provided by conflicting findings (i.e. <75% of the 
studies reported consistent findings). 
5. No evidence was provided when no studies could be found. 
A study was considered to be of high quality if the methodological quality score 
was > 60%. 
 
Data extraction 
Two researchers (AML and SMABZ) independently collected the characteristics of 
the included studies. They collected items concerning the definition of the studied 
population, how the presence or absence of hip OA was assessed, the 
assessment of HD, if the study corrected for potential confounding factors, and 
which results were reported. 
 
Results 
Identification and selection of the literature 
2921 references were identified. After an initial shifting on the title and the abstract 
of the references, the full text papers were screened whether they met our 
selection criteria. Of these, 12 articles met the criteria.6,9,19-28  
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After screening the reference lists of the selected studies, one other study was 
included. 8 
For three studies, there was more than one publication, reporting different aspects 
of the studies.20,21, 6,22, 9,19,28 All publications were used to extract data regarding 
the methods used and the results. 
Finally, 9 studies were included in this review. 
 
Description of the studies included 
Table 1 gives a description of the characteristics of the included studies. 
Five studies had a cohort design.6,20,23,25,28 After screening the reference lists of 
the selected studies, one other study was included.8 
For three studies, there was more than one publication, reporting different aspects 
of the studies.20,21, 6,22, 9,19,28 and four studies had a case-control design.8,24,26,27 
Three of the five cohort studies collected the data in a prospective manner,6,20,25 
and only one study followed up patients without hip OA, forward in time.6 
One study included only males,23 and one other only females.6 Six studies 
included patients with the age of 60 – 65 years or older,6,23-25,27,28 the other three 
included a population with younger individuals as well.8,20,26 Data on congenital HD 
are lacking. 
Three studies reported data on Asian,20 or on Asian and Caucasian 
populations.23,28 All others reported on Caucasian people. 
Only one study was community based,6 all others were hospital based. Of these 
hospital-based studies, two actually selected the patients not on the presence or 
absence of hip OA, but on having had an intra-venous urography (IVU).23,28 
In all studies, the assessment of HD was done by measuring the center-edge 
(CE)angle (is the angle between 1) a vertical line drawn from the center of the 
femoral head at right angles to the line joining the 2 femoral head centers, and 2) a 
line from the center of the femoral head to the lateral edge of the acetabular roof). 
Seven of the nine studies also measured the acetabular depth (AD; the 
perpendicular distance from the deepest point of the acetabular roof to the line 
joining the the lateral margin of the acetabular roof and the upper corner of the 
symphisis pubis on the same side), index or ratio.6,8,20,23,25,27,28 
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Table 1: Details of the studies included in this review 
Author Cases/ 
population 
Definition 
controls 
Definition 
hip OA 
Definition 
dysplasia 
Results 
Cohort
 
Lane6,22 White female in four regions of the 
USA with (K&L 2-4) and without 
(K&L 0) hip OA  (n=58/118, ≥65 yr.) 
Nested case control with 8.3 (7.4-
10.4) yr. prospective follow-up 
X-ray (K&L) CE-angle 
<30° 
AD <9mm. 
Female with vs. without hip OA had  
a smaller CE-angle  OR 3.3 (1.1-10.1) 
a smaller AD            OR 0.6 (0.1-3.3)  
dysplasia                 OR 2.8 (1.0-7.9) 
Murphy25 Patients after THR because of hip 
OA, with (K&L 3-4) and without (K&L 
0-2) controlateral hip OA (n=74/43, 
≥65 yr.) Nested case control 
prospective follow-up 
X-ray (K&L) CE-angle 
AD index 
(depth/width) 
CE-angle and acetabular index were 
significantly smaller in the OA patients 
(p<0.0001)  
Hasegawa 
20,21 
Japanese patients with pre or early 
hip OA (n=64, 13-62 yr.) 
Prosp. follow-up 12.8(10-25) yr. 
X-ray (JSN, 
sclerosis) 
CE-angle 
AD-ratio 
Patients with a fast progression from pre 
to early hip OA had a significant smaller 
CE-angle, and a smaller AD-ratio 
(p<0.001) 
Yoshimura 
28 Croft19 
Smith9 
British patients after IV urography 
(n=1498, 60-75 yr.) and Japanese 
people after pelvic X-ray (n=198, 60-
79yr.) Cross sectional 
X-ray 
(MJS) 
CE-angle 
AD 
Correlation between MJS and CE-angle: 
British male r = -0.37   female r= -0.25 
Jappanese male r= -0.39  female r= -0.26 
Correlation between MJS and AD:  
British male r = -0.15  female r= -0.11 
Jappanese male r=-0.09  female r=-0.07 
Lau23 Male Chinese and British* patients 
after IV urography (n=999, 60-75 
yr.) Cross-sectional 
X-ray 
(MJS≤1.5) 
CE-angle 
<25° 
AD <9mm. 
People with a MJS ≤1.5 vs. >4 mm had a 
smaller AD (OR 0.4 (0.05-2.9)) and a 
smaller CE-angle (OR 0.5 (0.03-8.7)) 
Case-control 
Laforgia24 Patients in Italy 
on waiting list for 
osteotomy or 
THR (n=60, age 
77 yr.) Cross-
sectional 
Trauma patients 
with an X-ray 
without hip OA 
(n=49, age 77) 
Waiting list CE-angle CE-angle is significantly smaller in 
superolat. OA, and sign. higher in 
concentral/ medial OA as compared to 
controls 
Murray8 British patients 
with hip OA 
(n=50) 
Cross-sectional 
Patients without 
hip OA (n=200) 
Clinical 
(patients) 
X-ray (JSN, 
cysts, 
osteophyte
s) 
CE-angle 
<25° 
AD <9mm. 
Patients with HD showed an earlier age 
of onset of hip OA (50,8 yr. versus 57,7 
yr. in control) 
Terjesen26 Patients in 
Norway at 
orthopaedics 
with hip 
complaints, with 
CE≥20° (n=50, 
48-81 yr.)  
Cross-sectional 
Patients of the 
same 
department 
without a hip 
disease, with 
CE≥20° (n=30, 
52-84 yr.) 
Clinical 
(pain, 
disability) 
X-ray  
CE-angle 
<25° 
No significant difference in CE-angle 
between patients with vs. without hip OA 
Wedge27 Patients in 
Canada with 
prim. hip OA 
(n=30, 65 yr.) 
Retrospective 
Random 
selection of post 
injury X-rays 
n=54 52 yr. 
Clinical 
(patients) 
X-ray 
CE-angle 
<25° 
AD <14mm. 
on AP X-ray 
Patients with hip OA had a significant 
smaller CE-angle and AD 
K&L= Kllgren and Lawrence  AD= acetabular depth  IV= intra venous JSN= joint space narrowing  MJS= mean joint space 
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The cut-off point for the definition of HD according to the CE-angle was ≤25° in 
three studies6,8,23,27 and ≤30° in one study.6 One study used a CE-angle ≤20° as 
an exclusion criterion for the studied patients.26 
Two of the five cohort studies defined the presence of hip OA by a radiographic 
scoring system, described by Kellgren and Lawrence.6,25 In the three other cohort 
studies, the assessment of hip OA was based on the measurements of the joint 
space width. The four case-control studies based their case series on hospital 
patients with hip OA, so their definition of hip OA was a combination of clinical 
signs or complaints and radiographic abnormalities.8,24,26,27 
 
Results of the studies included 
The included studies presented their results in various ways; one reported a 
correlation coefficient,28 and two reported an odds ratio (OR).6,23 The six other 
studies described the outcomes in global terms only.8,20,24-27 
In order to provide a global overview of the reported outcomes, we assessed 
whether the relationship between HD and the occurrence of hip OA was ‘positive’ 
(the presence of HD is a risk factor for hip OA), ‘negative’ (HD protects for hip OA) 
or ‘no’ (there is no (significant) relation). A more detailed description of the 
outcomes is given in table 1.  
Six studies reported a positive association,6,8,20,24,25,27 ; five of them reported the 
outcomes in global terms, and the only prospective follow-up study reported that 
patients with dysplasia had a 2.8 higher risk in developing hip OA.6 Two studies 
reported a negative association23,28; one reported a correlation coefficient of 
approximately –0.38 implying that a smaller CE-angle is correlated to a broader 
MJS.28  The other study reported that people with dysplasia had a 0.5 to 0.4 
smaller risk of having a hip OA.23 Both studies reported partially on the same 
population. Only one study reported no relationship.26 
 
Methodological quality assessment 
The two reviewers scored 514 items and agreed on 467 items (95%, kappa 0.80). 
The 47 disagreements were resolved in a single consensus meeting. Table 2 
shows the studies in order of their methodological quality score, subdivided in the 
different types of study design (i.e. cohort and case-control studies). The scores 
range from 75% to 23%, and the average rating was 45%. 
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Table 2: Quality scores of the of the studies included in this review 
Criteria no. 1 2 3 4 5 
* 
6 7 8 9 10 11 12 
* 
13 14 15 16 
* 
17 
* 
18 19 
S
co
re
 
O
o
b
ta
in
ab
le
 
T
o
ta
l s
co
re
 
Cohort 
Lane 6,22 1 - 0 - 1 0 - 1 1 1 1 1 1 1 0 0 1 1 1 9 12 75% 
Murphy 25 1 - 1 - 1 0 - 1 1 1 1 1 1 0 0 0 1 0 0 7 12 58% 
Hasegawa 
20,21 
1 - 0 - 0 0 - 0 1 0 0 0 1 1 1 1 1 1 0 6 12 50% 
Yoshimura28, 
Croft19 
Smith9 
0 - 1 - 0 0 - 0 1 1 1 1 0 0 0 0 1 1 1 6 12 50% 
Lau 23 0 - 1 - 0 0 - 0 1 1 1 1 0 0 0 0 1 0 1 5 12 42% 
Case-control 
Laforgia 24 1 0 0 0 1 0 1 0 1 1 1 1 0 - - - 1 0 0 5 13 38% 
Murray 8 1 0 0 0 0 0 1 0 1 0 0 0 0 - - - 1 1 1 5 13 38% 
Terjesen 26 1 0 0 0 0 0 1 0 1 0 0 0 0 - - - 1 0 1 4 13 31% 
Wedge 27 1 0 0 0 0 0 1 1 0 0 0 0 0 - - - 1 0 0 3 13 23% 
 
- = Not applicable.    * = Informativity item. Not included in the analysis. 
 
Best evidence synthesis 
Only one of the three prospective cohort studies had the design that really could 
address to the research question, and this study reached the level of high quality. 
The other two prospective cohort studies did not reach the level of high quality.  
The high quality prospective cohort study reported a positive association between 
HD and the occurrence of hip OA with prospective data, implying that a patient 
with HD, has a higher chance of getting hip OA. This means that there is limited 
evidence for a positive association between HD and the development of hip OA. 
 
Discussion  
In this systematic review, we summarised the available evidence in the literature 
on the influence of HD on the development of hip OA. Based on the evidence, we 
may conclude that there is limited evidence for a positive association between HD 
and hip OA. However, most studies included persons at a higher age group (e.g. 
50-60 years or older). In younger age groups the relation between HD and OA or 
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hip complaints seem to be much higher.29 In these kind of populations however, it 
is difficult to study the relationship, because the power of a prospective cohort 
study to estimate an effect in this rare disease would need for implausibly large 
samples. 
Five out of nine studies had cross-sectional data. One of the most important 
biases in these studies is that the measurements of HD can be modified by the 
OA-process. For example, osteophyte formation might make it difficult to correctly 
locate the lateral acetabular margin, resulting in less reliable measurements of the 
CE-angle and AD. Moreover, medial migration of the femoral head may increase 
the CE-angle. 
In fact, the data we found support the theory that changes in the hip joint geometry 
as a result of OA may be responsible for the (weak) negative association. All three 
prospective studies, including the only study with a hip OA free population at the 
beginning of the study, reported a positive relationship between HD and the 
occurrence of hip OA, and the single retrospective study reported no association.  
Two of the five cohort studies included people after having had an IVU. Although 
these populations are hospital based, the requirement for an IVU implies no 
marked differences in acetabular dimensions, and therefore biases due to 
selection for treatment of hip OA, are avoided. But, the leg position during X-ray is 
not standardised for an IVU, and patients with sustained hip OA tend to lie with the 
leg in external rotation. This rotation of the hip may influence the measurements of 
the CE-angle. Although these differences are estimated to be small,30 they may 
produce less reliable results. Both studies performed with data from IVU reported 
a negative association, whereas five of the seven other studies reported a positive, 
and none reported a negative association. Also the difference in the X-ray 
techniques used (e.g. for trauma, IVU and before hip replacement) might make it 
more difficult to compare the data.  
Besides restrictions of the included studies, this review may suffer from several 
restrictions as well. 
 
Identification and selection of the literature 
Although we have put much effort into identifying all relevant articles, our literature 
search might have some limitations, not only because some relevant articles may 
have been missed because they used other keywords or had unclear abstracts, 
Review hip dysplasia and hip OA 
 
 
77 
but also not all published articles are indexed in databases. Besides that, we 
excluded articles written in languages other than English, Dutch, German, French, 
Danish, Norwegian or Swedish. 
To investigate the amount of potential publication bias for our study, we planned to 
make a funnel plot,10 but only three of the nine studies provided enough data to 
allow us making this funnel plot. Unfortunately this implies that we are unable to 
visualise the possibility of publication bias in this review. 
 
Quality assessment and best evidence synthesis 
The quality assessment was challenging because there were no previously tested 
and validated criteria lists published for observational studies in the field of OA. In 
addition, limited data was found on performing a best evidence synthesis with 
observational studies (in contrast with RCT's).31 We therefore presented our 
methods in a reproducible manner, in order to give the reader insight in the 
pathway how our level of evidence is reached. 
In the best evidence synthesis, we defined that only prospective cohort studies are 
able to address the research question. In fact only those with a disease free 
population at the beginning of the study are able to do that, but because 
populations with an early hip OA that were studied prospectively in time can 
support the evidence, we included them as well. We are however cautious with 
this kind of information because of the bias that can be introduced. (Acetabular 
deformity can pre-date hip OA)  
Despite the above mentioned biases and limitations, the evidence for an 
association between HD and the development of hip OA is limited. A hypothetical 
mechanism to explain the association is the increased joint stress due to 
decreased joint surface area (smaller CE-angle), or joint incongruity (smaller 
acetabular depth).32,33 
In view of the limited evidence on the positive relationship between mild forms of 
HD and the occurrence of hip OA in the elderly, and the lack of information in the 
younger individuals, more well designed prospective population based studies are 
needed in order to provide more precise and valid information on this relation. 
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Abstract 
Objective: To systematically summarise the available articles on the prognostic 
factors of osteoarthritis (OA) of the hip 
Methods: The identification of the articles was done by means of a systematic 
database search of Medline, Embase and the Cochrane library. Articles with the 
aim to study the prognostic factors of hip OA were selected and their 
methodological quality was assessed using a standardized set of criteria. Data of 
the individual studies were combined where possible and a best evidence 
synthesis was conducted. 
Results and conclusions: Twelve studies were included in this review. Ten 
studies had a cohort design, of which five collected their data prospectively. Two 
studies had a case-control design. The methodological quality scores ranged from 
25% to 100% of the maximum obtainable score for each type of study design. The 
mean quality score was 58%. Based on the evidence, we may conclude that there 
is strong evidence that people with a supero- (lateral) type of migration of the 
femur head or an atrophic bone response show a more rapid progression of hip 
OA as compared with a medial migration c.q. hypertrophic bone response. Also 
strong evidence is found that there is no relationship with obesity and the 
progression rate of hip OA. 
Limited evidence is found that, when there is a more severe joint space narrowing 
at first consultation, there will be an earlier need for a (total hip replacement) THR, 
as well as for no relation between hip dysplasia and the progression of hip OA. 
 
Arthritis Care and Research 2002; 47(5): 556-62. 
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Introduction 
Osteoarthritis (OA) of the hip affects 7-25% of Caucasian people over the age of 
55.1 In addition to the related pain and discomfort, hip OA has substantial 
economic consequences2, and with the current aging of the population in western 
societies this problem will increase. Unlike most other sites affected, hip OA can, 
besides remaining stable or progress, also show regression.3 Up to now, two 
reviews have been published on the prognosis of hip OA3,4, but due to sparse 
data5-7, no firm conclusions could be drawn, other than a brief summary of the 
information available. Since then several new studies investigating the prognosis 
of hip OA have been published.8-13 They describe prognostic factors, which 
potentially can predict the course of the disease. These prognostic factors are, 
unlike risk factors, not necessarily causally related to the outcome, rather than just 
describe the presence of an association. Some of these factors are modifiable, like 
obesity, and therefore will be appropriate for clinical intervention, but most of them 
are not modifiable (e.g. gender, age, type of bone response). Information on these 
factors can be of importance though; not only to give prognostic information to the 
patients and doctors, but also for health care provision. 
In order to gain insight in the different factors predicting the course of hip OA, we 
systematically reviewed the available studies on this topic, using modern methods 
of systematically identifying and assessing and summarizing the available 
evidence. 
 
Methods 
Identification and selection of the literature 
To identify the observational studies on this subject, relevant publications were 
searched using the following databases: Medline (1966- April 2000), Cochrane 
library (1993- April 2000) and Embase (1980-April 2000). The following keywords 
were used: (hip and (arthritis or arthrosis or osteoarthritis or osteoarthrosis) or 
coxarthrosis) and (prognosis or progression or progressive or disease course or 
predictive or precipitating or predictor) and (case-control or retrospective or 
prospective or longitudinal or follow up or cohort). (A detailed list can be obtained 
from the corresponding author.) The search was extended by screening the 
reference lists of all relevant articles identified. 
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A study was eligible for inclusion if it fulfilled all of the following criteria: 1) one of 
the aims of the study was to investigate factors associated with the progression of 
hip OA, 2) the articles were written in English, Dutch, German, French, Danish, 
Norwegian or Swedish, 3) the article was a full text article, 4) the patients in the 
studies had to have a radiological and/or clinical hip OA, a (total) hip replacement, 
or were on the waiting list for one, and 5) the study design was a cohort or a case-
control study. 
A study was excluded if the studied population had a specific underlying 
pathology, such as trauma (fractures), infection, rheumatoid arthritis, ankylosing 
spondylitis, Perthes' disease, tuberculosis, hemochromatosis, sickle cell disease, 
Cushing's disease, or femoral head necrosis. 
 
Methodological quality assessment 
The variation of the methodological quality of observational studies may influence 
the results and conclusions of a systematic review. Therefore, the quality of each 
included study was assessed using the following procedure. Two reviewers (AML 
and SMABZ) independently scored the quality of the selected papers according to 
a standardized set of criteria (Appendix 3). These criteria have been used in 
previous reviews of observational studies in the field of musculoskeletal 
disorders14-16 and were modified to cover the topic of our review. The criteria 
concern both the internal validity, and the informativeness of the study. Only items 
reflecting the internal validity of the studies were used to assess the 
methodological quality. 
In case of a disagreement, both reviewers tried to achieve consensus; if 
disagreements were not resolved, a third reviewer (BWK) was consulted in order 
to achieve a final judgement. 
 
Best evidence synthesis 
Because observational studies in this systematic review were considered to be 
heterogeneous with regard to the study population, methodological quality and 
determinants and outcome measures for hip OA, we on forehand refrained from 
statistically pooling the data17, and performed a "best evidence" synthesis.18-20 
First the studies were classified according to the type of study design. A cohort 
study was judged as the most valid design, followed by a case-control study. After 
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that, the studies were ranked according to their methodological quality score. The 
following ranking of the levels of evidence was formulated18 14,16; 
1. Strong evidence is provided by generally consistent findings in multiple high 
quality cohort studies. 
2. Moderate evidence is provided by general consistent findings 
- in one high quality cohort study and two or more high quality case-control 
studies. 
- in three or more high quality case-control studies. 
3. Limited evidence is provided by (general consistent) findings 
- in a single cohort study 
- in ≤ 2 case-control studies  
4. Conflicting evidence was provided by conflicting findings (i.e. <75% of the 
studies reported consistent findings). 
5. No evidence was provided when no studies could be found. 
A study was considered to be of high quality if the methodological quality score 
was ≥ 60%. 
 
Results 
Identification and selection of the literature 
Twelve of the initially 2921 identified references, met our selection criteria.6-12,21-25 
For two studies, there was more than one publication22,23 and11,12,21, reporting 
different aspects of the study. All publications were used to extract data regarding 
the methods used and the results reported. Also two studies reported of the same 
source population, but had a totally different design8,9, so these will be discussed 
separately. After screening the reference lists, another three studies could be 
included.26-28 Thus, finally 12 articles were included. 
 
Description of the studies included 
Tables 1 and 2 give detailed description of the characteristics of the included 
studies. 
We included 10 cohort studies6,7,9-11,22,24-27, of which five collected their data 
prospectively6,7,9,11,22, and two case-control studies.8,28 All studies were hospital-
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based. None of the studies reported on regression of hip OA, there were only 
reports on the progression of hip OA.  
 
Table 1: Details of the studies included. 
 
Author  Study design Definition population Assessment 
progression 
Results 
Cohort studies 
Conrozier9 Prospective 
follow-up 1 yr. 
Patients referred to a 
rheumatology dept. in Sweden or 
France with primary hip OA 
(ACR-criteria)(n=48)  
Mean age 56.4 (±14.1) yr. 
X-ray (JSN, 
YMN) 
r (JSW (at entry) - YMN)=0.66 
(p<0.001) 
no correlation between BMI and YMN 
Dougados11 Prospective 
follow-up 3 yr. 
Patients from a multicentre base 
in France with primary hip OA 
(ACR-criteria and K&L-grade) 
(n=508) 
Mean age 63 (50-75) yr. 
Clinical (need 
for THR) 
Parameters predictive for the 
requirement for a THR: 
Age ≥ 70 RR 1.65 (1.06-2.56) 
Female RR 1.71 (1.11-2.62) 
Superolateral migration RR 1.96 (1.27-
3.02) 
JSW < 2 mm RR 1.85 (1.18-2.90) 
Conrozier10 Retrospective 
follow-up 64 
(18-300) 
months 
All patients who received a THR 
at 2 hospitals in France between 
'92-'93 because of primary hip 
OA (superior JSN and evidence 
for OA at operation) (n=61) 
Mean age 62 (30-80) yr. 
X-ray (YMN) Correlation to YMN: 
Atrophic bone response 
More superolateral migration (NS) 
No correlation to YMN: 
gender, age, weight, height, hip 
dysplasia, JSW at entry 
Ledingham7 Pros- and 
retrospective 
follow-up 24 (3-
72) months 
Patients attended to 
rheumatology/ orthopaedic clinic 
with symptomatic hip OA (K&L ≥ 
2) (n=136 prospective, 30 
retrospective) 
Mean age 65 (29-86) yr. 
Clinical (need 
for THR) 
X-ray (JSN, 
osteophytes, 
cysts, 
sclerosis and 
attrition) 
Rapid progression on X-ray:  
female OR 2.53 (0.91-7.41) 
atrophic bone response OR 8.31 
(3.18-21.98) 
superior migration OR 9.0 (1.24-
183.52) 
THR needed: atrophic bone response 
OR 3.13 (1.28-7.69) 
Tron24 Retrospective 
follow-up 5.2 
(±3.6) yr. 
Patients at a clinic in France with 
symptomatic hip OA (K&L) (n=39) 
Mean age 55.5 (30-87) yr. 
X-ray (YMN) r (YMN - BMI)= 0.26 (p=0.06) 
r (YMN-CE-angle)= -0.28 (p<0.05) 
Superolateral deteriorated more than 
other locations (NS) 
YMN older age > YMN younger age 
(p=0.008) 
YMN atrophic bone response >YMN 
hypertrophic bone response (NS) 
YMN was not related to gender 
Danielsson6 Prospective 
follow-up 8-12 
yr. 
All patients who attended to the 
only orthopaedic clinic in Malmö 
with hip complaints and X-ray 
changes (n=168) 
Mean age 69.4 (± 0.91) yr. 
Clinical (need 
for THR) 
X-ray (JSN, 
osteophytes, 
cysts and 
sclerosis) 
X-ray progression was greater in a 
lateral localization than in the medial or 
mixed type 
Need for THR not age related 
Hasegawa 
22 
Prospective 
follow-up 13 
(10-26) yr. 
Patients of 6 hospitals in Japan, 
with subluxation or dysplasia from 
the hip (n=64) 
Average age 29.5 (13-62) yr. 
X-ray (JSN) Joint incongruence (p≤0.05), and a 
broken Shenton's line (p≤0.01) were 
predictors for a development from 
pre/early- hip OA to advanced hip OA 
Age and BMI are not related. 
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Author Study design Definition 
cases 
Definition 
controls 
Assessment 
progression 
Results 
Vinciguerra 
25 
Retrospective 
follow-up 58 (1-
358) months 
Outpatients of a rheumatology 
clinic in France with hip OA 
(ACR) (n=149) 
Mean age 58 (±14) yr. 
Clinical (need 
for a THR) 
Factors predictive for a THR: 
Age at diagnosis > 54 yr. RR 3.15 
(1.81-4.48) 
More severe JSN RR 2.97 (1.66-5.32) 
BMI > 27  RR 2.26 (1.23-3.99) 
Auquier26 Retrospective 
follow-up 10 (6-
23) yr. 
Patients who went to a health 
resort in France and were treated 
for hip OA (n=273) 
Mean age 51.8 (±8.6) yr. 
Clinical 
(functional 
status: pain, 
walking 
distance, 
walking stick) 
Primary OA in women showed more 
worsening than other forms (0.05 < p < 
0.02)) 
Macys27 Retrospective 
follow-up 
Patients who received a THR at a 
clinic in the US, because of prim 
hip OA (n=183) 
Clinical (need 
for a THR) 
At least 50% of the males had 
symptoms for > 5 years prior to 
surgery, which was longer than most 
females 
Case-control studies    
Conrozier8 Retrospective 
follow-up 
study 64 (18-
300 months 
Patients from 
a cohort study 
9 with a 
rapidly 
progressive 
hip OA 
(YMN> 1mm) 
(n=11) Mean 
age 71.2 
(±10.6) 
Patients from the 
same cohort with a 
slowly progressive 
hip OA (YMN<0.2 
mm) (n=24) Mean 
age 60.5 (±11.8) 
yr. 
X-ray (YMN) CRP, JSW and the age were all 
independently related to the rapidly 
progressive group as compared to the 
slowly progressive group (p=0.01, 
p=0.006 and p=0.02) 
Perry28 Retrospective 
follow-up 
study 5 yr. 
Patients from 
rheumatology 
clinic in 
England with 
hip OA (K&L 
≥2) with 
recovery of 
JSW after 5 
yr. (n=14) 
Age 58,6 (43-
71) 
Patients from the 
same clinic with 
hip OA (K&L ≥2) 
and progressive 
deterioration of the 
JSW after 5 yr. 
(n=9) 
Age 56,3 (43-69) 
X-ray (JSW) The average weight for each group 
was comparable 
JSW= joint space width, JSN= joint space narrowing, K&L-grade= Kellgren and Lawrence grade, YMN= yearly mean narrowing 
of the joint space, THR= total hip replacement surgery, BMI= body mass index, VAS= visual analogue scale, COMP= cartilage 
oligomeric matrix protein, BSP= bone sialoprotein. 
 
The assessment of the course of hip OA can be divided in two main categories; 
progression on clinical parameters (e.g. the need for a total hip replacement 
(THR)), or progression measured by radiological parameters, like the joint space 
narrowing (JSN) or the yearly mean narrowing (YMN) of the joint space. Six 
studies reported on a clinical assessment of the hip OA progression.6,7,11,25-27 
Seven studies assessed the deterioration with radiological parameters.6-10,22,24,28 
A variety of factors, which may influence the progression of hip OA, have been 
studied. The seven most frequently studied factors are: age at first consultation, 
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gender, the site of the JSN (type of migration), joint space width (JSW) at first 
radiograph, type of bone response (e.g. hypertrophic, atrophic), BMI or weight and 
hip dysplasia. Other factors like the presence of osteophytes, cysts or Heberden's 
nodes, or the Kellgren and Lawrence classification, pain or functional status at 
entry were studied only in one or two publications, and therefore will not be 
discussed in this review. 
 
Table 2: Results of the methodological quality score of the studies. 
Item 1 2 3 4 5 
* 
6 7 8 9 10 11 12 
* 
13 14 15 16 
* 
17 
* 
18 19 
S
co
re
 
O
ta
in
ab
le
 
T
o
ta
l 
sc
o
re
 
Cohort 
Conrozier 9 1 - 1 - 1 1 - 1 1 1 1 1 1 1 1 1 1 1 1 12 12 100% 
Dougados 
11 
1 - 1 - 1 1 - 1 1 1 1 1 1 1 1 1 1 1 1 12 12 100% 
Conrozier 
10 
1 - 1 - 1 0 - 0 1 1 1 1 0 1 0 0 1 1 1 8 12 67% 
Ledingham 
7 
1 - 1 - 1 0 - 0 1 1 1 1 1 1 0 0 1 0 1 8 12 67% 
Tron 24 1 - 1 - 1 1 - 0 1 1 1 1 0 1 0 0 1 0 0 7 12 58% 
Danielsson 
6 
1 - 0 - 0 0 - 1 0 1 1 0 1 1 0 0 0 0 0 6 12 50% 
Hasegawa 
22 
1 - 0 - 0 0 - 0 1 0 0 0 1 1 1 1 1 1 0 6 12 50% 
Vinciguerra 
25 
1 - 0 - 1 0 - 0 1 1 1 1 0 0 0 0 1 1 0 5 12 42% 
Auquier 26 1 - 0 - 1 0 - 0 1 0 0 0 0 1 0 0 1 0 0 3 12 25% 
Macys 27 1 - 0 - 1 0 - 0 1 0 0 0 0 0 0 0 1 0 1 3 12 25% 
Case-control 
Conrozier 8 1 1 1 1 1 0 1 0 1 1 1 1 0 - - - 1 1 1 10 13 77% 
Perry 28 1 1 0 0 0 0 1 0 1 0 0 0 1 - - - 1 0 0 5 13 38% 
 
Each item was scored as "1" when it did meet the criteria listed in Appendix A. (see chapter  
 appendices” When it did not meet the criteria a "0" was assigned. Positive validity scores were summed up to an overall 
internal validity score. 
na = not applicable. *= informativity item. Not included in the analysis. 
 
 
Results of the studies included, their methodologic quality assessment and best 
evidence synthesis 
The included studies presented their results in various ways. Six studies described 
the outcome in global terms only.6,8,22,26-28 The others presented the measures of 
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association with an OR of RR7,11,25 or a correlation coefficient9,10,24 (Table 1). 
Because of this poor data presentation, we present the outcomes in terms of a 
'positive' (the factor studied, increases the progression of hip OA), a 'negative' (the 
factor decreases the progression of hip OA) or 'no' (the factor has no influence on 
the progression of hip OA) association (Table 3).  
 
Table 3: Results of the best evidence synthesis. 
Factor Studies * Association † Best evidence synthesis 
Higher age 
at T0 
2 HQ cohort studies 10,11 
1 HQ case control study 8 
4 LQ studies 6,22,24,25 
No, positive 
Positive 
No, no, positive, positive 
Conflicting evidence 
Female  3 HQ cohort studies 7,10,11 
3 LQ studies 22,24,27 
No, positive, positive 
No, no, positive 
Conflicting evidence 
Migration 3 HQ cohort studies 7,10,11 
2 LQ studies 6,24 
Superolateral, superolateral, 
superior 
Lateral, superolateral 
Strong evidence for a faster 
progression in a supero-lateral 
migration of the femur head 
JSW at Baseline   
Need for THR 1 HQ cohort study 11 
1 LQ study 25 
negative 
negative 
Limited evidence for a negative 
relationship (smaller JSW increases 
the risk for a THR) 
Progression of 
YMN 
2 HQ cohort studies 9,10 
1 HQ case-control study 8 
No, positive 
Negative 
Conflicting evidence 
Atrophic 
response 
2 HQ cohort studies 7,10 
1 LQ study 24 
Positive, positive 
Positive 
Strong evidence for faster 
progression when there is an 
atrophic bone response  
BMI/ 
weight 
2 HQ cohort studies 9,10 
4 LQ studies 22,24,25,28 
No, no 
No, positive, positive, no 
Strong evidence for no relationship 
between BMI/weight and 
progression 
Dysplasia 1 HQ cohort study 10 
2 LQ studies 22,24 
No 
Positive, positive 
Limited evidence for no relationship 
between dysplasia and progression 
Underlined outcomes are studies with a clinical assessment of the progression of hip OA. 
T0= Measured at baseline  *=HQ: High quality/ LQ: Low quality study (measured with methodological quality score) 
†= Positive association: the presence/higher level of the factor will result in a faster deterioration of hip OA. 
                     No association: the rate op progression is not influenced by the factor. 
                     Negative: the presence/higher level of the factor will result in a slower deterioration of hip OA. 
 
 
 
The two reviewers scored 594 items and agreed on 562 items (95%, kappa 0.89). 
The 32 disagreements were resolved in a single consensus meeting. Table 2 
shows the studies in order of the study design (i.e. cohort/ case-control study) and 
their methodological quality score. The scores ranged from 25% to 100% of the 
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maximum obtainable score for each study design. The mean methodological 
quality score was 58%. 
 
Age at first consultation 
Seven studies reported outcomes on the relationship between the age of the 
patient at consultation, and the progression of the hip OA.6,8,10,11,22,24,25 Of these, 
two high quality cohort studies reported no10, respectively a positive11 association. 
The one high quality case-control study8 reported a positive association. This 
means that there is conflicting evidence for an association between the age of first 
consultation and the progression rate of hip OA. 
Gender 
Six studies reported on the gender in relation with the progression of the hip 
OA.7,10,11,22,24,27 Two of the three high quality cohort studies7,11 in this group, 
reported that females had a higher progression of hip OA than men. The other 
high quality cohort study reported that there was no association.10 There were no 
high quality case-control studies; therefore, we may conclude that there is 
conflicting evidence for an association between gender and the progression of hip 
OA. 
Type of migration 
Five studies reported on the association between the site of the JSN (type of 
migration) (e.g. superior, lateral, medial) and the progression of hip OA.6,7,10,11,24 
Two of the three high quality cohort studies reported a more rapid progression of 
hip OA when there was a superolateral migration of the femur head.10,11 The other 
high quality cohort study reported a higher rate in a superior migration.7 This 
means that we can conclude that there is strong evidence for a more rapid 
progression of hip OA when there is a supero- (lateral) migration of the femoral 
head, as compared to a medial migration. 
Joint space width at the first X-ray 
Because of the different ways of correlation (when there is a small JSW, the part 
left to decrease (the YMN) will be small), we subdivided these studies in type of 
outcome; need for a THR and YMN. 
There were two studies reporting on the relationship of the JSW at first X-ray and 
the need for a THR.11,25 There was one high quality cohort study11, so we can 
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conclude that there is only limited evidence for a negative relationship (the smaller 
the JSW at entry, the higher the need for a THR). 
JSW and YMN 
We found three studies reporting on the association between the YMN (measured 
in mm) and the first measured JSW.8,9,10  Because8 and9 reported of the same 
baseline population, these conclusions will not be summed up in the best evidence 
synthesis, but only the data of one study9 will be included in the conclusion. Both 
studies9,10 had a high quality score, but showed conflicting results, so we can 
conclude that there is conflicting evidence for an association between the JSW at 
entry and the YMN. 
Atrophic bone response 
Three cohort studies investigating this relationship7,10,24 showed a positive 
association, of which two reached the level of high quality.7,10 Therefore we may 
conclude that there is strong evidence for a positive relationship, implying a faster 
progression of hip OA when there is atrophic bone response, as compared to a 
hypertrophic bone response. 
BMI / Weight 
Six studies investigated the relationship between weight or the BMI and the 
progression of hip OA9,10,22,28, of which two high quality cohort studies both 
reported no association.9,10 There were no case-control studies of high quality. 
This means that we found strong evidence for no association between the BMI 
and the progression rate of hip OA. 
Hip dysplasia 
Three studies reported on the relationship between hip OA and the CE-
angle10,22,24, and of these, only one reached the level of high quality10, thus we can 
conclude that there is limited evidence for an absence of a relation between hip 
dysplasia and the progression of hip OA. 
 
Discussion 
In this systematic review, we summarized the available evidence in the literature 
on the influence of several factors on the course of hip OA. A problem by drawing 
conclusions in this systematic review is the way the included studies presented 
their results. A result described in this review as "no" association can mean 
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various outcomes; a not significant "positive", "negative" or "no" association. 
Because some articles only described their data globally, rather than by giving 
exact numbers, we were not able to distinguish between these different meanings 
of the results. 
Another problem arises with the selection of the populations studied; all of these 
populations were hospital based, so they are not representative of community-
based hip OA. Of all factors studied, the only factor that can be influenced is 
obesity. In this review, obesity appears to have no relationship with the 
progression of hip OA. We have to be cautious though, to not advise the obese 
patient with beginning hip OA to lose weight. This information is based only on 
studies where the BMI is measured at the beginning of the study. None of the 
studies assessed the BMI during follow-up. 
In a recent review the evidence found for a relationship between obesity and hip 
OA was moderate.29 One of the explanations for this relationship was that obese 
people suffer earlier from the same degree of hip OA. This very well might state 
our findings that obese persons suffer earlier, but show just as much progression 
of hip OA compared to non-obese persons. On the other hand, the findings in this 
review on obesity are based on six studies, and only one of them used clinical 
parameters as an outcome. All the others used radiological parameters.  
Besides the limitations related to the included studies, there are some restrictions 
of this review itself. Although we put much effort into identifying all relevant 
articles, our literature search might have some limitations. Besides some relevant 
articles that may have been missed because they used other keywords, had 
unclear abstracts or were not indexed in databases, we also excluded articles 
written in languages other than English, Dutch, German, French, Danish, 
Norwegian or Swedish. 
In our analysis we did not include the paper of Seifert and colleagues5, although it 
has been cited frequently, because the publication was an abstract and we 
refrained from including publications other that full text articles. However, we did 
score the methodological quality of this paper, and mainly due to the short 
descriptions they would have only scored 25% of the obtainable 100%. 
The quality assessment was challenging because there were no previously tested 
and validated criteria lists published for observational studies in the field of OA. In 
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addition, limited data was found on performing a best evidence synthesis with 
observational studies (in contrast with RCT's). 
In spite of the presented limitations, we argue that the use of this systematic 
approach with scoring the quality of the studies included and defining levels of 
evidence is appropriate. One important aspect of this relatively new approach of 
observational studies is to give the reader insight into the process of reaching 
conclusions. Readers are now able to repeat the analysis and it provides insight in 
how the results might be influenced if slight changes are made in the assessment 
of the findings or the methodological quality of the studies. 
For example, if only the studies in which the progression of hip OA was assessed 
by clinical findings6,7,11,25,27, the results in the best evidence synthesis would have 
changed slightly, except for the analysis on the subgroup of gender; the 
conclusion would than change from "conflicting evidence" to "strong evidence" for 
a faster progression in women. 
This illustration also suggests that when more articles will become available in 
time, the conclusions will become more solid. Now one additional single 
publication can have an enormous impact on the results.  
Future research, especially prospective cohort studies, with an adequate follow-up 
time, is needed to strengthen the conclusions.  
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Abstract 
Background: Trochanteric pain is the second most important diagnosis of hip 
problems presenting in primary care. The incidence and prognosis though is 
largely unknown. 
Aim: To determine the one and five-year prognosis of trochanteric pain and the 
predictive variables for consistent complaints. 
Design of the study: Retrospective cohort study. 
Setting: One hundred and sixty-four patients (mean age = 55 years, 80% female) 
with incidental trochanteric pain in the years 1996 or 2000 were asked in 2001 for 
past and present symptoms of trochanteric pain. Therapeutic interventions, 
demographic factors and co-morbidity were also investigated. 
Methods: The databases of 39 general practitioners were screened in order to 
identify all incident cases with a suspicion of trochanteric pain in the years 1996 or 
2000. These cases were sent a questionnaire. 
Results: The incidence of trochanteric pain in primary care is 1.8 patients per 
1000 per year. After 1 year 36% still suffered from trochanteric pain, and after 5 
years this was 29%.  
Patients with osteoarthritis in the lower limbs had a 4.8-fold risk of persistent 
symptoms after one year, as compared to patients without osteoarthritis. Patients 
who had received a corticosteroid injection had a 2.7-fold chance of recovery after 
5 years, as compared to patients who had not received an injection. 
Conclusion: Trochanteric pain shows to be a chronic disease in a substantial part 
of the cases. The disorder is associated with much impairment in daily activities. 
 
British Journal of General Practice 2005; 55: 199-204 
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Introduction 
Trochanteric pain, also known as trochanteric bursitis or pseudotrochanteric 
bursitis is a frequently occurring problem. The pain experienced by 10-20% of all 
patients with hip problems presenting in primary care can be attributed to 
trochanteric pain.1 
In 1979, Little described trochanteric pain as pain at the lateral side of the upper 
thigh, often with radiation to the knee.2 Although it has been attributed to 
trochanteric bursitis and/or tendinitis, one study reported that sonographic effusion 
of the bursa was seldom found. Effusion around the trochanteric tendons, 
however, was more often present than in other patients with hip pain.3 
Trochanteric pain has been described as a solitary syndrome, as a result of 
trauma but also as a co-morbid condition in patients with low-back pain or 
osteoarthritis (OA) of the hip.4-6, 7-10 Some authors have even described 
trochanteric pain as one of the first symptoms in developing hip OA.9,11  
In order to gain more insight in trochanteric pain, we performed a retrospective 
cohort study in general practice, focussing on the one and the five-year prognosis. 
In this article we want to address the following questions: 
− What is the incidence of trochanteric pain in general practice? 
− What is the impact of trochanteric pain on daily activities? 
− What therapy is given? 
− What is the prognosis of trochanteric pain after 1 and 5 years? 
− What variables might predict the prognosis? 
 
Methods 
Identification and selection of the cases 
General practitioners (GPs) using electronic medical databases were approached 
in the year 2001 for participation in the study. Patients aged 18 years and older 
who presented to their GP in the 1996 or 2000 with pain at the region of the 
greater trochanter were identified. The identification of these patients was done in 
the electronic medical databases using the keywords troch* or pain* and hip*. The 
medical records of these patients were read and they were identified as possible 
incident cases if they had consulted their GP for the first time in two years with 
these symptoms. Only patients who confirmed by questionnaire that they had 
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suffered from pain at the lateral side of the upper leg were considered incident 
cases with trochanteric pain. Patients with trochanteric pain in 1996 were asked 
for the present condition of their symptoms. These data were used for the 
prognosis after five years. The data from patients with trochanteric pain in 2000 
were used for the “one year” follow-up, subdivided in four groups: those presenting 
in January / March 2000 were asked for the 16 months follow-up, those from April / 
June for the 13 months follow up, from July / September for the 10 months, and 
finally those from October / December 2000 for the seven months follow-up. 
 
Questionnaire 
The questionnaire covered patient characteristics, (demographic data, daily 
activities and co morbidity) and various characteristics of the trochanteric pain, 
(past and present symptoms, localisation, pain severity (VAS, 0-100) and kind of 
therapy). 
The present quality of life was assessed with the Euroqol (0=worst possible quality 
of life – 1=best possible quality of life).12 The present functional disability due to 
the trochanteric pain was assessed with the WOMAC (Western Ontario and 
McMaster) osteoarthritis index).13 This index is used to assess disability due to 
arthritis of the hip or knee. It has three discrete domains: pain (five questions, 
possible subscale score 0-20), stiffness (two questions, 0-8) and physical 
functioning (17 questions, 0-68) and has a minimum score of 0 (best score) and a 
maximum score of 96 (worst score). 
 
Data-analysis 
We investigated the percentage of patients who still had symptoms of trochanteric 
pain in 2001 (observed values). In a sensitivity analysis we assessed whether 
these figures would change due to potential selective non-response (expected 
values). In the first analysis we assumed that all non-responders did have 
trochanteric pain at baseline and were free of trochanteric pain at the time of 
investigation (best case scenario). In the second analysis we assumed them to still 
suffer from trochanteric pain at the end of the follow-up (worst case scenario). 
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Left and right censoring 
There were only two measurements in time for each patient: time of diagnosis and 
the follow-up investigation. This implies that the data on a specified time are only 
based on that particular subgroup of patients. For example patients with a follow-
up of 13 months do not have data on the 7, 10, 16 or 60 months. So if someone 
has recovered at 13 months, he could already have been recovered at 7 or 10 
months. Also, when he has not recovered at that time, he could have been 
recovered at 16 or 60 months. This is called left and right censoring. In order to 
correct for this kind of censoring we analysed our data with the SAS program proc 
life reg. (version 6.12). 
 
Predictive variables 
Variables that might have predicted improvement were evaluated using the binary 
logistic regression mode in SPSS. Variables with a P-value of 0.20 or less in the 
univariate analysis were considered in the backward stepwise multivariate model. 
Variables with a P-value of 0.10 or less in the multivariate model were left in the 
model.  
 
Results 
Incidence 
Forty-one GPs in the south-west region of the Netherlands were approached, and 
39 were willing to participate. A total number of 95297 persons were registered at 
these GPs.  Three hundred and forty-five patients with a suspicion of trochanteric 
pain were identified and sent a questionnaire, of whom 187 (54%) replied. Of 
these responders, 164 (87,7%) met our criteria of trochanteric pain (cases). The 
remaining 23 patients reported pain symptoms in the low back, groin, buttock or 
knees and not in the region of the greater trochanter. Figure 1 shows the flow 
chart of the patients and responders.  
There were no statistically significant differences between sex and age between 
the non-responder, responders and cases. Also, no statistically significant 
differences were found for co-morbidity between the responders and the cases, 
see table 1. 
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Figure 1: Flow chart of patients and responders 
 
 
 
 
 
 
 
 
 
Table 1: Characteristics of all identified patients 
 Identified patients Non-responders Responders Cases 
N (number of patients) 345 158 187 164 
Age, mean (sd) 55.3 (15.4) 54.4 (17.4) 56.0 (13.5) 55.4 (13.5) 
Female gender, % 75% 69% 79.9% 79.9% 
Arthritis on lower limbs or low back pain, %  48% 58% 
 
Patient characteristics and impact of trochanteric pain 
Of the 164 cases 79.9% were female and the mean age at diagnosis was 55.4 
years (range 21 - 87 years). For more patient characteristics, see table 2. 
Of those working, about 34% were (very) much troubled during work related 
activities and about a quarter of them have had a history of sick leave due to the 
trochanteric pain. About 40% of the patients were disturbed during sleeping. Fifty-
four percent of the sporting people were (greatly) impaired during their sporting 
activities. The mean VAS score for hip pain in patients still suffering from 
trochanteric pain at follow-up is 46,0 and their mean WOMAC score is 36.5. The 
WOMAC scores for those recovered are 11.2. 
The mean Euroqol score for those with prolonged symptoms is 0.97 and for those 
recovered 0.99. The state of health assessed with the VAS was 68.5 for those with 
symptoms at follow-up, and 78.6 for those recovered. See table 3. 
Patients with 
Trochanteric pain 
n=164 
Electronic search 
persons with suspicion of trochanteric pain 
n=345 
Replay on questionnaire 
n=187 
No response 
n=158 
Patients with 
pain not in region of 
greater trochanter 
n=23 
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Table 2: Characteristics of the patients (n=164) with trochanteric pain  
 Baseline Follow-up 
Age in years, mean (sd) 55.4 (13.5)  
Female gender, % 79.9 79.9 
Localisation:   right, % 
          bilateral, % 
40 
23 
40 
23 
Body Mass Index 
          overweight (BMI 25-30), % 
          obese (BMI >30), % 
  
35 
15 
Hip osteoarthritis, %  24 
Knee osteoarthritis, %  16 
Low-back pain, %  14 
 
 
Table 3: Pain scores and quality of life scores at follow-up (n=164) 
 
 With GTPS symptoms 
at follow-up  
(n=116 ) 
Without GTPS 
symptoms at follow-up 
(n=48) 
P-value) 
Pain (VAS 0-100) 46.0 4.4  (<0.0001) 
WOMAC pain (0-20) 8.6 2.3  (<0.0001) 
WOMAC function (0-68) 25.0 7.6  (<0.0001) 
WOMAC stiffness (0-8) 3.1 1.3  (<0.0001) 
WOMAC total (0-96) 36.5 11.2  (<0.0001) 
Euroqol 0.970 0.992 (0.024) 
State of health (VAS 0-100) 68.5 78.6  (0.008) 
 
 
Therapy 
Of all patients, half of them (55%) were treated by their GP or specialist with 
medication (paracetamol, NSAID’s), and 52% of these patients mentioned 
(temporarily) improvement. Thirty-seven percent of the cases were injected in the 
region of the greater trochanter with corticosteroids (66% with improvement). 
A third (35%) of the patients were only treated by their GP. Of these, 53% received 
paracetamol or NSAID’s (48% with improvement) and 34% were injected (60% 
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with improvement). Half (52%) of the patients received physiotherapy (two-third 
mentioned improvement). A third (36%) of the cases went to the hospital where 
therapy consisted of administration of paracetamol or NSAID’s (36%), or a local 
corticosteroid injection (34%). Three out of the five patients who received an 
operative treatment reported a reduction of the pain. 
 
Prognosis 
At one year of follow-up, 76% of the responders still suffered from trochanteric 
pain and at 5 years 63% still did. 
In the best case scenario (all non-responders were cured at the time of 
investigation), at 1 year follow-up, 36% still had trochanteric pain and at 5 years, 
29% did. 
In the worst case scenario (all non-responders were not cured at the time of 
investigation), these percentages changed to 84% and 83% respectively.  
In the best-fitted analysis (proc life reg. SAS), 78% of the responders had 
symptoms at one year and 60% at 5 years. All these observed and expected 
values are shown in Figure 2. 
 
Figure 2: Percentage of patients with symptoms at follow-up time. 
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Predictive variables 
For the prognosis at 1 year, there were 2 variables that predicted sustained 
symptoms of trochanteric pain; duration of symptoms before the patient visited the 
GP (more vs. less than 1 week) (odds ratio (OR) 4.9,  90% confidence interval (CI) 
(1.8-13.2)) and the presence of OA in the lower limb(s) at follow-up (OR 4.8 (CI 
1.2-18.5)). In this model, age and gender were considered confounders (Table 4). 
 
Table 4: Possible determinants for prolonged complaints of  trochanteric pain 
(univariate and multivariate analysis) 
 
 1 Year follow-up 5 year follow-up 
Variables Univariate  OR   
(P-value) 
Multivariate   OR (CI) Univariate  OR  
(P-value) 
Multivariate  OR (CI) 
Age (continuous) 1.02 (0.30) 1.01 (0.97 – 1.04) 1.00 (0.95) 1.00 (0.96 – 1.04) 
Gender (male/female) 1.75 (0.41) 1.39 (0.41 – 4.77) 1.23 (0.74) 0.78 (0.25 – 2.38) 
Bilateral symptoms (-/+) 1.03 (0.96)  2.32 (0.19) 2.35 (0.66 – 8.35) 
BMI     normal (<25) 
           overweight (25-30) 
           obese (>30) 
0.55 (0.21) 
2.32 (0.13) 
0.83 (0.77) 
 
2.38 (0.81 – 6.98) 
** 
** 
** 
 
Level of education 
           Low (prim. school) 
           Normal (sec. school) 
           High (high school) 
 
2.98 (0.07) 
0.32 (0.03) 
1.33 (0.68) 
  
1.73 (0.31) 
0.96 (0.94) 
0.42 (0.19) 
 
 
 
0.38 (0.11 – 1.33) 
Duration of symptoms* 5.53 (0.003) 4.88 (1.81 – 13.16) 4.50 (0.10) 5.29 (1.05 – 26.57) 
Analgetics (-/+) 1.68 (0.27)  0.63 (0.37)  
Corticosteroid injection (-/+) 1.24 (0.66)  0.45 (0.15) 0.37 (0.13 – 1.00) 
Arthritis lower extremities (-/+) 4.26 (0.03) 4.77 (1.23 – 18.50) **  
Low-back symptoms (-/+) 4.19 (0.18) 2.70 (0.42 – 17.52) **  
     
*) before visit to the GP (less than 1 week/ 1 week or more) 
**) retrospective data. Not considered continues over time period of 5 years 
CI= 90% confidence interval 
 
Patients developing OA did not receive corticosteroid injections more or less often 
as compared to patients not developing osteoarthritis (chi-square 1.43 P-value 
0.71). Also no statistical significant differences were found in specific symptoms at 
first presentation like pain located only at the greater trochanter or occurrence of 
the pain by applying pressure (chi-square 1.43 reps. 0.18, and P-value 0.71 and 
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0.33). In this model, age, gender, BMI, use of analgesics or consultancy of 
physiotherapy all showed no significant relationship with the prognosis of 
trochanteric pain.  
For the long term prognosis at 5 years, there were 2 variables that predicted 
sustained symptoms of trochanteric pain; duration of symptoms before the patient 
visited the GP (more vs. less than 1 week) (OR 5.3 (CI 1.1- 26.6)), and having had 
a corticosteroid injection (OR 0.4 (CI 0.1–1.0)). Also in this model age and gender 
were considered confounders.  
 
Discussion 
Summary of main findings 
The incidence of trochanteric pain in primary care is 1.8/1000/year. After one year, 
76% of the responders still suffer from trochanteric pain and after 5 years 
approximately 63% does. Due to possible selection bias, these figures will 
probably be lower in reality, but not lower than 36% and 29% respectively. 
Predictors associated with improvement within one year are duration of symptoms 
at the first visit to the GP and the absence of osteoarthritis in the lower limbs. For 
the improvement within five years, again the duration of symptoms before the first 
visit to the GP, as well as having had a corticosteroid injection are predictive. 
 
The strengths and limitations of this study 
This study is vulnerable for different biases. The first is selection bias. This may be 
a result of the high number of non responders (46%) and it is probable that 
patients with sustained symptoms were more likely to return the questionnaire. We 
were able to correct for this kind of bias in the calculation of the prognosis of 
trochanteric pain (best/worse case scenario). Likewise it could be that patients 
without symptoms at the time of the investigation did not return the questionnaire. 
Therefore, we expect that the real percentage with sustained symptoms is lower 
than observed, and will approximate those from the best case scenario. 
For the calculation of the incidence of trochanteric pain however, the data are 
likely to be influenced by this selection bias. That is why we choose not 
extrapolate the 12% inaccurately selected patients with pain located elsewhere, to 
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the non-responders group, but to calculate the incidence directly from the patients 
with trochanteric pain as reported by the GP. 
The impact of trochanteric pain seems to be substantial; about 30-40% of the 
patients were impaired in their daily activities. However, these data are also prone 
to selection bias, because it is likely that patients with sustained symptoms 
returned the questionnaire more often. Moreover, these data are also prone to a 
second type of bias introduced; the so called recall bias (historical information 
reported by the participants is known to be inaccurate). 
The third type of bias in this study is the bias by indication. An important finding of 
this study is that patients who received a corticosteroid injection in the region of 
the greater trochanter, showed a better prognosis of their hip problems after five 
years. There might have been bias by indication; perhaps only patients with a lot 
of pain received this injection. Due to the retrospective character of this study, we 
were not able to correct for this potential confounder. However, assuming that the 
more severe cases have a worse prognosis, but also receive an injection earlier, 
this study gives an indication that corticosteroid injections are more effective than 
other treatments in trochanteric pain. 
To look for other potentially biases by indication, we analysed whether there were 
variables that might influence the choice of the GP to give an injection. The only 
two variables found were pain elicited when the patient lay on the affected side 
and the development of low-back pain at the time of follow-up. However, these 
variables do not significantly influence the model.  
Finally, our study results suggest that patients with osteoarthritis had a higher risk 
on persistent symptoms after one year, as compared to patients without 
osteoarthritis. This finding can be biased because the greater trochanter is one of 
the sites to which hip or knee OA may be referred to.  
As we only had information from the questionnaire, we did not have objective 
information of the condition of the patients. Besides that, the data on OA were 
collected at the end of the follow-up period, and not at the beginning of the 
symptoms of trochanteric pain. Therefore, confusion between cause and 
consequence is possible. Nonetheless we think that data on OA would not have 
changed much and are quite stable in time period of one year. Therefore, we used 
them in the model for the one-year follow-up, but not for the five-year follow-up.  
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Comparison with existing literature 
Prognosis 
This is the first study on the long-term prognosis of trochanteric pain. There are 
only a few case series available of patients receiving one type of intervention, but 
the longest follow-up time reported was 2 years. In that study a recovery rate of 
about 90% was reported.5 Another study reported on a follow-up after surgery of 
maximal 60 months.14 These highly selected patients however, are not 
comparable with our population in primary care. 
Therapy 
In our study-population, 37% received corticosteroid injection(s), and about 66% 
reported an improvement. This is comparable with the outcome of a case-series, 
in which about 61% of the patients improved half a year after local injection of 
corticosteroid and lidocaine.15  
The improvement found in our study however, differ from earlier case-series in 
which all patients reported improvement after local corticosteroid injection(s). 5,16 
This discrepancy can be due to pre-selection of the patients (outpatient clinic) or 
the previously mentioned selection bias (patients with sustained symptoms 
returned the questionnaire more often). 
 
Implications for future research or clinical practice 
These data show that trochanteric pain is a prolonged chronic disease in a 
substantial part of the cases. The disorder is associated with great impairment in 
daily activities. 
A trial, which compares oral medication (analgesics) with corticosteroid injection, is 
needed in order to investigate common and promising interventions in primary 
care for patients with trochanteric pain. 
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Abstract 
Objective To determine in patients with hip pain, disease progression after 3 and 
6 years of follow-up and the incidence of total hip replacement (THR). 
Design Prospective cohort follow-up study. 
Setting General practices in the area of Rotterdam (the Netherlands). 
Participants 224 men and women aged 50 years and older initially presenting 
with incident hip pain who were subsequently referred for an X-ray. 
Main outcome measures Disease progression was defined as a THR or a high 
score on the Western Ontario and McMaster Universities osteoarthritis index 
(WOMAC). 
Results After 3 years disease progressed in 29 (15%) patients (23 (12%) with a 
THR), and after 6 years in 45 (28%) (36 (22%) with a THR). The prognostic 
variables for a THR after 3 and 6 years related to history taking are age ≥60 years, 
morning stiffness, and pain in the groin/medial thigh; related to physical 
examination: decreased extension/adduction, painful internal rotation, and a body 
mass index (BMI) ≥30 (negative predictive); and for radiological findings a 
Kellgren-Lawrence grade of ≥2. After adjusting this model for overoptimism, the 
area under the curve was 0.93. 
Conclusion In this study-population about 12% of those presenting with hip pain 
and subsequently referred for an X-ray of the hip will undergo a THR within three 
years, and about 22% after six years. 
Using the variables obtained from history taking, physical examination and 
radiological findings enable to better identify persons at high risk for progression of 
hip OA. This can be helpful to inform patients more precisely about the course of 
hip pain, and to guide clinical trials regarding subgroup or case definition. 
 
 
Submitted
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Introduction 
Osteoarthritis (OA) of the hip is a growing problem in western societies; it affects 
7-25% of Caucasians aged ≥55 years and this number will increase with the 
further aging of the population.1,2  
Although the pathogenesis and riskfactors for the development of OA of the hip 
have been reviewed3-5 few studies have reported on (radiological) variables 
predicting the prognosis of hip OA.6  
For many patients the general practitioner (GP) is the first physician consulted in 
the OA process. The GP will diagnose OA of the hip based on history taking, 
physical examination and possibly on radiographic information, but is unable to 
give evidence based information about the further course of OA. 
Therefore, we conducted a prospective longitudinal study in patients presenting to 
their GP with pain in the hip region. This study started in 1996, and some reports 
related to baseline measurements have already been published.7,8 The 3 and 6 
year follow-up data from this study have now become available. The current study 
addresses the following questions: 
− What percentage of the patients received a total hip replacement (THR) or 
showed signs of severe hip symptoms 3 and 6 years after the initial visit to 
their GP? 
− Which variables are predictive for progression of hip complaints? 
To make these data clinically accessible we developed a clinical prediction rule 
with the aim to predict the risk of having a THR within 3 years. 
 
Subjects and methods 
During 1996, we included consecutive patients aged 50 years and older who 
presented at their GP with hip pain persisting for 1 month to 2 years and for 
whom the GP requested an X-ray at one of the two participating hospitals in 
Rotterdam (the Netherlands). Excluded were subjects with a hip arthroplasty on 
the painful side, or a suspicion of fracture or tumour, or when participation was 
not possible due to co-morbidity.  
After informed consent was given, all subjects underwent a standardised history 
taking and physical examination of the low back, hips and knees by one of the 
authors (SMABZ). Radiographs were taken from both hips separately (in frog leg 
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position) and from the pelvic region (AP pelvic). Additionally, a sonographic 
examination of the hip area was performed. Laboratory tests included the 
erythrocyte sedimentation rate. All examinations were carried out on the same 
day. Details on patient selection and baseline examination have been described 
previously. 8,9 In 1999, the 3-year follow-up examination took place. All patients 
were visited at home and a questionnaire was administered. The 6-year follow-up 
investigation took place in 2002; a questionnaire was sent to the home address, 
or in case the person reported to be unable to fill in the questionnaire the 
researchers visited them at home to help them to complete the questionnaire. 
 
Disease course 
We defined disease progression using two clinical outcome parameters. First, 
whether the patient had received a THR during the follow-up period. Secondly, 
the patient’s health status was assessed using the Western Ontario and 
McMaster Universities Osteoarthritis Index (WOMAC).10 A total WOMAC score up 
to 32.0 was recoded as mild complaints, over a score of 32.1 and 64.0 was 
recoded as moderate, and a score over 64.0 was recoded as severe 
complaints.11,12 Persons who had a THR were included in the patient group with 
the maximum WOMAC score. 
 
Analysis 
Developing the model 
The aim of the analysis was to present a combination of potentially relevant 
baseline variables that most accurately predict the progression of hip pain within 
3 or 6 years. We performed a logistic regression analysis (SPSS version 11.0.1). 
Variables were entered in the model because they were assumed to have a 
relation with the risk to have a THR based on earlier studies, plausibility of 
biological associations, or empirical data derived from general practice. Variables 
that were univariate significantly associated (P-value ≤0.20) with having had a 
THR or a WOMAC score >64.0 were entered as candidate variables into a 
backward stepwise regression model and sequentially removed from the model if 
their contribution to this model was not significant at a level of P=0.10. With a 
Wald test, we assessed the statistical significance of the improvement in the 
model after deleting the different variables. 
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The prognostic factors associated with the disease course were clustered 
according to the stepwise approach that follows the decision-making process in 
clinical practice. Disease history is always available to the GP and was therefore 
used in the first step. In the second step, variables measured by physical 
examination were added. 
In the third step, information available from X-ray and sonography were added. 
These steps together resulted in the final model. 
 
Adjusting the model 
In a prognostic model, each variable has its own strength of contribution to the 
total prediction, expressed in the regression coefficients. Models are known to be 
overoptimistic in predicting when applied in other or future patient groups. To 
adjust the estimated regression coefficients for overoptimism, we used the 
shrinkage factor of van Houwelingen and le Cessie.13,14 The intercept of the 
model was adjusted such that the number of predicted THR corresponded with 
the number of observed THR. 
To make the total model more useful for daily practice we devised a score chart 
to obtain a total score for an individual patient, based on the model for predicting 
a THR at 3 years follow-up; with this score, for each individual the risk for a THR 
within 3 years can be obtained. The regression coefficients were divided by the 
smallest regression coefficient, multiplied by 10 and rounded for easy 
presentation. 
 
Evaluating the model 
The predictive accuracy of the models was estimated by their reliability and 
discrimination. The model’s reliability was evaluated by comparing the model’s 
predicted probability of a THR, with the observed probability, and tested using the 
Hosmer and Lemeshow goodness-of-fit test.15 The model’s ability to discriminate 
between patients with and without a THR was estimated by the area under the 
curve (AUC) of a receiver operating characteristic (ROC) curve.  
 
Validating the model 
Bootstrapping techniques were used to validate the final prediction model, i.e. to 
adjust the model performance for overoptimism. The bootstrap samples consisted 
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of 193 patients, randomly drawn with replacement from the original dataset, and 
was replicated 100 times. The regression model was fit in these samples to 
obtain an impression of the optimism in the model. The model’s performance 
obtained after bootstrapping can be considered as the performance that can be 
expected in other or future patient groups.  
 
Results 
Patient characteristics 
In a period of 12 months, 244 consecutive patients complied with the inclusion 
criteria; 227 patients gave informed consent and were examined. Additional 
exclusion of 3 patients based on severe co-morbidity resulted in a study 
population of 224 cases. The total study population had a mean age at baseline 
of 65.6 (SD 9.6) years and 73% was female (Table 1).  
 
Table 1: Patient characteristics 
 Baseline 3 years Follow-up 6 years Follow-up 
N (%) 224 193 (86) 163 (73) 
Follow-up time years (SD) - 2.7 (0.3) 5.8 (0.3) 
Age years: mean (SD) 65.6 (9.6) 68.6 (9.7) 71.6 (9.3) 
Gender % female 73.1 72.0 71.8 
BMI mean (SD) 27.5 (5.0) 27.0 (4.3) 26.8 (4.2) 
THR N (%) - 23 (11.9) 36 (22.1) 
WOMAC score mean (SD)* - 35.33 (29.8) 45.24 (35.0) 
WOMAC >64 N(%)** - 6 (3.1) 9 (5.5) 
THR or WOMAC >64 N (%) - 29 (15.0) 45 (27.6) 
Pain severity (VAS 0-10) mean 
(SD)* 
6.12 (2.08) 5.21 (3.4) 4.64 (3.8) 
Pain ≥7 N(%)** 95 (42.4) 62 (32.1) 51 (31.3) 
*) people after a THR were recoded as highest score   **) including patients after aTHR  
 
The median duration of follow-up was 2.7 (min. 2.2, max. 3.3, SD 0.25) years for 
the short-term follow-up, and 5.8 (min. 5.3, max. 6.6, SD 0.30) years for the long-
term follow-up. After follow-up there was no selective drop-out by age or gender. 
After 3 years of follow-up the study population consisted of 193 persons (86%); 
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10 patients were deceased, 6 had moved to an unknown address, 1 had 
developed severe co-morbidity and was unable to respond, 4 no longer wanted to 
participate, and 10 were lost to follow-up due to unknown reasons. After 6 years 
of follow-up, the study population consisted of 163 (73%) patients; an additional 7 
patients had died, 4 no longer wanted to participate, 1 suffered from dementia, 5 
were too busy, and 13 patients were lost to follow-up due to unknown reasons. 
 
Progression of hip pain 
During the 3 year follow-up period 23 (12%) patients had received a THR; after 6 
years this number had increased to 36 (22%). 
The mean WOMAC score after 3 and 6 years was 35.3 (SD 29.8) and 45.2 (SD 
35.0), respectively. After 3 years, 29 patients (13%) had a WOMAC score of 
≥64.0 compared with 45 patients (20%) after 6 years. These high WOMAC scores 
include those patients with a THR. At baseline, 95 patients (42%) had a VAS pain 
score of ≤7, compared with 62 patients (32%) at 3 years and 51 patients (31%) at 
6 years Patients with a THR after follow-up were included in the group with the 
highest score (Table 1). 
 
Predictive variables for progression 
The univariate predictors for a THR within 3 and 6 years are shown in Table 2, 
and the multivariate predictors are shown in Table 3. 
History 
The key clinical variables obtained from history to predict a THR within 3 or 6 
years are age ≥60 years, morning stiffness, and pain in the groin and/or medial 
thigh. The same variables are also predictive for a high WOMAC score. 
Physical examination 
The only variable obtained from physical examination (additional to the selected 
history variables) that positively predicts a THR within 3 or 6 years, is a 
decreased active extension of the hip joint. This variable is also predictive for a 
high WOMAC score after 3 years.  
A painful passive internal rotation of the joint is a positive predictive variable for a 
THR within 3 years, but not for the 6 years outcome. A decreased passive 
adduction is an additional positive predictive variable for a THR within 6 years, 
but not within 3 years.  
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Table 2: Univariate analysis of the prediction of THR at 3 and 6 years of follow-up  
 3 years 6 years 
Variable (dichotomous) 
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History 
Female gender 72 1.2 0.78 1.2 0.70 
Age ≥60 years 69 11.7 0.02 6.3 <0.01 
Pain duration ≥ 3 months 65 2.1 0.16 1.8 0.16 
Pain intensity (VAS score) ≥7 42 1.0 0.94 0.9 0.67 
Nocturnal pain 15 0.9 0.83 1.6 0.35 
Morning stiffness 39 5.5 <0.01 2.7 0.01 
Side of complaints (right) 52 1.5 0.36 1.8 0.11 
Bilateral complaints 13 0.6 0.52 0.6 0.37 
Pain aggravation      
            By sitting 30 0.6 0.36 0.6 0.26 
            By only moving the hip joint 32 1.8 0.22 1.9 0.08 
            By lying on the side 60 0.9 0.71 0.8 0.54 
            By walking 67 2.6 0.10 2.4 0.06 
            After load 51 1.9 0.16 2.2 0.04 
            On initial step after rest 76 1.6 0.44 1.1 0.80 
Worst pain distribution      
            Groin 21 4.4 <0.01 4.4 <0.01 
            Trochanter 32 0.6 0.28 0.7 0.35 
            Medial thigh 3 1.9 0.58 7.1 0.04 
            Anterior thigh 10 2.2 0.21 1.7 0.37 
            Lateral thigh 7 <0.01 0.71 <0.01 0.68 
            Buttock 28 0.4 0.1 0.3 0.02 
Physical examination 
BMI ≥30 31 0.4 0.06 0.6 0.23 
Heberden/ Bouchard noduli 27 1.9 0.17 1.7 0.18 
Trendelenburg sign positive 37 1.2 0.69 1.0 0.92 
Pain at straight leg raising 11 0.3 0.31 0.2 0.12 
Trochanteric tenderness by palpation 59 0.9 0.83 0.9 0.69 
Groin tenderness by palpation 24 4.4 <0.01 2.9 0.01 
Inguinal ligament tenderness by palpation 29 2.6 0.04 2.0 0.07 
Superior iliac posterior spines tenderness by palpation 36 0.8 0.57 0.8 0.47 
Sacroiliac joint tenderness by palpation 36 1.4 0.45 1.5 0.26 
Ischial nerve tenderness by palpation 16 0.2 0.15 0.4 0.20 
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 3 years 6 years 
Variable (dichotomous) 
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Decreased active hip motion with      
            Flexion 50 3.3 0.02 2.8 0.01 
            Extension 39 5.3 <0.01 4.0 <0.01 
            Abduction 67 3.6 0.04 3.6 0.01 
            Adduction 32 6.2 <0.01 5.4 <0.01 
            Internal rotation 45 3.3 0.01 3.1 <0.01 
            External rotation 18 2.3 0.09 3.1 0.01 
Painful passive hip motion in      
            Flexion 64 1.7 0.28 1.9 0.12 
            Extension 40 1.4 0.44 1.4 0.36 
            Abduction 69 1.7 0.33 2.1 0.11 
            Adduction 55 2.6 0.06 3.6 <0.01 
            Internal rotation 62 4.8 0.01 1.8 0.15 
            External rotation 41 1.4 0.48 1.4 0.40 
Laboratory tests 
ESR >20 mm/h 11 1.3 0.71 1.5 0.49 
Ultrasound/ Radiology 
Joint effusion 36 0.9 0.78 1.3 0.49 
Fluid around tendon 4 <0.01 0.79 <0.01 0.68 
Fluid around trochanteric bursa 1 0.02 0.79 0.01 0.76 
Kellgren and Lawrence score ≥2 34 13.0 <0.01 17.8 <0.01 
Osteophyte formation present 45 3.3 0.01 3.1 <0.01 
Joint space <2.5 mm 27 6.6 <0.01 7.1 <0.01 
 
A negative predictive variable for a THR after 3 or 6 years, and for a high 
WOMAC score after 3 years is a body mass index (BMI) ≥30. However, the BMI 
is not predictive for a high WOMAC score after 6 years. 
These models differ significantly from the variables of history taking only (P-value 
<0.001 and 0.001, respectively)  
 
Radiology 
For both the 3 and 6 years prognosis for a THR, a Kellgren and Lawrence (K-L) 
score of ≥2 is a positive predictive variable in addition to those variables found in 
history taking and physical examination. It is also a positive predictor for a high 
WOMAC score after both 3 and 6 years. 
This model also differs significantly from the variables of history taking and 
physical examination together (P-value 0.02 and <0.001, respectively). 
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Table 3: Multivariate analysis of the prediction of THR at 3 and 6 years of follow-up 
 History History & 
Physical 
examination 
History, 
Physical examination 
& Radiology 
OR after 
shrinkage 
3 YEARS  OR (95% confidence interval) 
History 
Age ≥60 years 12.5 (2.2 - 70.6) 14.3 (2.4 – 85.8) 9.9 (1.0 – 96.0) 7.6 
Morning stiffness 5.2 (2.2 - 12.4) 4.8 (1.8 – 12.3) 5.3 (1.5 – 18.2) 4.3 
Worst pain distribution     
          Groin 4.3 (1.9 – 10.0) 2.5 (0.9 – 6.7) 1.6 (0.4 – 5.9) 1.5 
          Medial thigh     
Physical examination 
BMI ≥30  0.1 (0.03 – 0.5) 0,1 (0.02 – 0.6) 0.1 
Decreased active hip motion with     
          Extension  3.8 (1.4 – 9.9) 2.9 ( 0.8 – 10.1) 2.5 
          Adduction     
Painful passive internal rotation  3.5 (1.1 – 11.2) 3.0 (0.7 - 13.2) 2.7 
Ultrasound/ Radiology 
Kellgren and Lawrence score ≥2   7.0 (1.9 – 25.8) 5.6 
6 YEARS  OR (95% confidence interval) 
History 
Age ≥60 years 7.9 (2.1 – 29.6) 5.2 (1.4 – 19.8) 3.5 (0.9 – 14.3) 
Morning stiffness 2.4 (1.1 – 5.4) 1.9 (0.8 – 4.5) 1.6 (0.6 – 4.3) 
Worst pain distribution    
Groin  3.5 (1.4 – 9.2) 2.8 (1.0 – 8.1) 
Medial thigh  17.8 (1.2 – 260.6) 14.1 (0.4 – 457.2) 
Physical examination 
BMI ≥30  0.4 (0.1 – 1.0) 0.3 (0.1 – 1.0) 
Decreased active hip motion with    
Extension  3.0 (1.2 – 7.6) 2.2 (0.8 – 6.4) 
Adduction  2.4 (0.9 – 6.0) 2.1 (0.8 – 5.8) 
Painful passive internal rotation    
Ultrasound/ Radiology 
Kellgren and Lawrence score ≥2   8.6 (3.0 – 24.6) 
 
 
Prognostic modelling 
Adjusting the model 
The calculated shrinkage factor was 0.88. Multiplying the regression coefficient 
with this factor, and e raised to the power of this shrunken regression coefficient, 
resulted in the adjusted ORs shown in Table 3. The exact formula to calculate the 
individual risk to have a THR within 3 years is: 
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P= 1/(1+EXP(-(-6.33 + (2.03 * age 60 or above) + ( 1.47 * morning stiffness) + 
(0.41 * pain in the groin) + (-2.01 * BMI >30) + (0.93 * decreased extension) + 
(0.98 * painful internal rotation) + (0.716 * K-L ≥2)))).  
The clinical prediction rule is presented in the score chart (Figure 1). The risk 
scores of the individual prognostic factors add up to a total score that 
corresponds to the probability to have a THR within 3 years. 
 
Figure 1: Score chart to obtain the individual risk for a patient for the need of a THR within 
3 years 
SCORE CHART
To predict the risk of a total hip replacement within 3 years.
Age ≥60 50 → …
Morning stiffness 36 → …
Pain in groin 10 → …
BMI ≥30 -50 → …
Decreased extension 23 → …
Painful internal rotation 24 → …
Kellgren-Lawrence ≥2 18 → …
--------------+
TOTAL INDIVIDUAL SCORE = …
If a variable is reviewed positively, the given number needs to be filled in. 
Subsequently the scores are added to calculate the total individual score. 
With this total score, the individual risk (%) to undergo a hip replacement 
within 3 years can be read from the graph.
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Evaluating the model 
The Hosmer-Lemeshow goodness-of-fit statistic was nonsignificant (P=0.45 for 
the 3-year follow-up, and 0.20 for the 6-year follow-up) suggesting adequate 
reliability of the model.  
The AUC was 0.93 (95% confidence interval (CI) 0.89 – 0.98) for the 3-year 
follow-up and 0.91 (CI 0.86 – 0.95) for the 6-year follow-up, indicating good 
discriminative ability (Figure 2).  
 
Validation of the model 
Bootstrapping did not change the AUC significantly (0.94 for the 3-year follow-up 
and 0.91 for the 6-year follow-up).  
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Figure 2: ROC for the 3 and 6 years prognosis 
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3 years follow-up AUC (95% CI) 
History 0.83 (0.75 – 0.91) 
History & physical examination 0.90 (0.85 – 0.95) 
History & physical examination & radiology 0.93 (0.89 – 0.98) 
Bootstrapping (mean) 0.93  
Adjusted model History 0.82 (0.73 – 0.90) 
 History & Physical Examination 0.90 (0.85 – 0.95) 
 History & Physical Examination & Radiology 0.93 (0.89 – 0.98) 
6 years follow-up   
History 0.78 (0.70 – 0.87) 
History & physical examination 0.83 (0.75 – 0.90) 
History & physical examination & radiology 0.91 (0.86 – 0.95) 
Bootstrapping (mean) 0.91  
AUC= area under the curve    CI= confidence interval 
 
history 
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examination 
history, physical 
examination & 
radiology 
history 
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examination 
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Discussion 
Statement of the main findings 
Approximately 12 - 22% of the patients initially presenting with hip pain at primary 
care will receive a THR after 3 and 6 years, respectively and an additional 3 - 5% 
will have much pain or disability due to their hip condition. 
Positive predictive variables for receiving a THR within 3 to 6 years are age ≥60 
years, morning stiffness, pain in the groin/medial thigh, restriction of active 
extension, a painful internal rotation of the hip joint, as well as a K-L score of ≥2. A 
negative predictive variable for receiving a THR within 3 years is a BMI ≥30. The 
discriminative ability of these variables combined is around 90%. 
 
Strengths and weaknesses of the study 
This is one of the first studies on hip pain in a primary care based population. We 
chose to include only those patients from whom the GP requested an X-ray, in 
order to increase the validity of a diagnosis of suspected hip OA. Although our 
dataset is relatively small (23 and 36 THR after 3 and 6 years of follow-up, 
respectively), our model appeared to be stable within the 4 outcome categories 
(THR and WOMAC after 3 and 6 years). Moreover, in our validation process the 
mean AUC in the bootstrap populations was comparable to the AUC in the original 
population. 
Another problem encountered was the loss to follow-up; 14% after 3 years and 
27% after 6 years. However, although there was no selective drop-out for age and 
gender, there was some drop-out related to the prognostic variables; people 
without morning stiffness and those with a painful internal rotation are more likely 
to drop out (P 0.005 and 0.04, respectively). Therefore, the number of THR or 
severe complaints may have been underestimated. 
Due to the nature of this study, we decided to define progression of hip OA as 
having had a THR (or not) during the follow-up period. Because surgery is also 
related to other factors (e.g. severe co-morbidity, patients’ willingness, age, BMI 
etc.) we might have introduced some bias, but we also verified the results in 
patients with a high WOMAC score. Moreover, operation selection was not an 
issue in our population.  
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Our choice to group the patients who received a THR together with patients with 
the highest WOMAC score might be questioned. Therefore, in retrospect it would 
have been better to have had a WOMAC score of these patients just before they 
received their operation. 
The performance of the predictive model on this dataset will be better than the 
performance in another (comparable) dataset. This so-called “optimism” can be 
estimated with the technique called bootstrapping. Bootstrapping replicates the 
process of sample generation from an underlying population by drawing samples 
with replacement from the original data set, of the same size as the original data 
set. In our bootstrap analysis, the prognostic rule seems to be robust. However, if 
time and costs were of no interest, the most accurate way to validate a prediction 
rule is to use a new comparable population. 
In our final model, 3 of the 7 variables are not significant at the 0.05 level. To see if 
the model would perform better without these variables, we analysed the 7 
variables in a backward stepwise procedure. The variables pain in the groin and a 
decreased extension would be removed from the model, while the Hosmer and 
Lemeshow would increase to a significance of 0.982 (better), and the AUC would 
stay about the same (0.917). Nonetheless, we decided to retain these variables in 
the model, because this modelling process more accurately reflects the stepwise 
decision making in practice. Also, in prognostic modelling, adding variables would 
per definition not introduce bias, but would add prognostic potential. 
 
Relationship to other studies 
Several articles have recently been published on factors related to the progression 
of hip pain/hip OA. 4,16-22  
Whereas we found a positive association between age and progression of hip 
pain, in our earlier review conflicting evidence was found 4. The difference might 
be attributed to selection for surgery: if a patient is relatively young, physicians 
tend  to postpone surgery to avoid the risk of re-surgery after 10-20 years. 
For the relationship between obesity and progression, the review found strong 
evidence for the lack of such an association 4, Flugsrud et al. reported a positive 
association17, and in our present study a negative association was found. We are 
aware, however, that this relationship is easily biased. 
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Other studies reported a positive association between radiographic evidence of 
OA and progression;16,21,22 our study is consistent with these findings.  
Three studies16 19,22reported a positive association between baseline hip pain and 
progression of hip OA, whereas we found no such association. The data of two of 
those studies are population-based.19,22 Which could explain the difference with 
our study: all our patients had hip pain complaints, which was the reason to 
consult their GP. However, a third study with outcome measurements comparable 
to ours, also found a positive relationship between pain and progression of hip 
complaints;16  the reason for this discrepancy is not yet clear. 
 
Explanation of the results found 
Not surprisingly, age, morning stiffness, pain in the groin/medial thigh, restriction of 
the active extension and adduction, a painful internal rotation of the hip joint, as 
well as radiographic evidence for hip OA were identified as positive predictors for 
receiving a THR after 3 or 6 years. A BMI ≥30 may be a less obvious finding. 
However, a BMI ≥30 is a relative contraindication for a THR because physicians 
tend to instruct the patient to lose weight in order to reduce the pain and the peri-
operative risks related to obesity. This advice may reduce the number of patients 
with OA who would have been operated. If so, the patients who were not operated 
due to a high BMI, would have a high WOMAC score. Therefore we also tried to 
analyse whether the BMI would also be a negative predictor for a high WOMAC 
score. However, because only 6 patients had a high WOMAC score (excluding 
patients who had a THR) there was insufficient power to perform a logistic 
regression analysis to see if BMI was associated with a high WOMAC score.  
 
Implications of our findings 
In this study about 12% of the population presenting to the GP with hip pain and 
were subsequently referred for an X-ray of the hip region, will undergo a THR 
within 3 years, and about 22% after 6 years. The baseline variables most 
predictive are age ≥60 years, morning stiffness, and pain in the groin and/or 
medial thigh, decreased extension of the hip joint, a painful internal rotation of the 
joint (3 years), a painful adduction (6 years), and arthritic changes on the X-ray. A 
negative predictive variable is a BMI ≥30. 
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We are now better able to identify persons who are at high risk for progression of 
hip OA. This can be helpful not only to inform patients more precisely about the 
course of their hip pain, but also for future clinical trials. 
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In the first part of this thesis, systematic reviews are presented focusing on the risk 
factors and prognostic factors of osteoarthritis (OA) of the hip. The second part 
presents studies investigating the prognosis of patients presenting with hip pain in 
primary care. In this final chapter, we summarize the results found, place them in a 
broader perspective, and present recommendations for future research. 
 
Hip pain 
Two Dutch studies in the open population aged 55 years and older, revealed that 
about 15-17% of the women and about 7-8% of the men reported hip pain at the 
moment of the survey.1,2 Hip complaints in the elderly are generally attributed to 
hip OA. However, several other conditions can lead to hip pain, including 
trochanteric pain syndrome (also called trochanteric bursitis), meralgia 
paresthetica, muscular disorders, tumours, fractures, osteoporosis, and referred 
pain.3 
Two of the main causes of hip pain presenting in primary care are investigated in 
this thesis; osteoarthritis and trochanteric pain syndrome. 
 
Osteoarthritis 
Depending on the definition, in the Netherlands about 20,000 new cases of hip OA 
were diagnosed in 2000, and about 257,000 of the persons aged 55 years and 
over were suffering from hip OA.4 Hip OA causes a substantial disease burden 
and has a high impact on the quality of life in the elderly. 
Although new disease-modifying drugs for OA are promising,5 there is currently no 
curative therapy for osteoarthritis. In order to prevent the development and the 
end-stage of hip OA, it is desirable to detect hip OA and its determinants as early 
as possible. Besides, most of us want to become old, but not be old, implying that 
we want to delay the onset of morbidity as well as reduce the burden involved.  
It is therefore important to differentiate between determinants for occurrence of 
disease, which are useful for primary prevention in certain risk groups, and 
determinants for progression of disease, useful for secondary and tertiary 
prevention in individuals with existing complaints and early signs of hip OA.  
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Causes 
Risk factors for the onset of hip OA include those that are non-modifiable (e.g. 
age, gender, family history and race), as well as those amenable to modification, if 
not in practice, then at least in principle (e.g. obesity, occupational exposure, 
physical activity, joint injury, hip dysplasia). We are most interested in the latter. 
 
Obesity 
In 1945, Fletcher et al. suggested (as one of the first), that obesity is important in 
the aetiology of OA.6 From then on, the relationship between OA and obesity has 
been a matter of considerable debate in the rheumatologic and orthopaedic 
literature. Also in hip OA, the results of available studies are not unambiguous. For 
many years it was not clear whether being overweight preceded or occurred as a 
consequence of hip OA, given the amount of immobility and disability the disease 
can produce. However, a growing number of studies have shown that being 
overweight antedates the development of the disease.7-9 
In an effort to unravel the existing literature on this topic, (Chapter 2) our review 
showed that obesity increases the risk of hip OA.10 Kellgren called “the mechanical 
effect of excess body weight upon joints of the lower limbs self-evident.” This 
mechanical effect could explain the relationship between increased body weight 
and hip OA; however, the relationship with hip OA is weaker than its association 
with the disease in the knee.11 One of the explanations mentioned is that a 
substantial part of the adiposity, especially in women, lies below the hip joint, 
which does not contribute to the loading of the hip.12 However, the excess of OA in 
non-weight bearing joints (e.g. the DIP joints of the hand in overweight persons), 
does not support this theory, suggesting that the issue might be more than simply 
mechanical. Several studies reported a relationship between hypertension, 
hypercholesterolaemia, and blood glucose with OA,13-15 supporting the concept 
that OA has an important systemic and metabolic component in its aetiology. 
Moreover, it has been shown that leptin (a protein hormone with important effects 
in regulating metabolism) may play an important role in the metabolic 
pathophysiology of the onset of OA16. The difference in the strength of the 
relationship between obesity and hip OA and knee OA might thus be explained by 
the additional factors that make the joint more vulnerable.12 
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For hip OA it has been estimated that, if obesity is eliminated, the prevalence 
would decrease by 25%.17 However, although tempting, it cannot be concluded 
that weight loss is effective in preventing either the clinical manifestation or the 
progression of hip OA, especially if a metabolic component is responsible for the 
relation between obesity and OA. The finding in our review that obese patients 
with hip OA suffer earlier from the same grade of hip OA than non-obese 
patients,10 more or less implies that weight reduction would be beneficial. Weight 
reduction was also shown to be useful in lowering the risk for incident radiological 
knee OA,18 and for the reduction of symptoms in knee OA.18-22 However, Flugsrud 
and colleagues recently published data of a large-population based study, 
concluding that weight change during the fourth and fifth decade of life (age 34-47 
years), did not affect the risk for a total hip replacement resulting from primary 
OA.23 
Although we have now clarified some of the mysteries surrounding the relationship 
between obesity and the onset of hip OA, the different pathways of the causal 
relationship between obesity and OA remain an enigma. Hence, more research is 
needed to elucidate which metabolic components are responsible for the onset of 
OA. If these prove to be modifiable, primary prevention in certain risk groups may 
then become possible.  
 
Occupational factors 
With physical activities that are performed day in and day out, 8 hours a day, 40 
hours a week, more than 45 weeks a year, over many years, it is likely that some 
of these activities will have an effect on the musculoskeletal system. A number of 
studies have shown that repetitive activities of labourers lead to OA: e.g. in finger 
joints of cotton mill workers24, in the base of the thumb in physiotherapists25; in 
knees and spines of miners26; in elbows, wrists and metacarpophalangeal joints of 
jackhammer operators11, and in hip joints of farmers.27,28 Our review on workload 
and the occurrence of hip OA (Chapter 3), showed that previous heavy physical 
workload increases the risk of hip OA.29 The relation between OA and occupation 
is, however, difficult to investigate because of the long latency before the 
pathological process brings work incapacity or the need for medical consultation. 
Another finding of our review is that lifting heavy objects (≥25 kg) is likely to 
increase the risk for the occurrence of hip OA. The underlying mechanism is well 
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illustrated in a study on a patient who, at the time of total hip arthroplasty, was 
fitted with a prosthetic hip that contained multiple pressure sensors. 
Postoperatively this patient was studied in the gait laboratory under a variety of 
experimental conditions. It was reported that placing a 4.5 kg weight in either hand 
produced an increase in pressure in the hip.30 
Our review also showed that farmers may have an increased risk of hip OA, but 
the studies in our review could not reveal the exact mechanism. It has been 
postulated that driving tractors and jumping up and down from the tractor cabin 
plays a role. A recent study by Järvholm and colleagues, however, reported that 
the higher risk of hip OA in farmers, can not be attributed to driving vehicles with 
high levels of whole body vibration.31 Moreover, another study on a large group of 
farmers reported that farmers operating a large plant production area (>100 
hectares) and with few animal contacts, had a significantly lower risk of hip OA 
than farmers in general. The presence of animal production showed a significant 
positive relationship with the risk of hip OA (milking >40 cows/day, >5 h. in animal 
barns).32 
In summary, with respect to the relationship between occupation and hip OA, 
specific activities appear to increase the risk for hip OA purely by a mechanical 
effect. However, it is unclear whether a change in occupation reduces the risk of 
OA. It is also unclear whether ergonomic modification of the workplace prevents 
the development of OA, or lessens its burden. Therefore, further research in this 
area, especially on ergonomic factors associated with the development of OA, is 
needed. 
 
Sporting activities 
Due to the disappointingly low quality of the studies reporting on the relationship 
between sporting activities and the occurrence of hip OA, we could only conclude 
that there is limited evidence for such a relation (Chapter 4).33 Nevertheless, 
repetitive mechanical load on the joints might have some effects on the weight 
bearing joints. Moreover, a study on marathon runners showed that levels of 
cartilage oligomeric matrix protein (a marker of cartilage turnover and destruction) 
were raised at baseline as compared to healthy non-running controls (perhaps 
reflecting training), and increased during the marathon.34 The clinical significance 
of these findings is as yet unclear. 
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Similar to the review on obesity and hip OA, the review on sporting activities and 
hip OA reported a stronger relationship in studies reporting on clinically assessed 
hip OA compared with radiologically assessed hip OA, suggesting that people 
participating in regular sporting activities suffer more from the same degree of 
degeneration from the hip joint than do non-participants, perhaps because sporting 
activities places great demands on the body. However, another explanation could 
be that the hip complaint reflects hip symptoms due to non-articular problems (e.g. 
tendinitis, bursitis, muscle strain, etc.) because in the included studies, clinical hip 
OA was often defined as “hip pain”. 
Another factor probably involved in the onset of hip OA in people with regular 
sporting activities, is the amount of sporting injuries occurring during sporting 
activities. An injured joint might be more vulnerable to develop OA compared with 
a non-injured joint.11,35 
Although the evidence supporting preventive strategies is weak, efforts to 
decrease the risk for OA in sports participants should be made. These should 
include careful pre-participation evaluation of individual risk factors, training that 
improves joint dynamic stability, and modification of rules to decrease direct player 
contact and high intensity joint torsion. In addition, early diagnosis and effective 
treatment of joint injuries and ensuring complete rehabilitation after joint injury 
should decrease the risk for OA among sport participants. 
 
Hip dysplasia 
It is well known in the field of orthopaedics that congenital and developmental hip 
abnormalities occurring during infancy or childhood, predispose to hip OA in early 
adulthood (20-30 years). Up till now, however, very few studies have been 
published on this topic, and most of them reported cross-sectional data on elderly 
persons with mild forms of hip dysplasia only. The problem with these cross-
sectional data is that mild forms of hip dysplasia might cause hip OA, but signs of 
hip OA (joint space narrowing, osteophytes and medial migration of the femoral 
head) might make it difficult to correctly measure hip dysplasia. Therefore in our 
review (Chapter 5) we could only conclude that there is limited scientific evidence 
for a relationship between hip dysplasia and the onset of hip OA.36 
The most obvious mechanism to explain the association between acetabular 
dysplasia and hip OA is that the presence of a (mild form of a) biomechanical 
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abnormality, secondary to either joint incongruity (smaller acetabular depth) or 
decreased joint surface area (smaller CE angle), that may increase joint stresses. 
Given the current primary prevention policy in the Netherlands, whereby almost all 
newborns are examined for congenital hip abnormalities, it would be interesting to 
study all persons who were diagnosed with hip dysplasia in a given cohort about 
10, 20 and 30 years ago to look for evidence of some association between hip 
dysplasia and subsequent hip OA.  
 
Course 
Predicting the course of hip OA is not only important to give the patient accurate 
information on the disease course, but also for decisions concearning treatment 
options. For example for future research in order to define the most appropriate 
cases, or to enable subgroup analysis to correctly evaluate treatment effects. 
Secondly, to provide the patient with the most optimal treatment given their 
prognosis: e.g. although several studies reported the positive effect of 
glucosamines in pain reduction in OA, patients with more severe disease and 
higher pain scores do not seem to benefit.37 
In our systematic review of studies exploring variables predicting a fast 
progression of hip OA (Chapter 6), several variables were reported to have a 
relationship with the progression of hip OA.38 However, because all included 
studies were hospital-based and 5 of the 8 discussed variables were based on 
radiological information, the information from this review is of limited use in primary 
care. All the variables obtained from our prospective follow-up study on patients 
with hip pain presenting at primary care (Chapter 8) are signs of severe hip OA. 
Because surgery will be performed only in patients with signs of severe hip OA, 
these variables might be related to the study outcome (a total hip replacement), 
and some circular reasoning therefore is possible. Nonetheless, several intriguing 
factors will be discussed below. 
 
Obesity 
In contrast to the relationship between obesity and the onset of hip OA, our review 
showed that obesity seems to have no influence on the progression of hip OA.38 
Our follow-up data even reveal that obese persons are less likely to show 
progression of their hip complaints. This finding might be explained by the fact that 
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a BMI ≥30 is a relative contraindication for surgery. Physicians tend to instruct 
these patients to lose weight in order to reduce the pain and to reduce the peri-
operative risks involved with obesity. This advice may reduce the number of 
patients with OA who would have been operated upon. However, due to a lack of 
power we were not able to verify this explanation on patients with a high WOMAC 
score (a disability score for OA of the hip/knee). In knee OA, (radiographic) 
progression might be more dependent on being obese or not.39 It remains unclear 
whether a mechanical effect is more likely in knee OA, and a metabolic effect is 
more important in hip OA. Therefore, intervention studies are needed in which 
patients with incident complaints of hip OA are randomly put on dietary measures. 
Outcomes of such studies will give insight into the potential for secondary 
prevention of patients suffering from hip OA. 
 
Pain  
In our follow-up study, pain intensity at baseline was not predictive for progression. 
However, two recent population-based studies reported that people with 
radiographic findings of hip OA and hip pain showed a faster progression of 
radiographic and clinical hip OA as compared to people without hip pain.40,41 
Besides the fact that pain intensity is not totally comparable to the presence or 
absence of pain, our study is primary-care based rather than population-based (all 
our patients had pain in the hip) which means that these study populations are not 
comparable. However, Birrell et al. reported on the prognosis of hip OA in a 
primary-care based setting, and also reported that the severity of pain is predictive 
for being put on a waiting list for a total hip replacement.42  
Thus, if pain predicts progression, the question then arises: Why does pain predict 
OA progression? One of the possibilities is that, as in knee OA, synovial effusion is 
responsible for the pain and therefore for the deterioration of OA.43 However, in 
our follow-up study, we found no evidence to support this theory; in fact, joint 
effusion at baseline (assessed with ultrasound) is not associated with surgery after 
3 or 6 years. A postulated theory in the past about bone marrow oedema and pain 
in OA has recently been re-discovered.44,45 Perhaps the clue to pain in OA and its 
progression lies here; this would be an interesting pathway for further research. 
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Trochanteric pain 
Of all patients presenting in primary care with hip pain, 10-20% can be attributed 
to trochanteric pain. Although the term ‘trochanteric bursitis’ is often applied to this 
condition, the initial pathology usually occurs in the tendons attached to the 
greater trochanter and the adjacent bursae may then be secondarily involved. In 
some cases it can be an isolated condition, but it is often associated with other 
diseases such as low-back pain or sciatica46,47, OA of the hip46, avascular necrosis 
of the femur head48, or metastatic bone diseases.49 Therefore we argue that 
trochanteric pain should be classified as a syndrome occurring in several diseases 
rather than a separate pathologic entity.  
 
In Chapter 7 we reported an incidence of trochanteric pain of 1.8/1000 persons per 
year.50 Another study on trochanteric pain in Dutch primary care, reported an 
incidence of 5.6/1000 persons per year.51 Because the data of our research were 
collected retrospectively, and therefore depended on the registration and definition 
used by the GP, this might have led to underreporting of the clinical presentation. 
However, due to the prospective study of the latter survey, overreporting might 
have occurred due to case finding. Nevertheless, trochanteric pain is a frequently 
occurring problem. Moreover, a considerable part of the patients enrolled in our 
study still suffered from pain complaints on the greater trochanter after 1 year and 
5 year follow-up. Whether these persisting complaints originate primarily from the 
soft tissue surrounding the greater trochanter, or from other co-morbid conditions, 
is not clear. We believe, however, that this co-morbidity is important in the 
prognosis of trochanteric pain. This finding was also suggested in our study: 
patients with OA of the lower limbs were almost five times more likely to have 
sustained complaints after 1 year. However, due to the study design (retrospective 
questionnaire), we were not able to examine the patients objectively concerning 
specific co-morbid conditions. Given these considerations, it is important to 
distinguish any co-morbid condition; firstly, to enable the physician to give the 
patient optimal information about the prognosis and treatment, secondly, to better 
define appropriate cases or enable subgroup analysis to correctly evaluate 
treatment effects in future studies. 
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The chronicity and burden of the syndrome in patients with trochanteric pain, 
justifies future research efforts on the pathophysiology, the prognosis, and the 
treatment options. Therefore, a group of patients presenting to the general 
practitioner with complaints of trochanteric pain should be enrolled into a 
prospective study in which a thorough history taking should take place to look for 
any potential cause, such as co-morbidity, trauma or repetitive strain. A physical 
examination should also be performed, including at least a low back and hip 
examination. In addition, a radiological examination should reveal any 
pathophysiological changes in the region. This cohort of patients should be 
followed for at least 3 years in order to establish the prognosis and to examine 
whether these patients more often develop conditions such as osteoarthritis and 
low-back pain. 
After we are able to define relevant subgroups (based on any co-morbid condition 
and/or the prognosis), intervention studies are needed to find the most effective 
treatment for patients with trochanteric pain. 
 
In conclusion, the studies in this thesis have provided some evidence-based 
results to guide physicians, policy makers and future research on the cause and 
the course of hip pain in general practice.  
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Arthritic musculoskeletal complaints are one of the main causes of pain and 
disability in the elderly. Hip pain is after knee complaints, the most frequent 
diagnosis in this field of disorders. Hip pain in the elderly is commonly attributed to 
osteoarthritis (OA) of the hip, but another widespread diagnosis is trochanteric 
pain syndrome. Knowledge about the determinants on the cause and the course of 
hip pain in general practice is essential for medical doctors, decision makers and 
researchers. Therefore we looked at the determinants on the cause and course of 
hip pain in general practice. 
 
In chapter 2 to 6 presents four studies in which we systematically summarized the 
available literature addressing the influence of obesity, occupational activities, 
sporting activities and dysplasia on the occurrence of the hip OA In the final 
review, we systematically summarized all available papers on prognostic factors of 
hip OA. A bibliographical search of Medline, Embase and the Cochrane library 
until April 2000 was carried out and articles with the aim to study a relationship 
between obesity occupational activities, sporting activities, dysplasia or the 
progression of hip OA were selected. The quality of the studies was assessed 
using a standardised set of criteria. The outcome of the studies was compared 
with respect to study characteristics, and the quality score. A best evidence 
synthesis was used to summarise the results of the individual studies. 
 
In chapter 2, the review on obesity and the occurrence of hip OA showed that the 
evidence for a positive influence of obesity on the development of hip OA is 
moderate, with an OR of approximately 2. This conclusion was based on 5 
longitudinal and 7 cross-sectional papers. The associations between obesity and 
hip OA were stronger in studies in which the diagnosis hip OA was based not only 
on radiological criteria, but on clinical symptoms as well.  
Chapter 3 presents the data of the review on the influence of physical workload on 
the occurrence of hip OA. In this review 2 retrospective cohort studies and 14 
case-control studies were included. Almost all papers included in this review were 
prone to biases. Overall, moderate evidence was found for a positive association, 
with an OR of approximately 3, between previous heavy physical workload and the 
occurrence of hip OA. In addition, for the subcategories, i.e. ≥10 years farming or 
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lifting heavy weights (≥25 kg), moderate evidence was found for a positive 
relationship with hip OA. 
Chapter 4 describes the review on sporting activities and the occurrence of hip 
OA. 
In this review, one cohort study and 21 cross-sectional studies were included, and 
overall, moderate evidence was found for a positive association between physical 
sporting activities and the occurrence of hip OA, with an OR of approximately 2. 
The highest risks are found in high intensity activities, especially for hip OA with a 
clinical presentation. Possible selection of the studied populations however, may 
partly be responsible for the association found, or may have diluted the real 
association. 
In chapter 5 we reviewed the influence of acetabular dysplasia on the 
development of hip OA. Five cohort studies and four case-control studies were 
included in this review, but only one cohort study had the correct design to be able 
to address to the question and reached the level of high quality study. This study 
reported a positive association between acetabular dysplasia and hip OA. Overall, 
limited evidence was found for a positive association between acetabular 
dysplasia and hip OA. However, most studies included persons at a higher age 
group. In younger age groups the relation between acetabular dysplasia and OA 
or hip complaints may be much higher.  
In chapter 6, a systematic review on the prognostic factors of hip OA is presented. 
Twelve studies were included in this review. Ten studies had a cohort design, of 
which five collected their data prospectively. Two studies had a case-control 
design. Based on the evidence, we may conclude that there is strong evidence 
that people with a supero- (lateral) type of migration of the femur head or an 
atrophic bone response show a more rapid progression of hip OA as compared 
with a medial migration or hypertrophic bone response. Also strong evidence is 
found that there is no relationship with obesity and the progression rate of hip OA. 
Limited evidence is found that, when there is a more severe joint space narrowing 
at first consultation, there will be an earlier need for a (total hip replacement) THR, 
as well as for no relation between hip dysplasia and the progression of hip OA. 
In the retrospective study presented in chapter 7, we investigated the 1 and 5 
years prognosis of patients presenting with trochanteric pain in primary care. 
Patients with incidental trochanteric pain in the years 1996 or 2000 were 
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questioned in 2001 for past and present symptoms of trochanteric pain. The 
conclusions of this study were that the incidence of trochanteric pain in primary 
care is 1.8 / 1000 patients / year. After one year 36 (best case scenario)-76% 
(worst case scenario) still suffered from trochanteric pain, and after 5 years this 
was 29-63% respectively. Patients with osteoarthritis in the lower limbs had a 4.8-
fold risk of persistent symptoms after one year, as compared to patients without 
osteoarthritis. Patients who had received a corticosteroid injection had a 2.7-fold 
chance of recovery after 5 years, as compared to patients who had not received 
an injection. 
In chapter 8, we described a prospective follow-up study on patients with incident 
complaints of hip pain presenting at the GP and were referred for an X-ray. After 3 
years 12% and after 6 years 22% of the patients received a total hip replacement. 
With variables obtained from history taking (age ≥60, morning stiffness, pain in the 
groin/medial thigh), physical examination (decreased extension or adduction, 
painful internal rotation and a body mass index (BMI) ≥30 (negative predictive)) 
and radiological findings (Kellgren-Lawrence grade of ≥2), we are better able to 
identify persons who are at high risk for a total hip replacement after 3 and 6 
years.  
Chapter 9 discusses the main findings of this thesis and put them in a broader 
perspective.  
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Artrotische klachten van het bewegingsapparaat zijn een belangrijke oorzaak van 
pijn en beperkingen in de oudere populatie. Na knieklachten zijn heupklachten de 
meest voorkomende diagnose binnen deze groep aandoeningen. Heupklachten bij 
ouderen wordt meestal toegeschreven aan artrose van het heupgewricht, maar 
een andere, veel voorkomende diagnose is het trochantair pijn syndroom. 
Kennis over de oorzaken en de prognose van heuppijn in de huisartspraktijk is 
essentieel voor medici, voor beleidsmakers en voor onderzoekers. De 
hoofddoelstelling van dit onderzoek is dan ook de oorzaken en de prognose van 
heuppijn in de oudere populatie in de huisartspraktijk te onderzoeken. 
 
In hoofdstuk 2 tot en met 6 presenteren we 4 studies waarin we de beschikbare 
wetenschappelijke literatuur over de invloed van overgewicht, werk, sport en 
heupdysplasie op het ontstaan van heupartrose op een systematische wijze 
hebben samengevat. In de laatste review hebben we de literatuur samengevat 
over de prognose van heupartrose. 
We hebben een zoekactie verricht in Medline, Embase en de Cochrane 
bibliotheek tot april 2000 en artikelen met het doel het onderzoeken van de relatie 
tussen overgewicht, werk, sport, heupdysplasie of de progressie van heupartrose 
werden geselecteerd. De kwaliteit van de studies werd gemeten met een 
gestandaardiseerde set criteria en de uitkomsten van de studies werden met 
behulp van een best evidence synthese samengevat. 
 
In hoofdstuk 2 werd een matig bewijs gevonden voor de relatie tussen 
overgewicht en het ontstaan van heupartrose, met een Odds Ratio (OR) van 
ongeveer 2. Deze conclusie was gebaseerd op 5 longitudinale en 7 cross-
sectionele studies. De relatie tussen overgewicht en heupartrose was sterker in 
studies die niet een radiologisch gemeten artrose (bijvoorbeeld 
gewrichtsspleetvernauwing), maar klinische symptomen van de heupartrose 
(bijvoorbeeld pijn of een heupvervangende operatie) als uitkomstmaat hadden. 
In hoofdstuk 3 presenteren we de data van de review over de invloed van werk 
op het ontstaan van heupartrose. In deze review werden 2 retrospectieve cohort 
studies en 14 patiënt-controle studies geïncludeerd. Vrijwel alle studies die we in 
deze review hebben geïncludeerd zijn gevoelig voor bias. Uiteindelijk werd ook 
hier een matig bewijs gevonden voor een positieve relatie tussen zwaar lichamelijk 
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werk en het ontstaan van heupartrose, met een OR van ongeveer 3. Daarnaast 
werd voor de subgroepen ≥10 jaar werken op een boerenbedrijf, of het tillen van 
zware objecten (≥25 kg), ook een matig bewijs gevonden op het ontstaan van 
heupartrose. 
Hoofdstuk 4 beschrijft de review over de invloed van sporten op het ontstaan van 
heupartrose. In deze review werden 1 cohort en 21 cross-sectionele studies 
geïncludeerd en ook hier weer werd een matig bewijs gevonden voor de invloed 
van fysieke sportactiviteiten op het ontstaan van heupartrose. De OR is ongeveer 
2. De hoogste risico’s werden beschreven in de studies over hoog intensiteit 
sportactiviteiten, voornamelijk in studies waarin een klinische presentatie van 
heupartrose als uitkomstmaat werd genomen. Selectie van de bestudeerde 
populaties kan echter een deel van de gevonden relatie verklaren, of kan de 
sterkte van de relatie hebben verdund.  
In hoofdstuk 5 hebben we de invloed van heupdysplasie op het ontstaan van 
heupartrose onderzocht. In deze review werden 5 cohort studies en 4 patiënt-
controle studies geïncludeerd, maar slechts 1 studie had het juiste design om de 
onderzoeksvraag te beantwoorden. Deze studie rapporteerde een positieve 
associatie tussen heupdysplasie en het ontstaan van heupartrose. De gehele 
review kon maar tot een beperkt bewijs komen voor de veronderstelde relatie. Alle 
onderzoeken echter, waren voornamelijk gericht op milde vormen van dysplasie 
op de oudere leeftijd en niet op vormen van dysplasie op kinderleeftijd. In vormen 
van dysplasie in de jongere leeftijdsgroepen kan de relatie met het ontstaan van 
heupartrose dus sterker zijn. 
In hoofdstuk 6 wordt een review gepresenteerd over de prognostische factoren 
van heupartrose. In deze review werden 12 studies geïncludeerd; 10 hadden een 
cohort design, waarvan 5 de data prospectief hadden verzameld en 2 studies 
hadden een patiënt-controle design. Uit de review bleek dat er sterk bewijs was 
voor een snellere progressie van heupartrose bij mensen met een supero/laterale 
vorm van migratie van de femurkop, of een atrofische botrespons, ten opzichte 
van mensen met een mediale migratie of een hypertrofische botrespons. Ook 
bleek dat er sterk bewijs was voor een afwezige relatie tussen overgewicht en 
progressie van heupartrose. Er was beperkt bewijs voor een snelle progressie bij 
een ernstige mate van gewrichtsspleetvernauwing bij de eerste consultatie en bij 
de aanwezigheid van heupdysplasie. 
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In de retrospectieve studie in hoofdstuk 7 hebben we de 1 en de 5 jaars 
prognose van trochantaire pijn onderzocht bij mensen die zich presenteerden met 
deze klacht bij de huisarts. Patiënten met incidente klachten van trochantaire pijn 
in 1996 of 2000 werden in 2001 gevraagd naar hun initiële en hun eventuele 
huidige klachten van trochantaire pijn. De conclusies van het onderzoek waren dat 
de incidentie van trochantaire pijnklachten in de huisartspraktijk 1.8 patiënten per 
1000 per jaar is en dat na 1 jaar nog 36% en na 5 jaar nog 29% last had. 
Patiënten met artrose aan de onderste extremiteiten hadden 4.8 keer zoveel kans 
op persisterende klachten na een jaar ten opzichte van mensen zonder artrose. 
Patiënten die een corticosteroïd injectie hadden gekregen hadden 2.7 keer meer 
kans op herstel na 5 jaar vergeleken met patiënten die geen corticosteroïd injectie 
hadden gekregen. 
In hoofdstuk 8 presenteren we de resultaten van een prospectieve follow-up 
studie van patiënten met incidente klachten van heuppijn, die zich presenteren bij 
de huisarts en die waren verwezen voor een röntgenfoto van het heupgewricht. Na 
3 jaar had 12% en na 6 jaar had 22% een heupvervangende operatie ondergaan. 
Met variabelen verkregen bij de anamnese (leeftijd ≥60 jaar, ochtendstijfheid, 
liespijn), lichamelijk onderzoek (verminderde extensie/adductie, pijnlijke 
endorotatie en een body mass index ≤30) en radiologische bevindingen (Kellgren 
and Lawrence ≥2) zijn we nu beter in staat om patiënten te identificeren die een 
grotere kans hebben op een heupvervangende operatie na 3 of na 6 jaar. 
In hoofdstuk 9 bespreken we de belangrijkste bevindingen van dit proefschrift en 
plaatsen we ze in een breder perspectief. 
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Appendix 1: 
List of criteria for the assessment of the methodological quality  
for cohort and case-control designed studies measuring risk factors 
Item Criteria V/I* CH/CC† 
Study population 
1 Selection before disease was present or at uniform point V CH/CC 
2 Cases and controls were drawn from the same population V CC 
3 Participation rate ≥80% for cases/cohort V CH/CC 
4 Participation rate ≥80% for controls V CC 
5 Sufficient description of baseline characteristics I CH/CC 
Assessment of risk factor 
6 Exposure assessment was blinded V CH/CC 
7 Exposure was measured identical in studied population V CC 
8 Exposure was assessed prior to the outcome V CH/CC 
Assessment of hip OA 
9 Hip OA was assessed identical in studied population V CH/CC 
10 Presence of hip OA was assessed reproducibly V CH/CC 
11 Presence of hip OA was according to valid definitions V CH/CC 
12 Classification was standardised I CH/CC 
Study design 
13 Prospective design was used V CH/CC 
14 Follow-up time ≥ 3 years V CH 
15 Withdrawals ≤ 20% V CH 
16 Information on completers vs. withdrawals I CH 
Analysis and data presentation 
17 Frequencies of most important outcomes was given I CH/CC 
18 Appropriate analysis techniques were used V CH/CC 
19 Adjusted for at least age and gender V CH/CC 
 
* 
 V= criterion on validity/precision  I= criterion on informativeness. 
†  CH= applicable to cohort designed studies  
    CC= applicable to case-control designed studies. 
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Appendix 2: 
Specified criteria list for the methodological quality assessment (see appendix 1). 
Study population 
1. Positive if the study population was selected before any clinical or radiological 
sign of hip OA was present 
Positive if (sub-) groups were selected at a uniform point of the disease 
2. Positive if the cases and the controls were drawn from the same source 
population (primary study base) 
3. Positive if the participation rate of the cases/population selected and invited to 
participate at baseline was at least 80%  
4. Positive if the controls selected and invited to participate at baseline was at 
least 80% 
5. Positive if at least 7 of the following 12 items were reported at baseline 
- Age (mean and standard deviation) 
- Gender (number and/or percentage) 
- Weight (mean and standard deviation)  
- Body Mass Index (BMI)(mean and standard deviation) 
- Race 
- Job description  
- Sport/leisure time exposure 
- History of trauma 
- Smoking 
- Hormone replacement therapy 
- Signs of OA in other joints (OA objectivated in other joints, Heberden's 
nodes) 
- Characteristics of OA on X-ray or other imaging techniques 
Assessment of risk factors 
6. Positive if the exposure assessment was blinded with respect to disease status 
7. Positive if exposure was measured in an identical way for the whole studied 
population 
8. Positive if the exposure was assessed prior to the disease outcome 
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Assessment of hip OA 
9. Positive if the way of assessing hip OA was identical for the entire studied 
population 
10. Positive if the measurement instruments used for observing or identifying the 
presence of hip OA were reproducible 
Positive if (waiting for) a (total) hip replacement (THR) was used as an 
outcome measure for hip OA  
11. Positive if the measurement instruments used for observing or identifying the 
presence of hip OA were standardised using validated definitions  
Positive if (waiting for) a THR was used as an outcome 
12. Positive if the classification of the radiological osteoarthrosis was standardised 
using the Kellgren and Lawrence or the Croft classification 
Positive if the classification of the clinical osteoarthritis was standardised using 
the ACR criteria 
Positive if (waiting for) a THR was used 
Study design 
13. Positive if a prospective design was used 
14. Positive if the total follow-up time was ≥ 3 years 
15. Positive if the total number of withdrawals was ≤ 20% (in case a retrospective 
cohort design was used, a negative score was assigned) 
16. Positive if demographic/clinical information was presented for completers and 
withdrawals (in case a retrospective study design was used, a negative score 
was assigned) 
Analysis and data presentation 
17. Positive if frequency or percentage (or mean and standard deviation/CI) of the 
outcome(s) of the risk factor(s) were used  
18. Positive if confounding variables were used in the statistical analysis. 
(Validated techniques such as multivariate regression or Mantel-Haenszel must 
have been used) 
Positive if (sub-) group analysis were made in a heterogeneous population 
Positive if no (sub-) group analysis was made in a homogeneous cohort at 
baseline Positive if there was at least corrected for the confounders age and 
gender by means of matching, restriction or adjustment in the analysis.
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Appendix 3: 
List of criteria for the assessment of the methodological quality  
for cohort and case-control designed studies measuring progression. 
Item Criteria V/I* CH/CC† 
Study population 
1 Selection before disease was present or at uniform point V CH/CC 
2 Cases and controls were drawn from the same population V CC 
3 Participation rate ≥80% for cases/cohort V CH/CC 
4 Participation rate ≥80% for controls V CC 
5 Sufficient description of baseline characteristics I CH/CC 
Assessment of prognostic factors 
6 Exposure assessment was blinded V CH/CC 
7 Exposure was measured identical in studied population V CC 
8 Exposure was assessed prior to the outcome V CH/CC 
Assessment of hip OA 
9 Hip OA was assessed identical in studied population V CH/CC 
10 Presence of hip OA was assessed reproducibly V CH/CC 
11 Presence of hip OA was according to valid definitions V CH/CC 
12 Classification was standardized I CH/CC 
Study design 
13 Prospective design was used V CH/CC 
14 Follow-up time ≥ 6 months/1 year V CH/CC 
15 Withdrawals ≤ 20% V CH/CC 
16 Information on completers vs. withdrawals I CH/CC 
Analysis and data presentation 
17 Frequencies of most important outcomes was given I CH/CC 
18 Appropriate analysis techniques were used V CH/CC 
19 Adjusted for at least age and gender V CH/CC 
 
*  V= criterion on validity/precision  I= criterion on informativeness. 
†  CH= applicable to cohort designed studies  
    CC= applicable to case-control designed studies. 
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Appendix 4:  
Specified criteria list for the methodological quality assessment (see appendix 3). 
Study population 
1. Positive if the study population was selected before any clinical or radiological 
sign of hip OA was present 
Positive if (sub-) groups were selected at a uniform point of the disease or 
exposure 
2. Positive if the cases and the controls were drawn from the same source 
population (primary study base) 
3. Positive if the participation rate of the cases/population selected and invited to 
participate at baseline was at least 80%  
4. Positive if the controls selected and invited to participate at baseline was at 
least 80% 
5. Positive if at least 7 of the following 12 items were reported at baseline 
- Age (mean and standard deviation) 
- Gender (number and/or percentage) 
- Weight (mean and standard deviation)  
- Body Mass Index (BMI)(mean and standard deviation) 
- Race 
- Job description  
- Sport/leisure time exposure 
- History of trauma 
- Smoking 
- Hormone replacement therapy 
- Signs of OA in other joints (OA objectivated in other joints, Heberden’s 
nodes) 
- Characteristics of OA on X-ray or other imaging techniques 
Assessment of prognostic factors 
6. Positive if the exposure assessment was blinded with respect to disease status 
7. Positive if the exposure was measured in an identical way for the whole studied 
population 
8. Positive if the exposure was assessed prior to the disease outcome 
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Assessment of hip OA 
9. Positive if the way of assessing hip OA was identical for the entire population 
10. Positive if the measurement instruments used for observing or identifying the 
presence of hip OA were reproducible. Positive if (waiting for) a (total) hip 
replacement (THR) was used as an outcome measure for hip OA  
11. Positive if the measurement instruments used for observing or identifying the 
presence of hip OA were standardized using validated definitions. 
Positive if (waiting for) a THR was used as an outcome 
12. Positive if the classification of the radiological osteoarthritis was standardized 
using the Kellgren and Lawrence or the Croft classification 
Positive if the classification of the clinical osteoarthritis was standardized using 
the HAQ or the ACR criteria, the Lequesne or the Womac score. 
Positive if (waiting for) a THR was used 
Study design 
13. Positive if a prospective design was used 
14. Positive if the total follow-up time was ≥ 12 months if radiographic parameters 
were used as an outcome measure. 
Positive if the total follow-up time was ≥ 6 months if clinical parameters were 
used as an outcome measure. 
15. Positive if the total number of withdrawals was ≤ 20% (in case a retrospective 
design was used, a negative score was assigned) 
16. Positive if demographic/clinical information was presented for completers and 
withdrawals (in case of a retrospective design, a negative score was assigned) 
Analysis and data presentation 
17. Positive if frequency or percentage (or mean and standard deviation/CI) of the 
outcome(s) of the risk factor(s) were used  
18. Positive if confounding variables were used in the statistical analysis. (with 
validated techniques such as multivariate regression or Mantel-Haenszel) 
Positive if (sub-) group analysis were made in a heterogeneous population  
Positive if no (sub-) group analysis was made in a homogeneous cohort at 
baseline  
Positive if there was at least corrected for the confounders age and gender by 
means of matching, restriction or adjustment in the analysis
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Bedankt allemaal! 
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Tja, daar kom ik natuurlijk niet mee weg. En zou dat ook niet willen. 
De afgelopen jaren waren een echte joint venture. Mede dankzij velen was het 
een succesvolle en mooie tijd. 
Professor Koes, beste Bart, zelfs de meest slechte manuscripten wist jij te 
voorzien van positief commentaar. Jouw opmerkingen sloegen vaak de spijker op 
de kop en zorgden voor verheldering en duidelijkheid. Mijn dank daarvoor. 
Beste Sita, ik heb veel geleerd van je enorme enthousiasme en fascinatie voor 
wetenschappelijk onderzoek en je expertise op het gebied van artrose (van de 
heup). Het was altijd weer inspirerend om even met je van gedachten te wisselen. 
Bij het uitvoeren van het onderzoek heb je mij een grote mate van zelfstandigheid 
gelaten, waarvoor mijn dank.  
Beste professor Verhaar, hoe druk u het ook had, de manuscripten die ik u 
opstuurde waren altijd ruim op tijd terug, voorzien van praktische opmerkingen. 
Bedankt voor al uw stimulerende commentaar en suggesties.  
Arianne, in onze (maar liefst 5!) systematische reviews heb je mij met gedegen en 
gestructureerd commentaar op het goede spoor weten te zetten. Dank voor je 
adviezen en deskundigheid. 
Arthur Bohnen, je tekstuele, concrete en methodologische commentaren op onze 
artikelen waren altijd vele malen beter dan je tijdsplanning. In het bijzonder dan 
ook bedankt voor het eerste. 
Siep, bedankt voor je “vrijdagmiddagpraatjes”, je nuchtere kijk op dingen en je 
helderheid. Het is fijn dat er iemand aan het roer staat die AIOTO’s belangrijk vindt 
en dat ook met woord en daad kenbaar maakt. 
Roos, naast het genieten van het uitzicht op grote hoogte na het traplopen, gaf jij 
mij naast vele lachmomenten ook inzicht in de soms oh zo complexe statistiek. 
Mijn dank daarvoor. 
Hans v.d. Wouden, bedankt voor al je kundige commentaren en suggesties 
Frits en Herman, bedankt voor voor de (geslaagde!) inzet om de wetenschap te 
combineren met de huisartsopleiding. Olof, bedankt voor al het geregel en de vele 
brandjes die je voor me hebt geblust. 
Laraine Visser-Isles heeft menig manuscript in een waar rood kunstwerk 
omgetoverd tijdens haar correctie van mijn Engels. 
Mede AIOTO’s: Marco (bedankt voor je inspirerende discussies, je tomeloze inzet 
en je steun), Hanneke (op WK 131 hebben we samen de nodige hoogte- en 
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dieptepunten van onze laatste zware loodjes beleefd), Boris (bedankt voor je hulp 
in mijn onderzoek, fijn dat je bent gebleven), Janneke (bedankt voor alle klusjes 
die je hebt gedaan voor me en succes met al je mooie plannen!) en Ümit (onze 
stille kracht). 
Oud collega’s (Christel, Claudia, Lya, Vivian, Petra, Artrid, Max, Jennie, Jaques) 
en huidige collega’s (velen) bedank ik voor hun inspirerende discussies tijdens de 
werkbesprekingen en in de wandelgangen en voor de vele andere leuke en 
inspirerende momenten tijdens het werk. Kamergenote Edith: heel veel succes 
met het afronden van jou deel binnen het enorme Honeur project en bedankt voor 
al je (computer) hulp en de leuke tijd in Stockholm. 
Bijzondere dank gaat natuurlijk uit naar de patiënten die de energie hadden voor 
het invullen van de soms erg lange vragenlijsten. Zonder hun medewerking had ik 
hier niet kunnen staan. 
 
Promotiewerk en een opleiding tot huisarts gaan niet altijd hand in hand. Zonder 
opleiders die hier positief tegenover stonden was me dit nooit gelukt. Herman 
Ferguson: bedankt dat je me de nodige ruimte hebt gegeven en dat je, met jou 
visie op onderzoek binnen de huisartsgeneeskunde, mij een ruimere blik hebt 
gegeven. 
Hans van den Brule: bij jou in de praktijk kreeg ik niet alleen de ruimte voor mijn 
onderzoek, maar ook voor mijn steeds maar dikker wordende buik en de vomitus 
aanvallen die daar bij hoorden. 
Herman de Noo: je relaxte houding, maar vooral ook je interesse in het onderzoek 
heb ik altijd erg gewaardeerd. Onze discussies over sensitiviteit, specificiteit, 
positief en negatief voorspellende waarden zal ik missen! Bedankt ook voor je 
tolerante instelling t.a.v. het kolven en de open bloesjes die daar bij schenen te 
horen. 
Erik de Hoog: jij mag in dit rijtje niet ontbreken. Jij hebt me het huisartsenvak laten 
zien en mede door jou ben ik met de huisartsopleiding begonnen.  
Ook bedank ik alle HAIO’s en de groepsbegeleiders die hebben bijgedragen aan 
de inspirerende (en soms saaie) terugkomdagen. Vooral Martine, Annelies, 
Monique, Leon en Jacomien: ik ben nog steeds trots op ons gezamenlijk artikel! 
Het was een vermoeiend maar leuk project.  
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Mijn ouders. Lieve Ma en Pa. Bedankt voor jullie onvoorwaardelijke steun en 
relativerende stimulatie in alles wat ik doe en gedaan heb. Ma, ik zal niet naast 
mijn schoenen gaan lopen! 
Irma, André en Paul: Dank voor alle feestelijke, lieve en opbeurende momenten. 
Lieve Irma, weinig mensen zijn zo verweven met mijn leven als jij. Bedankt dat je 
er altijd bent! Ook mijn andere broers en zussen (Hans & Inge, Yvon, Luuk en 
Elbert & Inge): de een zie ik wat vaker dan de ander, maar jullie hebben allemaal 
een speciaal plekje in mijn hart. Bedankt dat jullie me laten zien dat er meer is in 
de wereld (op vele fronten…) En Gerrie; de herinneringen aan jou draag ik met 
een warm gevoel mee. 
Mijn schoonfamilie dank ik voor hun betrokkenheid en interesse voor mijn 
onderzoek en mijn opleiding tot huisarts en voor alle discussies over het wel en 
wee van de wereld. 
Mijn vrienden (Pascale & Marcel, Mariëlle & Peter, Guus & Bianca, Natascha, 
Caroline, en Frank & Mandy) en kennissen bedank ik voor alle inspirerende en 
leuke momenten. Ik hoop dat we nog vele mooie herinneringen zullen maken. 
 
Tot slot het allerbelangrijkste: Mijn “thuis”.  
Lieve Arend, zonder jou liefde, stimulatie en interesse was het nooit zover 
gekomen. Maar ook bedankt voor zoveel meer dan dat… 
Lieve Willem, jouw wonder is met niets te vergelijken. Jij bewijst dat iemand tijdens 
een promotie toch iets volmaakts kan voortbrengen. 
Arend en Willem; de wereld met jullie is zoveel mooier. Jullie zijn het beste wat me 
is overkomen. 
  
 
Annet Lievense werd geboren in Goes, op 8 maart 1971, samen met haar 
tweelingbroer Elbert. Met haar twee zussen en drie broers groeide zij op in 
Nieuwerkerk; een klein dorp in de provincie Zeeland. Na het behalen van haar 
VWO diploma aan de Professor Zeemanschool in Zierikzee in 1990, begon ze met 
haar studie geneeskunde aan de Erasmus Universiteit Rotterdam. Tijdens haar 
studie participeerde zij in diverse (landelijke) commissies met als doel het 
verbeteren van het medisch onderwijs. Aansluitend aan het behalen van het 
artsexamen in 1997 werkte zij tot 1999 als arts-assistent chirurgie in het 
Diaconessenhuis in Voorburg. Van 1999 tot 2000 werkte zij op de heelkunde 
intensive care van het Dijkzigt ziekenhuis in Rotterdam. 
Sinds maart 2000 werkt zij op de afdeling huisartsgeneeskunde van het Erasmus 
MC als arts in opleiding tot huisarts en onderzoeker (AIOT(H)O); een 
combinatietraject van de opleiding tot huisarts en de opleiding tot onderzoeker. In 
juli 2003 behaalde zij haar Master of Science in de klinische epidemiologie aan het 
Nederlands Institute for Health Sciences (NIHES). Sinds 4 februari 2005 staat zij 
ingeschreven als huisarts in het huisartsregister.  
Op 11 september 1999 huwde zij met Arend de Weger met wie zij een zoon heeft 
(Willem, 2-4-2004) en met wie zij een tweede kindje verwacht. 
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